
<html lang="en"     class="pb-page"  data-request-id="48911a54-2f2c-4adf-8b23-3b4d1e120f75"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm2008369;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2011.54.issue-23;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor" /></meta><meta name="dc.Creator" content="Nicholas S.  Stock" /></meta><meta name="dc.Creator" content="Gretchen  Bain" /></meta><meta name="dc.Creator" content="Jasmine  Zunic" /></meta><meta name="dc.Creator" content="Yiwei  Li" /></meta><meta name="dc.Creator" content="Jeannie  Ziff" /></meta><meta name="dc.Creator" content="Jeffrey  Roppe" /></meta><meta name="dc.Creator" content="Angelina  Santini" /></meta><meta name="dc.Creator" content="Janice  Darlington" /></meta><meta name="dc.Creator" content="Pat  Prodanovich" /></meta><meta name="dc.Creator" content="Christopher D.  King" /></meta><meta name="dc.Creator" content="Christopher  Baccei" /></meta><meta name="dc.Creator" content="Catherine  Lee" /></meta><meta name="dc.Creator" content="Haojing  Rong" /></meta><meta name="dc.Creator" content="Charles  Chapman" /></meta><meta name="dc.Creator" content="Alex  Broadhead" /></meta><meta name="dc.Creator" content="Dan  Lorrain" /></meta><meta name="dc.Creator" content="Lucia  Correa" /></meta><meta name="dc.Creator" content="John H.  Hutchinson" /></meta><meta name="dc.Creator" content="Jilly F.  Evans" /></meta><meta name="dc.Creator" content="Peppi  Prasit" /></meta><meta name="dc.Description" content="The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11..." /></meta><meta name="Description" content="The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 7, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2008369" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2008369" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2008369" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2008369" /></link>
        
    
    

<title>5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2008369" /></meta><meta property="og:title" content="5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0007.jpeg" /></meta><meta property="og:description" content="The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11cc is described (AM803, now GSK2190915). Building upon AM103 (1) (Hutchinson et al. J. Med Chem.2009, 52, 5803–5815; Stock et al. Bioorg. Med. Chem. Lett. 2010, 20, 213–217; Stock et al. Bioorg. Med. Chem. Lett.2010, 20, 4598–4601), SAR studies centering around the pyridine moiety led to the discovery of compounds that exhibit significantly increased potency in a human whole blood assay measuring LTB4 inhibition with longer drug preincubation times (15 min vs 5 h). Further studies identified 11cc with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood (5 h incubation) and excellent preclinical toxicology and pharmacokinetics in rat and dog. 11cc also demonstrated an extended pharmacodynamic effect in a rodent bronchoalveolar lavage (BAL) model. This compound has successfully completed phase 1 clinical studies in healthy volunteers and is currently undergoing phase 2 trials in asthmatic patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2008369"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2008369">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2008369&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2008369&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2008369&amp;href=/doi/10.1021/jm2008369" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 8013-8029</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200789r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2008634" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+S.++Stock">Nicholas S. Stock</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gretchen++Bain">Gretchen Bain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jasmine++Zunic">Jasmine Zunic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yiwei++Li">Yiwei Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeannie++Ziff">Jeannie Ziff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Roppe">Jeffrey Roppe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelina++Santini">Angelina Santini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janice++Darlington">Janice Darlington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pat++Prodanovich">Pat Prodanovich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+D.++King">Christopher D. King</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Baccei">Christopher Baccei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Lee">Catherine Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haojing++Rong">Haojing Rong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Chapman">Charles Chapman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex++Broadhead">Alex Broadhead</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Lorrain">Dan Lorrain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucia++Correa">Lucia Correa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+H.++Hutchinson">John H. Hutchinson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jilly+F.++Evans">Jilly F. Evans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peppi++Prasit">Peppi Prasit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>†</sup>Chemistry, <sup>‡</sup>Biology, and <sup>§</sup>Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road, Suite 100, San Diego, California 92121, United States</span></div><div class="corresp-info">Phone: 858 224 7715. Fax: 858 224 7795. E-mail: <a href="/cdn-cgi/l/email-protection#84eaf7f0ebe7efc4edeae7e1f4f0edebeaf7e7edaae7ebe9"><span class="__cf_email__" data-cfemail="157b66617a767e557c7b767065617c7a7b66767c3b767a78">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2008369&amp;href=/doi/10.1021%2Fjm2008369" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 8013–8029</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 7, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 June 2011</li><li><span class="item_label"><b>Published</b> online</span>7 November 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 December 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2008369" title="DOI URL">https://doi.org/10.1021/jm2008369</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8013%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicholas%2BS.%2BStock%252C%2BGretchen%2BBain%252C%2BJasmine%2BZunic%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D23%26contentID%3Djm2008369%26title%3D5-Lipoxygenase-Activating%2BProtein%2B%2528FLAP%2529%2BInhibitors.%2BPart%2B4%253A%2BDevelopment%2Bof%2B3-%255B3-tert-Butylsulfanyl-1-%255B4-%25286-ethoxypyridin-3-yl%2529benzyl%255D-5-%25285-methylpyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethylpropionic%2BAcid%2B%2528AM803%2529%252C%2Ba%2BPotent%252C%2BOral%252C%2BOnce%2BDaily%2BFLAP%2BInhibitor%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8029%26publicationDate%3DDecember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2008369"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3116</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2008369" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;S. Stock&quot;},{&quot;first_name&quot;:&quot;Gretchen&quot;,&quot;last_name&quot;:&quot;Bain&quot;},{&quot;first_name&quot;:&quot;Jasmine&quot;,&quot;last_name&quot;:&quot;Zunic&quot;},{&quot;first_name&quot;:&quot;Yiwei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jeannie&quot;,&quot;last_name&quot;:&quot;Ziff&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Roppe&quot;},{&quot;first_name&quot;:&quot;Angelina&quot;,&quot;last_name&quot;:&quot;Santini&quot;},{&quot;first_name&quot;:&quot;Janice&quot;,&quot;last_name&quot;:&quot;Darlington&quot;},{&quot;first_name&quot;:&quot;Pat&quot;,&quot;last_name&quot;:&quot;Prodanovich&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;D. King&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Baccei&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Haojing&quot;,&quot;last_name&quot;:&quot;Rong&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Chapman&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;Broadhead&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Lorrain&quot;},{&quot;first_name&quot;:&quot;Lucia&quot;,&quot;last_name&quot;:&quot;Correa&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;H. Hutchinson&quot;},{&quot;first_name&quot;:&quot;Jilly&quot;,&quot;last_name&quot;:&quot;F. Evans&quot;},{&quot;first_name&quot;:&quot;Peppi&quot;,&quot;last_name&quot;:&quot;Prasit&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;8013-8029&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2008369&quot;},&quot;abstract&quot;:&quot;The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11cc is described (AM803, now GSK2190915). Building upon AM103 (1) (Hutchinson et al. J. Med Chem.2009, 52, 5803–5815; Stock et al. Bioorg. Med. Chem. Lett. 2010, 20, 213–217; Stock et al. Bioorg. Med. Chem. Lett.2010, 20, 4598–4601), SAR studies centering around the pyridine moiety led to the discovery of compounds that exhibit significantly increased potency in a human whole blood assay measuring LTB4 inhibition with longer drug preincubation times (15 min vs 5 h). Further studies identified 11cc with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood (5 h incubation) and excellent preclinical toxicology and pharmacokinetics in rat and dog. 11cc also demonstrated an extended pharmacodynamic effect in a rodent bronchoalveolar lavage (BAL) model. This compound has successfully &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2008369&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2008369" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2008369&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2008369" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2008369&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2008369" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2008369&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2008369&amp;href=/doi/10.1021/jm2008369" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2008369" /></input><a href="/doi/pdf/10.1021/jm2008369" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (610 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2008369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2008369%26sid%3Dliteratum%253Aachs%26pmid%3D22059882%26genre%3Darticle%26aulast%3DStock%26date%3D2011%26atitle%3D5-Lipoxygenase-Activating%2BProtein%2B%2528FLAP%2529%2BInhibitors.%2BPart%2B4%253A%2BDevelopment%2Bof%2B3-%255B3-tert-Butylsulfanyl-1-%255B4-%25286-ethoxypyridin-3-yl%2529benzyl%255D-5-%25285-methylpyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethylpropionic%2BAcid%2B%2528AM803%2529%252C%2Ba%2BPotent%252C%2BOral%252C%2BOnce%2BDaily%2BFLAP%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D23%26spage%3D8013%26epage%3D8029%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jmcmar.2011.54.issue-23/production/jmcmar.2011.54.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-<i>tert</i>-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid <b>11cc</b> is described (AM803, now GSK2190915). Building upon AM103 (<b>1</b>) (Hutchinson et al. <i>J. Med Chem.</i><b>2009</b>, <i>52</i>, 5803–5815; Stock et al. <i>Bioorg. Med. Chem. Lett</i>. <b>2010</b>, <i>20</i>, 213–217; Stock et al. <i>Bioorg. Med. Chem. Lett.</i><b>2010</b>, <i>20</i>, 4598–4601), SAR studies centering around the pyridine moiety led to the discovery of compounds that exhibit significantly increased potency in a human whole blood assay measuring LTB<sub>4</sub> inhibition with longer drug preincubation times (15 min vs 5 h). Further studies identified <b>11cc</b> with a potency of 2.9 nM in FLAP binding, an IC<sub>50</sub> of 76 nM for inhibition of LTB<sub>4</sub> in human blood (5 h incubation) and excellent preclinical toxicology and pharmacokinetics in rat and dog. <b>11cc</b> also demonstrated an extended pharmacodynamic effect in a rodent bronchoalveolar lavage (BAL) model. This compound has successfully completed phase 1 clinical studies in healthy volunteers and is currently undergoing phase 2 trials in asthmatic patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The leukotrienes (LTs) are a family of eicosanoid bioactive lipids implicated in a variety of pathophysiological states such as asthma, allergic rhinitis, and atherosclerosis. Biosynthesis of leukotrienes is initiated through an immune, allergic, or inflammatory stimulus.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> They are derived from arachidonic acid (AA) through the concerted action of the enzyme 5-lipoxygenase (5-LO) with 5-lipoxygenase activating protein (FLAP), initially converting AA to (5S,6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (5-HpETE, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Subsequent dehydration of 5-HpETE yields leukotriene A<sub>4</sub> (LTA<sub>4</sub>), an unstable epoxide that is transformed to either leukotriene B<sub>4</sub> (LTB<sub>4</sub>) by the enzyme LTA<sub>4</sub> hydrolase or leukotriene C<sub>4</sub> (LTC<sub>4</sub>) via conjugation of glutathione by LTC<sub>4</sub> synthase. 5-HpETE can alternatively be converted to 5-oxo-ETE, a potent human chemoattractant for eosinophils, immune cells that play important roles in a variety of diseases including asthma and cardiovascular disease (CVD).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> LTC<sub>4</sub> is further metabolized to leukotriene D<sub>4</sub> (LTD<sub>4</sub>) and leukotriene E<sub>4</sub> (LTE<sub>4</sub>) through sequential amide bond cleavages, and collectively these three molecules are known as the cysteinyl leukotrienes (CysLTs) or historically as the slow-reacting substance of anaphylaxis (SRS-A). The biological effects of the LTs arise through binding to their respective G-protein-coupled receptors (GPCRs).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> LTB<sub>4</sub> binds to two distinct GPCRs, namely, BLT<sub>1</sub> and BLT<sub>2</sub>, resulting in neutrophil and eosinophil chemotaxis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The CysLTs activate at least two well-defined GPCRs, namely, CysLT<sub>1</sub><a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and CysLT<sub>2</sub>,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the activation of the former leading to contraction of smooth muscle (bronchoconstriction), edema, eosinophil migration, and mucus secretion. The precise role of the CysLT<sub>2</sub> receptor remains unclear, but mice deficient in this receptor indicate a role for CysLT<sub>2</sub> in vascular permeability and inflammation<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and its expression in myocytes, fibroblasts, and vascular smooth muscle cells may point to a function within the cardiovascular system.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Recent evidence also points to the existence of other receptors that may preferentially bind CysLTs, namely, GPR17,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> P2Y<sub>12</sub>,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and a putative CysLT<sub>E</sub> receptor.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Leukotriene biosynthesis pathway and associated GPCRs (in italics).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Chemical interference in the LT pathway is not a novel concept, as both a 5-LO inhibitor (zileuton, <b>3</b>) and CysLT<sub>1</sub> receptor antagonists (e.g., montelukast, <b>2</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) are currently marketed for the treatment of asthma. Direct 5-LO inhibition has been an active research area for several decades, and only the iron chelator (redox inhibitor) <b>3</b> is used clinically, with no nonredox inhibitors currently on the market. However, <b>3</b> is not widely prescribed for asthma because of a high dose regimen (600 mg q.i.d. or 1200 mg b.i.d.), low but significant hepatotoxicity, and subsequent need for liver function testing.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><b>2</b>, a CysLT<sub>1</sub> receptor antagonist, is widely prescribed to asthmatics because of its efficacy, excellent safety profile, and low dosing requirements (10 mg q.d.). CysLT<sub>1</sub> antagonism obviously only blocks the action of this receptor and does not perturb the biosynthesis or pathophysiological action of the other LTs. Several clinical trials have evaluated FLAP inhibitors (DG-031/BAY X1005 <b>4</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> MK-886 <b>5</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> MK-591 <b>6</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>) in human and shown them to be effective. For various reasons, none of these compounds have reached the market. Development of compounds <b>4</b> and <b>5</b> was likely halted because of incomplete LT synthesis inhibition at clinically tolerable doses, and compound <b>6</b> was halted after phase 2 trials in favor of the LTD<sub>4</sub> receptor antagonist <b>2</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of leukotriene pathway inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significant evidence also points to the potential for LT inhibitors to have a positive impact on CVD. Genetic data implicate polymorphic variants in the ALOX5AP (FLAP) gene that predispose these individuals to an increased risk of myocardial infarction and stroke (deCODE study).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This genetic correlation has now been confirmed in several other populations<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and more recently associated with an increased risk for coronary arterial disease in a European–American population.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A murine 5LO-knockout model of CVD also supports the rationale for LT inhibition in this disease setting, as these mice were protected against the development of atherosclerotic lesions when fed a high fat, high cholesterol diet.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Inhibition of the FLAP protein by <b>5</b> has also been shown to reduce atherosclerosis in an apoE/LDLR-double knockout mouse model.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Of more significance is the observation that in humans, the 5-LO inhibitor <b>7</b> (VIA-2291, formerly known as ABT-761) reduces biomarkers of CVD and shows statistically significant reduction in the rate of plaque volume growth in patients with acute coronary syndrome.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The FLAP inhibitor <b>4</b> has also been shown to reduce biomarkers in a CVD setting in a phase 2b study.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">The significant animal and human data implicating leukotrienes in various disease states prompted us to reassess the potential of FLAP inhibitors as an anti-inflammatory treatment paradigm. Safe and potent inhibitors of FLAP would prevent the biosynthesis of all LTs and may provide an improved therapy for respiratory diseases and potentially CVD. In this paper we detail the design of 3-[3-<i>tert</i>-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid <b>11cc</b> (AM803, now GSK2190915), a potent derivative of our recently disclosed FLAP inhibitor AM103 <b>1</b>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A key part in the discovery of <b>11cc</b> was the finding that certain compounds exhibit a heretofore unknown time-dependent increase in potency when assayed for LTB<sub>4</sub> inhibition in a human blood assay (hWB). We herein discuss our findings, the SAR around this time-dependent phenomenon, and the ultimate identification of <b>11cc</b> as a once a day, orally bioavailable FLAP inhibitor that has successfully finished phase 1 clinical trials and is currently in phase 2 trials in asthmatic patients.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds prepared in this study were synthesized predominantly through two synthetic routes, A and B, as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, and the resulting product structures are given in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> along with the route employed. Route A involves alkylation of the phenol of the previously reported indole <b>8</b><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> with the appropriate electrophile, using Cs<sub>2</sub>CO<sub>3</sub> as base, yielding the indoles <b>9</b>. Conversion of these aryl bromides to the pinacol boronate esters <b>10</b> was achieved using standard conditions (Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, bis(pinacolato)diboron, <i>p</i>-dioxane, heat). This boronate served as a robust handle to cross-couple a variety of heteroaryl halides under Suzuki coupling conditions (Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O). Hydrolysis of the hindered geminal dimethyl ester using LiOH in MeOH/THF/H<sub>2</sub>O yielded the desired carboxylic acids <b>11</b>. Route B reverses the order of steps by converting the indole <b>8</b> to the boronate derivative <b>12</b> and cross-coupling with the appropriate heteroaryl halide to generate compounds <b>13</b>. Alkylation of these phenols using Cs<sub>2</sub>CO<sub>3</sub> as base and the requisite electrophiles and subsequent ester hydrolysis afforded the target compounds <b>11</b>. The commercially unavailable alkylating reagents were prepared as follows (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The pyrazinyl and quinoxalinyl chlorides <b>14</b> and <b>15</b> were synthesized using standard radical chlorination conditions (NCS with 2,5-dimethylpyrazine or trichloroisocyanuric acid with 2-methylquinoxaline, respectively).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The symmetrical 2,5-dimethylpyrazine gave a mixture of monochlorides and bis-chlorides that were readily separable by column chromatography. The 2-chloromethyl alkyl substituted pyridines (<b>16a</b>–<b>d</b>,<b>f</b>) and 2-chloromethyl-6-methylquinoline <b>17</b> hydrochlorides were prepared through synthesis of the <i>N</i>-oxide (<i>m-</i>CPBA), rearrangement of the <i>N</i>-oxide under refluxing acetic anhydride conditions to furnish the pyridine methylacetate, hydrolysis with concentrated hydrochloric acid, and reaction of the resulting alcohols with thionyl chloride to give the desired chloromethyl pyridines/quinoline as the HCl salt. Pyridine <b>16d</b> was obtained from reaction of the commercially available 6-hydroxymethyl-2-methylpyridine with thionyl chloride. The pyridine <i>N</i>-oxide <b>16g</b> was synthesized through <i>m</i>-CPBA oxidation of the pyridine <b>16c</b>. 5-Methoxy-2-methylpyridine, prepared from the corresponding phenol by reaction with TMSN<sub>2</sub>, was brominated using NBS and benzoyl peroxide in refluxing benzene to afford bromide <b>18</b>. Similar bromination conditions were used to provide the 5-cyano-2-bromomethylpyridine <b>19</b> and the 6- and 7-fluoroquinoline derivatives <b>20</b> and <b>21</b>. Heterocycles <b>22</b>–<b>25</b> were prepared from the commercially available alcohols using refluxing thionyl chloride. 5,6-Dimethyl-2-chloromethylpyridine hydrochloride <b>26</b> was prepared from 2,3-lutidine through conversion to the <i>N</i>-oxide (<i>m</i>-CPBA) and then rearrangement to 2-cyano-5,6-dimethylpyridine (TMSCN, diethylcarboamoyl chloride). Acidic methanolysis of the resulting nitrile to the methyl ester, reduction of the ester with DIBAl-H under standard conditions, and treatment of the alcohol with thionyl chloride afforded <b>26</b>. 5-Chloro-2-chloromethylpyridine <b>27</b> was derived from borane reduction of 5-chloropyridine-2-carboxylic acid and conversion of the resulting alcohol to the chloride using thionyl chloride. Finally, the Boc-protected indole <b>28</b> was synthesized from 1<i>H</i>-indole-2-carboxylic acid ethyl ester via reaction with Boc anhydride under standard conditions (DMAP, MeCN), reduction of the ester with DIBAl-H, and conversion of the resulting alcohol to the corresponding halide using a mixture of LiBr and MsCl in dichloromethane.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The mixture of products from this halide displacement was used without further purification in the subsequent alkylation of the indole phenol <b>8</b>. The Boc-protecting group was also removed during hydrolysis of the ester (route A) to give the indole compound <b>11g</b>. As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, the racemic sulfoxide <b>29</b> was prepared via oxidation of <b>11cc</b> with 1 equiv of <i>m</i>-CPBA. The acyl derivatives <b>31a</b>,<b>b</b> were prepared through removal of the <i>tert</i>-butylthio group with AlCl<sub>3</sub> and water<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> to give the 3<i>H</i> indole <b>30</b> and subsequent Friedel–Crafts like acylation with AlCl<sub>3</sub> and the relevant acid chloride in 1,2-dichloroethane and then ester hydrolysis. The pyridone <b>11jj</b> was isolated after prolonged reaction of the sodium salt of <b>11cc</b> in ethylene glycol with excess lithium hydroxide at 165 °C. The amide compound <b>11q</b> was the result of concomitant hydrolysis of the precursor nitrile (compound <b>19</b> used in the alkylation of the phenol <b>3</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) upon synthesis of the final carboxylic acid. Finally, the methoxypyrimidine derivative <b>11kk</b> was obtained from an S<sub>N</sub>Ar reaction. After cross-coupling of 2-chloro-5-fluoropyrimidine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, route B) and alkylation of the phenol with 2-chloromethyl-5-methylpyridine, methanol displaced the aromatic fluoride under the hydrolysis reaction conditions to afford the methoxypyrimidine <b>11kk</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>CH<sub>2</sub>Br (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), Cs<sub>2</sub>CO<sub>3</sub>, MeCN or DMF, room temp to 60 °C; (b) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (cat.), bis(pinacolato)diboron, KOAc, <i>p</i>-dioxane, 85 °C; (c) heteroaryl-X, Pd(PPh<sub>3</sub>)<sub>4</sub> (cat.), DME/H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 80–85 °C; (d) LiOH·H<sub>2</sub>O, THF, H<sub>2</sub>O, MeOH, 60 °C.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Alkylating Agents<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Chlorosuccinimide, C<sub>6</sub>H<sub>6</sub>, (PhCO)<sub>2</sub>, reflux; (b) trichloroisocyanuric acid, CHCl<sub>3</sub>, reflux; (c) <i>m</i>-CPBA, CHCl<sub>3</sub>; (d) Ac<sub>2</sub>O, 100 °C to reflux; (e) HCl (conc), reflux; (f) SOCl<sub>2</sub>, reflux; (g) <i>N</i>-bromosuccinimide, C<sub>6</sub>H<sub>6</sub>, (PhCO)<sub>2</sub>, reflux; (h) TMSCH<sub>2</sub>N<sub>2</sub>, toluene, MeOH; (i) TMSCN, Et<sub>2</sub>NC(O)Cl, CH<sub>2</sub>Cl<sub>2</sub>; (j) HCl (g), MeOH; (k) DIBAl-H, THF, −78 °C; (l) BH<sub>3</sub>·THF, THF, 0 °C; (m) Boc<sub>2</sub>O, DMAP, MeCN; (n) DIBAl-H, toluene, −40 °C; (o) LiBr, CH<sub>3</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. SAR at 3-Position of the Indole and Preparation of Pyridinone <b>11jj</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) LiOH·H<sub>2</sub>O, MeOH, THF, H<sub>2</sub>O, 60 °C; (b) <i>m</i>-CPBA (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, −20 to 0 °C; (c) AlCl<sub>3</sub>, H<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to room temp; (d) RC(O)Cl, AlCl<sub>3</sub>, DCE, 65 °C; (e) 1 N NaOH, EtOH; (f) LiOH·H<sub>2</sub>O, ethylene glycol, 165 °C.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Results of FLAP Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">NA, not applicable. ND, not determined. Values shown are ±standard deviation.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">FLAP inhibition of <sup>3</sup>H-ligand binding to FLAP membranes.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">hLA: inhibition of LTB<sub>4</sub> synthesis following ionophore (A23187) challenge in human leukocytes.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">hWB: inhibition of LTB<sub>4</sub> synthesis following ionophore challenge (A23187) in human blood after either 15 min or 5 h of preincubation of target compound.</p></div></div><div></div></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">All compounds were assayed in a FLAP binding assay using membranes prepared from human polymorphonuclear cells following a previously described protocol with minor modifications.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The ligand used was tritiated 3-[5-(pyrid-2-ylmethoxy)-3-<i>tert</i>-butylthio-1-benzylindol-2-yl]-2,2-dimethylpropionic acid (American Radiolabeled Chemicals, St. Louis, MO). Compounds were also screened in a cell-based human leukocyte assay (hLA) to measure the inhibition of LTB<sub>4</sub> production following calcium ionophore (A23187) challenge. To investigate the effect of blood protein binding on potency, compounds were tested in a human whole blood (hWB) or rat whole blood (rWB) assay to measure the inhibition of LTB<sub>4</sub> production following A23187 challenge (15 min or 5 h of compound preincubation).<a onclick="showRef(event, 'cit17a'); return false;" href="javascript:void(0);" class="ref cit17a">(17a)</a> Selected compounds were screened for inhibition of thromboxane B<sub>2</sub> synthesis in a human whole blood cyclooxygenase-1 assay (COX-1, 15 min of preincubation; see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During our research to identify a backup compound to the recently disclosed FLAP inhibitor <b>1</b>, we observed that in a rat bronchoalveolar lavage (BAL) LT inhibition assay compound <b>6</b> showed complete inhibition of LTB<sub>4</sub> and CysLTs in vivo 16 h after oral dosing. The measured plasma concentration (10 nM) at 16 h was significantly below its rat whole blood assay (rWB) potency against LTB<sub>4</sub> inhibition (IC<sub>50</sub> = 117 nM, 15 min assay preincubation). The apparent discrepancy between the measured LT inhibition and the in vitro potency of <b>6</b> in the rWB assay led us to repeat this assay with an extended compound preincubation time (4 h). Interestingly, when compound <b>6</b> was repeated in the rWB assay with this 4 h preincubation, the IC<sub>50</sub> had significantly decreased to 10 nM, a value more closely aligned with the in vivo potency observed in the rat BAL model. This indicated that the previous 15 min preincubation protocol did not permit the full potency of this class of FLAP inhibitors to be observed in blood. We had also previously screened and optimized compound selection using the hWB assay at 15 min preincubation times to ascertain their potency in the presence of human blood proteins. Therefore, we reanalyzed compounds in human blood with an extended compound preincubation time and identified certain compounds that gave significantly higher inhibitory potencies after these prolonged assay conditions. A time course analysis of both compounds <b>5</b> and <b>6</b> (15 min, 5 h, and 11 h) in the hWB assay indicated that near maximal inhibition occurred after 5 h of preincubation in human blood (hWB data for <b>5</b>, 15 min IC<sub>50</sub> = 1.4 μM, 5 h IC<sub>50</sub> = 1.1 μM, 11 h IC<sub>50</sub> = 1.0 μM; hWB data for <b>6</b>, 15 min IC<sub>50</sub> = 536 nM, 5 h IC<sub>50</sub> = 95 nM, 11 h IC<sub>50</sub> = 80 nM). For screening purposes the 5 h time point (5 h hWB) was chosen as the routine extended preincubation time. This time-dependent increase in potency represents a previously unrecognized property that has important implications for the design and selection of FLAP inhibitors suitable for clinical development. Furthermore, this phenomenon appears selective for this particular series of FLAP inhibitors, as compound <b>3</b> showed no such improvement in LT synthesis inhibition in hWB after prolonged incubation (15 min hWB IC<sub>50</sub> = 2.2 ± 1.2 μM (<i>n</i> = 3), 5 h hWB IC<sub>50</sub> = 4.2 ± 2.4 μM (<i>n</i> = 3).</div><div class="NLM_p">As discussed in our previous paper,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> both <b>1</b> (15 min hWB IC<sub>50</sub> = 349 nM) and <b>6</b> (15 min hWB IC<sub>50</sub> = 536 nM) are potent FLAP inhibitors, the latter of which has demonstrated efficacy in human trials for asthma.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Replacement of the chlorobenzyl substituent of <b>6</b> with a 2-methoxy-5-pyridyl moiety was part of the strategy in the identification of <b>1</b> to address some of the perceived liabilities of <b>6</b>. Keeping the methoxypyridine component constant (R<sup>2</sup> = 5-methoxypyridin-2-yl, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, compound <b>11</b>), we prepared a small, focused series of compounds, varying R<sup>1</sup> with aromatic groups including quinoline or similar aromatic bicycles (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All compounds were assayed in a human FLAP membrane binding assay to ascertain their intrinsic potency and in a cell-based LTB<sub>4</sub> inhibition assay (hLA). Compounds were further profiled in a 15 min LTB<sub>4</sub> inhibition assay (hWB) to measure the inhibition of FLAP in the presence of human blood. Inhibitors that showed good activity in the hWB assay (15 min hWB IC<sub>50</sub> < 1 μM) were further profiled using a 5 h compound preincubation period to determine if the blood LT inhibition potency increases over time. As can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, we identified several quinoline replacement groups that showed good potency in all three assays. Of particular note is the observation that compounds <b>6</b>, <b>11a</b>, and <b>11c</b> show an increase in hWB potency upon extended preincubation in this assay (<b>6</b>, 15 min IC<sub>50</sub> = 554 nM, 5 h IC<sub>50</sub> = 108 nM; <b>11a</b>, 15 min IC<sub>50</sub> = 502 nM, 5 h IC<sub>50</sub> = 194 nM). The quinoxinyl derivative <b>11b</b> possesses a similar in vitro profile, but the presence of a nitrogen at the 4-position apparently prevents this time dependent potency enhancement (15 min IC<sub>50</sub> = 542 nM, 5 h IC<sub>50</sub> = 486 nM), despite excellent cell-based hLA LTB<sub>4</sub> inhibition and FLAP binding IC<sub>50</sub> (0.7 and 11.4 nM, respectively). The 6-fluoro derivative <b>11c</b> shows good hLA activity, FLAP binding, and 15 min hWB LTB<sub>4</sub> inhibition and improves in potency by approximately 2-fold after extended preincubation in hWB. The 7-fluoroquinoline <b>11d</b> exhibits an unexpected dramatic loss of affinity in FLAP binding, presumably due to an unfavorable electronic effect. The 6-methylquinoline derivative <b>11e</b> also shows marked decrease in binding affinity for the FLAP protein and concomitant reduction in hWB potency. Subsequent to the completion of this work, X-ray crystal data of the FLAP protein were published indicating a restricted binding pocket for the quinoline moiety of <b>1</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This correlates well with our findings that the steric nature of the quinoline group alters activity against FLAP (e.g., compounds <b>11d</b> and <b>11e</b>). Replacement of the quinoline with the more basic imidazopyridine <b>11f</b> retained potency in both FLAP binding and leukocyte LTB<sub>4</sub> inhibition assays, but the extended preincubation hWB potency proved modest (15 min IC<sub>50</sub> = 980 nM, 5 h IC<sub>50</sub> = 552 nM). Replacement with an indole, compound <b>11g</b>, led to a significant decrease in potency in all three assays. With the knowledge that a pyridine replacement for the quinoline maintained high affinity for FLAP (compound <b>1</b>) we prepared a series of substituted pyridine derivatives in an attempt to probe the SAR around this group and find compounds that exhibited the same time dependent increase in potency in the hWB assay as demonstrated by <b>6</b>, <b>11a</b>, and <b>11c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). A scan of methyl groups around the pyridine moiety (<b>11h</b>, <b>11i</b>, <b>11j</b>, and <b>11k</b>) showed that the 5- and 6-methyl derivatives (<b>11j</b> and <b>11k)</b> kept intrinsic potency comparable to that of <b>1</b>, but only the 5-methyl derivative <b>11j</b> showed a significant increase in potency in the 5 h hWB assay (15 min IC<sub>50</sub> = 328 nM, 5 h IC<sub>50</sub> = 87 nM for <b>11j</b> vs 15 min IC<sub>50</sub> = 349 nM to 5 h IC<sub>50</sub> = 149 nM for <b>1</b>). Surprisingly, the 5-ethyl derivative <b>11l</b> did not show any increase in potency in blood, presumably because of the steric difference between methyl and ethyl groups, albeit small, highlighting that a subtle difference could have a significant impact on the extended preincubation enhancement in hWB. Combining the 5-methyl group with another methyl substituent as in compounds <b>11m</b> and <b>11n</b> showed no advantage, the 3,5-dimethyl analogue <b>11m</b> possessing intrinsically poorer potency in all assays and the 5,6-dimethyl compound <b>11n</b> exhibiting a weaker 5 h hWB IC<sub>50</sub> (225 nm) compared to <b>11j</b>. On the basis of the 5-methylpyridine imparting a favorable impact on hWB potency, several more 5-substituted analogues were examined. The 5-chloropyridine <b>11o</b> loses some affinity for FLAP and hence shows less inhibition of LTB<sub>4</sub> in the hWB assay, and the carboxamide <b>11q</b> suffers a dramatic loss in activity. However, the 5-methoxy derivative <b>11p</b> retained intrinsic hLA and FLAP binding activity but did not demonstrate any time-dependent increase in the 5 h hWB assay, a result similar to that observed with the 5-ethylpyridyl compound <b>11l</b>. The pyrazinyl derivative <b>11r</b>, like the quinoxinyl compound <b>11c</b>, again exemplified that although heterocycles incorporating a nitrogen at the 4-position are well tolerated in hLA and FLAP binding, they also show no significant change in potency with extended preincubation in the hWB assay. Attempts to mimic the 5-methylpyridine with other small heterocycles yielded significantly less potent compounds (<b>11s</b>, <b>11t</b>, and <b>11u</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Results of FLAP Inhibitors: Pyridine Replacement SAR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0001.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0002.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">NA, not applicable. ND, not determined. Values shown are ±standard deviation.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">FLAP inhibition of <sup>3</sup>H-ligand binding to FLAP membranes.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">hLA: inhibition of LTB<sub>4</sub> synthesis following ionophore (A23187) challenge in human leukocytes.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">hWB: inhibition of LTB<sub>4</sub> synthesis following ionophore challenge (A23187) in human blood after either 15 min or 5 h of preincubation of target compound.</p></div></div><div></div></div><div class="NLM_p">After identification of the 5-methylpyridine as a moiety that conferred significant potency in the 5 h hWB assay, continued SAR studies, primarily through modification of the indole <i>N</i>-benzyl substituent, addressed off-target activities and pharmacokinetic properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Apart from 5-LO and FLAP, several other enzyme systems utilize AA as their substrate, including the cyclooxygenase (COX) enzymes. Therefore, we counterscreened compounds of interest against COX-1 in a human blood thromboxane inhibition assay. We were surprised to discover that heteroaryl rings on the biaryl possessing a meta-substituent (<b>11v</b>, <b>11x</b>, <b>11bb</b>, <b>11dd</b>, <b>11gg</b>) or pseudo-meta in the case of the ethoxythiazole <b>11y</b> showed significant affinity for the COX-1 enzyme, with one compound, <b>11dd</b>, possessing considerable potency (IC<sub>50</sub> = 615 nM) in the COX-1 whole blood assay. The unsubstituted pyridines <b>11hh</b> and <b>11ii</b> also conferred some affinity for the COX-1 enzyme. Compounds bearing a para-substitutent on the terminal biphenyl ring (<b>11cc</b>, <b>11ee</b>, <b>11ff</b>, <b>11kk</b>) show low affinity for COX-1. The pyridinone derivative <b>11jj</b> is an example of a very polar biaryl functionality appended to the indole. This proved detrimental to inhibition of LTB<sub>4</sub> in the leukocyte assay but retained affinity for FLAP (binding IC<sub>50</sub> = 8.3 nM) and also shows the most significant improvement with extended preincubation in the hWB assay (15 min IC<sub>50</sub> = 10028 nM to 5 h IC<sub>50</sub> = 1279 nM ∼ 8-fold increase). However, this compound was not potent enough to warrant further investigation. To check for a potential time-dependent increase in potency against the COX-1 enzyme, we assayed compound <b>11j</b>, a compound that shows an increase in LT synthesis inhibition over time in hWB, in the COX-1 assay with both a 15 min and 5 h preincubation. Importantly, no increase in potency against COX-1 was measured over time (hWB COX-1, 15 min IC<sub>50</sub> = 12.3 μM, 5 h IC<sub>50</sub> = 17.3 μM). Manipulation of the 3-position of the indole core via removal of the <i>tert</i>-butylthio group of <b>11cc</b> significantly attenuates the binding to FLAP and potency in blood (compound <b>29</b>). Oxidation to the racemic sulfoxides <b>30</b> and the pyridine <i>N</i>-oxide (<b>11ll</b>) also significantly reduces affinity for the FLAP protein (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Appreciable activity could be returned to the scaffold through introduction of the <i>tert</i>-butylacetyl group at C3 of the indole, compound <b>31a</b>, and this was the most potent of these derivatives prepared. However, despite the presence of the 5-methylpyridine, no significant increase in hWB potency was observed in the 5 h preincubation assay for <b>31a</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Results of FLAP Inhibitors: SAR of Benzylic Biphenyl and COX-1 Counterscreen<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0003.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0004.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">ND, not determined. Values shown are ±standard deviation.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">FLAP inhibition of <sup>3</sup>H-ligand binding to FLAP membranes.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">hLA: inhibition of LTB<sub>4</sub> synthesis following ionophore (A23187) challenge in human leukocytes.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">hWB: inhibition of LTB<sub>4</sub> synthesis following ionophore challenge (A23187) in human blood after either 15 min or 5 h of preincubation of target compound.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Inhibition of TXB2 in human whole blood presented as either percent inhibition at 10 μM or IC<sub>50</sub>.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Results of FLAP Inhibitors: Modification of 3-Indole Position<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0005.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0006.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">ND, not determined. Values shown are ±standard deviation. Values in parentheses are the results of one experiment with two different donors.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">FLAP inhibition of <sup>3</sup>H-ligand binding to FLAP membranes.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">hLA: inhibition of LTB<sub>4</sub> synthesis following ionophore (A23187) challenge in human leukocytes.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">hWB: inhibition of LTB<sub>4</sub> synthesis following ionophore challenge (A23187) in human blood after either 15 min or 5 h of preincubation of target compound.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Investigation of Time Dependent Increase in Potency of FLAP Inhibitors</h3><div class="NLM_p">Having identified the structural motifs responsible for imparting improved 5 h potency in the hWB assay, we attempted to determine the physical basis for this phenomenon. Our initial hypothesis was that compounds exhibiting a potency shift between the 15 min and 5 h hWB time points may reflect an intrinsic difference in the on-rate or off-rate of the compound to the FLAP protein itself. However, after preparing radiolabeled (<sup>3</sup>H) versions of compounds <b>1</b> and <b>11a</b>, we determined that both compounds display fast on- and off-rates with no significant difference in on- or off-rates between compounds that demonstrate improved potency over time and those that do not (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). By employment of the hLA assay, in the absence of added human serum albumin (hSA) to the assay buffer, no potency increase was apparent between a 5 min and 1 h preincubation time for any of the compounds tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). However, addition of 0.5% hSA to the assay buffer resulted in a measurable shift in potency between a 10 min and 3 h preincubation time. These data indicate an equilibrium shift between compounds binding hSA and the target, FLAP. All of the compounds measured in these studies are highly lipophilic carboxylic acids and as such possess a very large degree of protein binding (≥99.5%, individual data not shown). Consequently, the time dependent increase in potency of this class of FLAP inhibitors in hWB might reflect subtle differences in the degree of protein binding that cannot be distinguished using conventional protein binding assays. Additionally, the time-dependent inhibition may also reflect differences in the off-rate from serum albumin. However, this does not fully explain the observed 5 h hWB differences between compounds such as <b>11z</b>, <b>11aa</b>, and <b>11cc</b>, for example. All three possess almost identical in vitro potencies in FLAP binding, hLA, and 15 min hWB, but <b>11cc</b> is twice as potent after 5 h of incubation in hWB. By analogy to the reported X-ray crystal structure for FLAP with compound <b>6</b> bound,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the differences between these three compounds were not anticipated to impart much variation in potency because of the biaryl portion of the molecule being directed away from the target protein and into the membrane space. The fact that <b>11cc</b> is the significantly more potent of the three compounds in 5 h hWB may be due to other, as yet undetermined factors or that, for certain compounds (e.g., <b>11z</b> and <b>11aa</b>), a 5 h preincubation in the hWB assay may still not be a fully equilibrated situation. We recently reported on a similar potency enhancement in our research on prostaglandin D<sub>2</sub> receptor (DP<sub>2</sub>) antagonists using an eosinophil shape change assay in human blood with extended compound preincubation.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. On-rates and off-rates for radiolabeled compounds <b>1</b> and <b>11a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Human Leukocyte Assay (hLA) IC<sub>50</sub> after Varying Preincubation Time in the Presence or Absence of 0.5% hSA<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">no hSA (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">0.5% hSA (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">5 min</th><th class="colsep0 rowsep0" align="center" char=".">1 h</th><th class="colsep0 rowsep0" align="center" char=".">10 min</th><th class="colsep0 rowsep0" align="center" char=".">3 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11cc</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">hLA: inhibition of LTB<sub>4</sub> synthesis following ionophore (A23187) challenge in human leukocytes resuspended in assay buffer either lacking (no hSA) or containing 0.5% hSA. hSA = human serum albumin.</p></div></div></div><div class="NLM_p">As part of our drug discovery effort, compounds are screened against the common human cytochrome P450 (hCYP) enzymes 3A4, 2C9, and 2D6 to minimize the possibility of drug–drug interactions or drug concentration variations upon long-term dosing. Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> shows the hCYP inhibition data for the four most potent compounds in the 5 h hWB assay: <b>11cc</b>, <b>11ee</b>, <b>11ff</b>, <b>11kk</b>. In general they show modest inhibition toward the hCYP isoforms tested, the fluoropyridine <b>11ff</b> showing the most activity against 2C9 with an IC<sub>50</sub> of 1.5 μM. Of particular note was compound <b>11cc</b>, which was essentially inactive against all three of the enzymes listed at the highest concentration tested (50 μM).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. CYP Inhibition Parameters for Four Most Potent FLAP Inhibitors (5 h hWB)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">CYP inhibition IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2D6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11cc</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ee</b></td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ff</b></td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11kk</b></td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Inhibition assays were performed in a manner similar to those published.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> All positive control inhibitors were within their published IC<sub>50</sub> values.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Further Profiling of <b>11cc</b> (AM803)</h3><div class="NLM_p">Compound <b>11cc</b>, 3-[3-<i>tert</i>-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid, was selected for further profiling because of its excellent in vitro potency against LTB<sub>4</sub> inhibition in the 5 h hWB assay, inactivity against the three major human CYP isoforms, and no COX-1 cross-reactivity. Additionally, it showed no induction or time-dependent inhibition of the CYP3A4 enzyme (measured at 10 μM; 0.01 min<sup>–1</sup> vs 0.054 min<sup>–1</sup> for troleandomycin control) and no inhibition of the CYP2C19, 2D6, and 1A2 enzymes (IC<sub>50</sub> > 40 μM). Furthermore, <b>11cc</b> showed very little activity toward other enzymes in the leukotriene pathway (LTA<sub>4</sub> hydrolase IC<sub>50</sub> > 100 μM, LTC<sub>4</sub> synthase IC<sub>50</sub> = 36 μM, 5-LO IC<sub>50</sub> = 20 μM) and no activity against the COX-2 enzyme (IC<sub>50</sub> > 100 μM in a human blood assay measuring PGE<sub>2</sub> inhibition). Pharmacokinetic parameters were assessed in Sprague–Dawley rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), and upon oral administration (10 mg/kg sodium carboxylate salt), <b>11cc</b> showed good bioavailability (76%) and a <i>C</i><sub>max</sub> of 10 μg/mL. Intravenous administration of <b>11cc</b> (2 mg/kg) showed a low systemic clearance of 5.2 mL min<sup>–1</sup> kg<sup>–1</sup> and a low volume of distribution (0.77 L/kg) with a 2–3 h terminal half-life. When dosed in dogs, <b>11cc</b> demonstrated good bioavailability (51%), very low clearance (0.6 mL min<sup>–1</sup> kg<sup>–1</sup>), low volume of distribution (0.2 L/kg), and a long iv half-life of 13 h. The low volume of distribution observed in dog is primarily attributable to <b>11cc</b> possessing a very high degree of plasma protein binding (rat, 99.8%; dog, 99.7%; human, 99.5%). To ascertain the ability of <b>11cc</b> to inhibit leukotriene synthesis in vivo, we employed a rodent BAL model.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> After a 3 mg/kg po dose 4 h prior to A23187 ionophore challenge, LTB<sub>4</sub> and CysLT concentrations in the rat BAL fluid were significantly reduced (100% and 80%, respectively, <i>n</i> = 5, average measured plasma concentration of <b>11cc</b> at 4 h of 1 μM). Of note is the observation that after a 3 mg/kg po dose of <b>11cc</b> 16 h prior to ionophore challenge in the rat lung, inhibition of LTB<sub>4</sub> (86%) and CysLT (41%) was maintained despite the measured plasma concentration (average of 3 nM, <i>n</i> = 5) being below the rWB IC<sub>50</sub> (15 min preincubation, 239 nM), potentially indicating an extended pharmacodynamic effect. However, the potency of <b>11cc</b> increased substantially with an extended 4 h preincubation period in rWB, yielding an IC<sub>50</sub> of 16 nM. The discrepancy between the measured plasma concentration in this 16 h pretreatment BAL experiment and the 4 h rWB potency (3 nM vs 16 nM) may reflect a concentration difference between lung tissue and plasma in the rat.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Measured Pharmacokinetic Parameters for Four Most Potent FLAP Inhibitors (5 h hWB)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> iv (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>po</sub> (h·μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub>(L/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11cc</b></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ee</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ff</b></td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">23.3</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11kk</b></td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">30.6</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Compounds were dosed as the corresponding sodium carboxylate salt, 10 mg/kg po (0.5% methylcellulose) and 2 mg/kg iv (water) in Sprague–Dawley rats (male).</p></div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have discovered that a certain subset of FLAP inhibitors in this indole series require longer incubation times in blood to reach their equilibrium potency for LTB<sub>4</sub> inhibition. From the SAR presented, this “time-dependent” effect appears limited to compounds bearing certain functional groups appended to the hydroxymethyl portion of the indole nucleus, the most potent of which are quinolines (for example, compounds <b>6</b>, <b>11a</b>, and <b>11c</b>) or 5-methylpyridines (e.g., <b>11cc</b>, <b>11ff</b>, <b>11kk</b>). Comparing the 5-methylpyridine derivative <b>11j</b> to <b>1</b> clearly shows that addition of the methyl group increases affinity in the FLAP binding assay and potency in the 5 h preincubation hWB LTB<sub>4</sub> assay. Utilizing this extended assay paradigm in hWB, we identified compound <b>11cc</b> (3-[3-<i>tert</i>-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid), which is a very effective inhibitor of LTB<sub>4</sub> production in human blood, does not inhibit any of the major human CYP isoforms or the COX enzymes, and demonstrates excellent pharmacokinetic parameters in rat and dog. Furthermore <b>11cc</b> demonstrated excellent in vivo inhibition of leukotrienes in a rodent BAL ionophore challenge model. <b>11cc</b> has subsequently completed phase 1 clinical trials and is currently in phase 2 studies in patients, the results of which will be reported in a separate publication.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> FLAP Binding Assay</h3><div class="NLM_p last">Packed human polymorphonuclear cell pellets (1.8 × 10<sup>9</sup> cells) (Biological Specialty Corporation) were resuspended and lysed, and 75000<i>g</i> pelleted membranes were prepared as described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The 75000<i>g</i> pelleted membranes were resuspended in a Tris buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM DTT, 30% glycerol) to yield a protein concentration of ∼4 mg/mL. An amount of 2.5 μg of membrane protein per well was added to 96-well deep well plates containing Tris-Tween buffer (100 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 5% glycerol, 0.05% Tween-20) and ∼30000 cpm of [<sup>3</sup>H]-3-[5-(pyrid-2-ylmethoxy)-3-<i>tert</i>-butylthio-1-benzylindol-2-yl]-2,2-dimethylpropionic acid and test compound in a total volume of 100 μL and incubated for 60 min at room temperature. The mixtures were then harvested onto GF/B filter plates using a Brandel 96-tip harvester and washed 3× with 1 mL of ice cold Tris-Tween buffer. The filter plates were dried and the bottoms sealed. An amount of 100 μL of scintillant was added. The plates were incubated for 1 h before reading on a Perkin-Elmer TopCount. Specific binding was defined as total radioactive binding minus nonspecific binding in the presence of 10 μM MK886. IC<sub>50</sub> values were determined using Graphpad Prism analysis of drug titration curves. Compounds <b>1</b> and <b>11a</b> were tritiated at American Radiolabeled Chemicals, St. Louis, MO. Analysis of on-rate was performed by incubating membranes with 10 μM cold competitor (for nonspecific binding) or vehicle (DMSO) for 5 min before addition of radioligand and further incubation with the radioligand for 1–60 min before harvesting by filtration. Analysis of the off-rate was performed by incubating membranes with radioligand for 30 min before addition of 10 μM cold competitor and further incubation with the cold competitor for 1–60 min before harvesting and filtration.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Human Leukocyte Inhibition Assay (hLA)</h3><div class="NLM_p last">Blood was drawn from consenting human volunteers into heparinized tubes, and <sup>1</sup>/<sub>3</sub> volume of 3% dextran was added. After sedimentation of red blood cells a hypotonic lysis of remaining red blood cells was performed and leukocytes were sedimented at 1200 rpm. The pellet was resuspended at 1.25 × 10<sup>5</sup> cells/mL in assay buffer (Hanks balanced salt solution containing 15 mM Hepes) and 250 μL aliquoted into wells containing 1 μL of DMSO (vehicle) or 1 μL of drug in DMSO. Samples were incubated for 5 min at 37 °C, and 5 μL of calcium ionophore A23817 (freshly diluted from a 50 mM DMSO stock diluted to 0.5 mM in Hanks balanced salt solution) was added, mixed, and the mixture incubated for 5 min at 37 °C. Samples were centrifuged at 1200 rpm (∼300<i>g</i>) for 10 min at 4 °C. The supernatant was removed and a 1:4 dilution assayed for LTB<sub>4</sub> concentration using ELISA (Assay Designs). Drug concentrations to achieve 50% inhibition (IC<sub>50</sub>) of vehicle LTB<sub>4</sub> were determined by nonlinear regression analysis (Graphpad Prism) of % inhibition versus logarithmic drug concentration. Modifications to the assay for analysis of time-dependent inhibition included resuspending the leukocytes in assay buffer plus or minus 0.5% human serum albumin and incubating leukocytes with test compound for 5 min to 3 h before stimulation with calcium ionophore.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Human Blood LTB<sub>4</sub> Inhibition Assay (hWB)</h3><div class="NLM_p last">Blood was drawn from consenting human volunteers into heparinized tubes, and 150 μL aliquots were added to wells containing 1.5 μL of DMSO (vehicle) or 1.5 μL of test compound in DMSO. Samples were incubated for either 15 min or 5 h at 37 °C. An amount of 2 μL of calcium ionophore A23187 (freshly diluted from a 50 mM DMSO stock to 1.5 mM in Hanks balanced salt solution) was added. The solution was mixed and incubated for 30 min at 37 °C. Samples were centrifuged at 1500 rpm (∼300<i>g</i>) for 10 min at 4 °C. Plasma was removed and a 1:100 dilution assayed for LTB<sub>4</sub> concentration using ELISA (Assay Designs). Drug concentrations to achieve 50% inhibition (IC<sub>50</sub>) of vehicle LTB<sub>4</sub> were determined by nonlinear regression analysis (Graphpad Prism) of percent inhibition versus logarithm of drug concentration. Each assay was performed using two different donors; drug concentrations are singletons.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> COX-1 Human Whole Blood Assay</h3><div class="NLM_p last">Human blood was obtained by venipuncture from consenting adult volunteers. Blood was anticoagulated by drawing into heparinized tubes and used within 2 h of draw. Aliquots of fresh blood (150 μL) were incubated for 15 min at 37 °C with 1 μL of test compound diluted in DMSO or with DMSO alone as a vehicle control. A concentration of 10 μM for routine screening was used, or for the generation of IC<sub>50</sub> values the final concentrations of the test compound were 100, 30, 10, 3, 1, 0.3, and 0.1 μM. Calcium ionophore A23187 (25 μM final concentration) was added from a 1.5 mM stock in HBSS (prepared by dilution from a 50 mM stock in DMSO). Incubations were continued for 30 min at 37 °C. Incubation mixtures were centrifuged at 1500 rpm for 10 min at 4 °C, and aliquots of the plasma were diluted 1:100 with assay buffer and analyzed for TXB2 by a competitive enzyme immunoassay according to the manufacturer's instructions (Assay Designs, Ann Harbor, MI, catalog no. 900-002).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Pharmacokinetic Studies</h3><div class="NLM_p last">Compounds were converted from the acid form to the sodium salt by treatment of the acid in ethanol/water with 1 equiv of 1 N NaOH and then removal of the solvent in vacuo. Male Sprague–Dawley rats surgically cannulated in their jugular vein (approximate weight of 300 g for male) were purchased from Charles River (Wilmington, MA). Compounds were administered intravenously (iv) (2 mg/kg) to two or three male rats (fasted overnight) as a solution in PEG400/ethanol/water (40/10/50, v/v/v) via a bolus injection into the jugular vein (2 mg/mL, 1 mL/kg) and orally (po) (10 mg/kg) to two or three male rats as a suspension in 0.5% methylcellulose via an oral gavage to the stomach (3.33 mg/mL, 3 mL/kg). Blood samples (approximately 300 μL) were taken from each rat via the jugular vein cannula at time intervals up to 24 h postdose (8–9 samples per animal). After each sample, the cannula was flushed with an equivalent volume of heparinized saline (0.1 mL at 40 units/mL). Plasma samples, prepared by centrifugation of whole blood, were stored frozen (−80 °C) prior to analysis.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Sample Preparation and Calibration Curve</h3><div class="NLM_p last">Known amounts of compound were added to thawed rat plasma to yield a concentration range from 5 to 5000 ng/mL. Plasma samples were precipitated using MeCN (1:5, v/v) containing the internal standard (IS) buspirone. An amount of 10 μL of the analyte mixture was injected using a Leap PAL autosampler. The calibration curves were constructed by plotting the peak areas of analyzed peaks against known concentrations. The data were subjected to linear regression analysis with 1/<i>x</i> weighting. The lower limits of quantitation (LLOQ) were 1–5 ng/mL.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> LC/MS Analysis</h3><div class="NLM_p last">Analyses were performed using an Agilent Zorbax SB-C8 column (2.1 mm × 50 mm, 5 μm) linked to a Shimadzu LC-10AD VP with SCL-10A VP system controller. Tandem mass spectrometric (MS/MS) detection was carried out on a PE Sciex API3200 in the positive ion mode (ESI) by multiple reaction monitoring (IS 386.2 → 122.2). The mobile phases contained 10 mM ammonium acetate in water with 0.05% formic acid (solvent A) and 10 mM ammonium acetate in 50% MeCN/50% MeOH with 0.05% formic acid (solvent B). The flow rate was maintained at 0.7 mL/min, and the total run time was 3 min. Analytes were separated using a linear gradient as follows: mobile phase was held for 1 min at 5% B; B was increased from 5% to 95% over then next 0.5 min; B was held constant for 1 min at 95%; B was returned to the initial gradient conditions.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Pharmacokinetic Calculations</h3><div class="NLM_p last">The pharmacokinetic parameters were calculated by a noncompartmental analysis using WinNonlin (Pharsight, Mountain View, CA). Maximum plasma concentrations (<i>C</i><sub>max</sub>) and their time of occurrence (<i>T</i><sub>max</sub>) were both obtained directly from the measured data. Half-life values were calculated from 4 to 8 h unless otherwise noted. Dog pharmacokinetic studies were performed at LAB Pre-Clinical Research International, Inc., Laval, Quebec, Canada, using female beagle dogs (<i>n</i> = 3 per group). Compound <b>11cc</b> was given intravenously at 2 mg/kg (2 mg/mL) in 75% PEG and 25% water and also orally at 5 mg/kg (1.67 mg/mL) dissolved in 0.5% Methocel. Plasma samples were shipped to Amira Pharmaceuticals and analyzed as described for rat.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p last">All procedures were carried out under a nitrogen atmosphere using commercially available solvents that were used without further purification. Starting materials were obtained from commercial sources and were used without further purification. Column chromatography was carried out either using glass columns packed with silica gel, eluting with the solvents reported, or using prepacked silica gel cartridges on a CombiFlash Rf separation system by Teledyne ISCO. Yields refer to chromatographically pure compounds as determined by TLC (single spot) and/or HPLC. HPLC analysis was carried out using an Agilent 1100 binary pump system using a diode array detector. The column used was a Waters Symmetry C18 3.5 μm, 4.6 mm × 150 mm. Final products had a purity of ≥95%. LCMS analyses were carried out using a Shimadzu LCMS-2010A system fitted with a SIL-HT autosampler, LC-10AD pumps, and a SPD-10AV UV–visible detector. NMR spectra were recorded using a Bruker Advance 300 MHz NMR spectrometer. Chemical shifts are reported in δ values relative to tetramethylsilane.</div></div><div id="sec3_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Chloromethyl-5-methylpyrazine (<b>14</b>)</h3><div class="NLM_p last">To a solution of 2,5-dimethylpyrazine (20.0 mL, 0.187 mol) in benzene (450 mL) were added <i>N</i>-chlorosuccinimide (25.0 g, 0.187 mol) and benzoyl peroxide (400 mg). The mixture was heated under reflux for 18 h. An additional 5.0 g of NCS was added, and heating continued for a further 6 h. TLC analysis indicated almost complete consumption of starting material and the presence of two less polar products. The reaction mixture was evaporated to dryness and purified on silica gel (ISCO, 0–15% EtOAc in hexanes), and the desired fractions repurified (ISCO: 25–100% hexanes in CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.60 (s, 3H), 4.67 (s, 2H), 8.44 (s, 1H), 8.61 (s, 1H). <i>R<sub>f</sub></i> = 0.4 (20% EtOAc in hexanes).</div></div><div id="sec3_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Chloromethylquinoxaline (<b>15</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h3><div class="NLM_p last">To a refluxing solution of 2-methylquinoxaline (10.0 g, 69.3 mmol) in CHCl<sub>3</sub> (100 mL) was added trichloroisocyanuric acid (7.10 g, 30.5 mmol) in ∼100 mg portions over the period of 1 h. The mixture was then heated at reflux for a further 30 min, allowed to cool, and poured into an ice–water mixture. Aliquots of a 50% aqueous NaOH solution were then added to adjust the pH to ∼9. The resulting solution was extracted with CHCl<sub>3</sub>, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness. The residue was purified on silica gel (ISCO, 0–15% EtOAc in hexanes) to afford the title compound as a purple solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 4.89 (s, 2H), 7.81 (m, 2H), 8.11 (m, 2H), 9.04 (s, 1H).</div></div><div id="sec3_9_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Chloromethyl-5-methylpyridine Hydrochloride (<b>16c</b>)</h3><div class="NLM_p">To an ice cooled solution of 2,5-lutidine (46.8 g, 0.436 mol) in CHCl<sub>3</sub> (750 mL) was added <i>m</i>-CPBA (129 g, 0.52 mol) in small portions over a period of 30 min. The reaction mixture was maintained at room temperature for 48 h, and then calcium hydroxide (81 g) was added with vigorous stirring leading to the formation of a thick precipitate. After being stirred for 4 h, the slurry was filtered through Celite, washing the residue with CHCl<sub>3</sub>. Evaporation of the filtrate afforded 46 g (86%) of 2,5-dimethylpyridine 1-oxide as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.28 (s, 3H), 2.49 (s, 3H), 7.00 (d, 1H), 7.14 (d, 1H), 8.13 (s, 1H).</div><div class="NLM_p">To acetic anhydride (150 mL) heated to 100 °C was very carefully added 2,5-dimethylpyridine 1-oxide (46 g, 0.373 mol) over a period of 30 min (<i>caution</i>: significant exotherm can occur after an induction period). After complete addition, an additional 50 mL of Ac<sub>2</sub>O was added and the reaction mixture heated to reflux for 1 h. Upon completion of heating, the reaction mixture was allowed to cool to ambient temperature and slowly quenched with the addition of EtOH (200 mL) and stirred for 12 h. Evaporation of the reaction mixture afforded a yellow oil which was purified using silica gel chromatography (0–40% EtOAc in hexanes), yielding acetic acid 5-methylpyridin-2-ylmethyl ester (52 g, 84%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.10 (s, 3H), 2.15 (s, 3H), 2.35 (s, 3H), 7.27 (d, 1H), 7.53 (d, 1H), 8.45 (s, 1H).</div><div class="NLM_p">To acetic acid 5-methyl-pyridin-2-ylmethyl ester (52 g, 0.314 mol) was added concentrated HCl (200 mL), and the mixture was heated to reflux for 1 h. Evaporation of the mixture under vacuum afforded (5-methylpyridin-2-yl)methanol hydrochloride as an orange solid which was used without further purification.</div><div class="NLM_p">To (5-methylpyridin-2-yl)methanol hydrochloride (40 g, 0.250 mol) was added SOCl<sub>2</sub> (140 mL) slowly with vigorous stirring under a reflux condenser (<i>caution</i>: significant gas evolution). After complete addition the reaction mixture was heated to reflux for 30 min, allowed to cool, and thoroughly evaporated to dryness to afford the title compound as a pale brown solid used without further purification.</div><div class="NLM_p last">Compounds <b>16a</b>, <b>16b</b>, <b>16e</b>, <b>16f</b> were prepared in an identical manner to the procedure given for compound <b>16b</b> from the commercially available alkylpyridines. Compound <b>16d</b> was prepared from the commercially available 6-methylpyridine-2-methanol through reaction with thionyl chloride as described for the final step of <b>16c</b>. Quinoline <b>17</b> was also prepared in an identical manner from commercially available 2,6-dimethylquinoline.</div></div><div id="sec3_9_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Chloromethyl-5-methylpyridine 1-Oxide (<b>16g</b>)</h3><div class="NLM_p last">To a mixture of 2-chloromethyl-5-methylpyridine hydrochloride (<b>16c</b>, 500 mg, 2.81 mmol) and <i>m</i>-CPBA (760 mg, 3.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added NaHCO<sub>3</sub> (300 mg, 3.57 mmol). The solution was stirred at ambient temperature for 24 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with water and the organic phase dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue on silica gel (ISCO: 0–100% EtOAc in hexanes) afforded 222 mg (50%) of the title compound as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.33 (s, 3H), 4.82 (s, 2H), 7.13 (d, 1H), 7.48 (d, 1H), 8.13 (s, 1H).</div></div><div id="sec3_9_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Bromomethyl-5-methoxypyridine (<b>18</b>)</h3><div class="NLM_p last">To a solution of 5-hydroxy-2-methylpyridine (1.0 g, 9.16 mmol) in a mixture of toluene (45 mL) and MeOH (45 mL) was added a solution of (trimethylsilyl)diazomethane (2 M in diethyl ether, 9.16 mL, 18.32 mmol). After the mixture was stirred at room temperature for 30 min, another 2 equiv of (trimethylsilyl)diazomethane was added and the solution maintained at ambient temperature for 12 h. Evaporation of the mixture in vacuo afforded 5-methoxy-2-methylpyridine, which was used without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.49 (s, 3H), 3.83 (s, 3H), 7.08 (d, 1H), 7.13 (dd, 1H), 8.20 (d, 1H). To a solution of the previously isolated 5-methoxy-2-methylpyridine (400 mg, 3.25 mmol) in benzene (16 mL) was added <i>N</i>-bromosuccinimide (636 mg, 3.57 mmol) and benzoyl peroxide (30 mg). The reaction mixture was refluxed for 16 h, evaporated to dryness and the residue purified using silica gel chromatography (ISCO, 15% EtOAc in hexanes) to afford 320 mg (44%) of the title compound.</div></div><div id="sec3_9_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Bromomethyl-6-fluoroquinoline (<b>20</b>)</h3><div class="NLM_p last">To a solution of 6-fluoro-2-methylquinoline (5.00 g, 31.0 mmol) in benzene (160 mL) was added <i>N</i>-bromosuccinimide (6.07 g, 34.1 mmol) and benzoyl peroxide (370 mg), and the mixture was heated at reflux for 16 h. After the mixture was cooled, the solvent was removed in vacuo and the residue purified by column chromatography on silica gel (ISCO, 0–20% EtOAc in hexanes) to afford 3.19 g (43%) of the title compound. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 4.70 (s, 2H), 7.50 (m, 2H), 7.58 (d, 1H), 8.06 (dd, 1H), 8.12 (d, 1H).</div></div><div id="seca" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-Bromomethylnicotinonitrile (<b>19</b>) and 2-Bromomethyl-7-fluoroquinoline (<b>21</b>)</h3><div class="NLM_p last"><b>19</b> and <b>21</b> were prepared in a similar manner to that described for <b>20</b>.</div></div><div id="sec3_9_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Chloromethylimidazo[1,2-<i>a</i>]pyridine Hydrochloride (<b>22</b>)</h3><div class="NLM_p last">Imidazo[1,2-<i>a</i>]pyridine-2-ylmethanol (500 mg, 3.37 mmol) and SOCl<sub>2</sub> (5 mL) were heated at reflux for 20 min and evaporated to dryness to afford the title compound used without further purification.</div></div><div id="secb" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-Chloromethyl-5-methylisoxazole (<b>23</b>), 3-Chloromethyl-1,5-dimethyl-1<i>H</i>-pyrazole (<b>24</b>), and 5-Chloromethyl-1,3-dimethyl-1<i>H</i>-pyrazole (<b>25</b>)</h3><div class="NLM_p last"><b>23</b>–<b>25</b> were prepared from their corresponding alcohols in a manner identical to that described for <b>22</b>.</div></div><div id="sec3_9_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-Chloromethyl-2,3-dimethylpyridine Hydrochloride (<b>26</b>)</h3><div class="NLM_p">2,3-Lutidine (30.0 g, 0.28 mol) was dissolved in CHCl<sub>3</sub> (500 mL) and cooled to 0 °C, after which <i>m</i>-CPBA (76.0 g, 0.31 mol) was added in small portions over a period of 5 min. The solution was allowed to warm to ambient temperature, and after 12 h solid Ca(OH)<sub>2</sub> (52 g) was added with vigorous stirring. A thick precipitate forms, and after a further 4 h of being stirred, the slurry was filtered through Celite, washing with CHCl<sub>3</sub>. Evaporation of the filtrate afforded a solid which was triturated with Et<sub>2</sub>O (200 mL) to afford 20 g (58%) of 2,3-dimethylpyridine 1-oxide as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.35 (s, 3H), 2.51 (s, 3H), 7.04 (m, 2H), 8.16 (m, 1H).</div><div class="NLM_p">To a solution of the previously isolated <i>N</i>-oxide (17.6 g, 0.143 mol) in CH<sub>2</sub>Cl<sub>2</sub> was added trimethylsilyl cyanide (19.8 mL, 0.148 mol). After 30 min, <i>N</i>,<i>N</i>-diethylcarbamoyl chloride (18.6 mL, 0.148 mol) was added slowly and the resulting reaction mixture maintained at ambient temperature for 60 h. A 10% aqueous solution of K<sub>2</sub>CO<sub>3</sub> was carefully added (100 mL) and the resulting two-phase mixture stirred rapidly for 30 min. The organic phase was separated, the aqueous layer extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified using silica gel chromatography (ISCO, 0–15% EtOAc in hexanes) to yield 10.1 g (53%) of 5,6-dimethylpyridine-2-carbonitrile as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.37 (s, 3H), 2.55 (s, 3H), 7.45 (d, 1H), 7.53 (d, 1H).</div><div class="NLM_p">5,6-Dimethylpyridine-2-carbonitrile (5.00 g, 37.8 mmol) in MeOH (500 mL) was cooled to −10 °C and dry HCl gas bubbled through the solution for 15 min. The vessel was sealed and allowed to stand at ambient temperature for 72 h. Water (12 mL) was added and the solution evaporated to dryness in vacuo. The residue was diluted with EtOAc, and saturated NaHCO<sub>3</sub> solution was added with caution (gas evolution) and vigorously stirred for 30 min. The EtOAc phase was separated, the aqueous layer was extracted (EtOAc), and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to afford 5.86 g (94%) of 5,6-dimethylpyridine-2-carboxylic acid methyl ester as a light tan solid.</div><div class="NLM_p">To the previously isolated methyl ester (5.86 g, 35.5 mmol) in dry THF (60 mL) cooled to −78 °C was slowly added DIBAl-H (1 M solution in THF, 100 mL, 100 mmol) over a period of 5 min. The reaction mixture was allowed to warm to 0 °C, after which saturated aqueous sodium potassium tartrate solution was carefully added to quench the reduction. After the mixture was stirred vigorously for 30 min, solid citric acid was added to adjust the pH to ∼8, the aqueous phase was extracted with EtOAc (×3), and the combined organics were dried (MgSO<sub>4</sub>), filtered, and evaporated. The residue was purified using silica gel chromatography (ISCO, 100% EtOAc) to afford 4.43 g (91%) of (5,6-dimethylpyridin-2-yl)methanol as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.27 (s, 3H), 2.49 (s, 3H), 4.21 (br s, 1H), 4.68 (s, 2H), 6.98 (d, 1H), 7.39 (d, 1H).</div><div class="NLM_p last">Thionyl chloride (5 mL) and the previously isolated alcohol (1.00 g, 0.73 mmol) were heated to reflux for 15 min, allowed to cool, and thoroughly evaporated to dryness in vacuo to afford the title compound as a pale brown solid used without further purification.</div></div><div id="sec3_9_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Chloro-2-chloromethylpyridine (<b>27</b>)</h3><div class="NLM_p last">5-Chloropyridine-2-carboxylic acid (0.50 g, 3.17 mmol) in THF (15 mL) was cooled to 0 °C, and BH<sub>3</sub>·THF (1 M solution in THF, 19 mL, 19 mmol) was added dropwise. The reaction mixture was then heated to 50 °C for 12 h. After the mixture was cooled to ambient temperature, water was slowly added to quench excess reagent, the reaction mixture was partitioned between EtOAc and water, the organic phase was separated, the aqueous layer was extracted (EtOAc), and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. To the isolated alcohol (237 mg, 1.65 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added SOCl<sub>2</sub> (0.6 mL, 8.25 mmol), and the mixture was stirred at ambient temperature for 30 min. Evaporation of the solvent in vacuo afforded the title compound which was used without further purification.</div></div><div id="sec3_9_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Chloromethylindole-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>28</b>)</h3><div class="NLM_p">To a solution of 1<i>H</i>-indole-2-carboxylic acid ethyl ester (5.00 g, 26.0 mmol) in MeCN (85 mL) were added Boc<sub>2</sub>O (6.92 g, 31.2 mmol) and DMAP (323 mg, 2.60 mmol). After 12 h at ambient temperature, 2-amino-5-diethylaminopentane (0.5 mL) was added and the reaction mixture evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–10% EtOAc in hexanes) afforded 7.5 g (99%) of indole-1,2-dicarboxylic acid 1-<i>tert</i>-butyl ester 2-ethyl ester. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.40 (t, 3H), 1.63 (s, 9H), 4.38 (q, 2H), 7.10 (s, 1H), 7.25 (m, 1H), 7.40 (m, 1H), 7.60 (d, 1H), 8.08 (d, 1H).</div><div class="NLM_p">To a solution of the previously isolated <i>tert</i>-butyl ester (7.50 g, 26.0 mmol) in toluene (50 mL) cooled to −40 °C was slowly added DIBAl-H (1 M soln in hexanes, 64.8 mL, 64.8 mmol) over a period of 20 min. After a further 20 min the reaction was carefully quenched upon addition of MeOH (20 mL) and then H<sub>2</sub>O (20 mL), and the mixture was stirred vigorously at ambient temperature for 10 min. The mixture was filtered and the filtrate washed with water, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–25% EtOAc in hexanes) afforded 5.3 g (83%) of 2-hydroxymethylindole-1-carboxylic acid <i>tert</i>-butyl ester. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.71 (s, 9H), 3.77 (t, 1H), 4.80 (d, 2H), 6.57 (s, 1H), 7.16–7.26 (m, 2H), 7.50 (d, 1H), 7.98 (d, 1H).</div><div class="NLM_p last">2-Hydroxymethylindole-1-carboxylic acid <i>tert</i>-butyl ester isolated above (1.60 g, 6.47 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and LiBr (5.45 g, 65 mmol) was added. Triethylamine (1.46 mL, 10.4 mmol) was added followed by methanesulfonyl chloride (816 μL, 10.4 mmol) and the solution maintained at ambient temperature for 24 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with aqueous saturated NaHCO<sub>3</sub> solution, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to afford the title compound which was used immediately without further purification.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Route A. 3-{-3-<i>tert</i>-Butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1-[4-(6-methoxypyridine-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11c</b>). Step 1: 3-[1-(4-Bromobenzyl)-3-<i>tert</i>-butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid Ethyl Ester</h3><div class="NLM_p last">To a solution of 3-[1-(4-bromobenzyl)-3-<i>tert</i>-butylsulfanyl-5-hydroxy-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid ethyl ester<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (2.00 g, 3.86 mmol) in MeCN (25 mL) was added cesium carbonate (2.50 g, 7.67 mmol) followed by 2-bromomethyl-6-fluoroquinoline <b>20</b> (1.02 g, 4.25 mmol), and the suspension was maintained at ambient temperature with vigorous stirring for 16 h. The reaction mixture was partitioned between EtOAc and water. The aqueous phase was extracted with EtOAc, and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The product residue was triturated using a mixture of EtOAc and hexanes and the solid collected by filtration to afford 1.43 g of the title compound. The mother liquor was purified by silica gel column chromatography (ISCO, 0–15% EtOAc in hexane gradient) to isolate a further 1.00 g of the title compound. Combined yield obtained was 2.43 g (93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.13 (s, 9H), 1.18 (t, 3H), 1.20 (s, 6H), 3.24 (s, 2H), 4.03 (q, 2H), 5.32 (s, 2H), 5.24 (s, 2H), 6.65 (d, 2H), 6.90 (d, 1H), 7.02 (d, 1H), 7.36 (d, 2H), 7.41 (m, 1H), 7.47 (m, 1H), 7.75 (d, 1H), 8.10 (m, 2H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 679; observed 679.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Step 2: 3-{3-<i>tert</i>-Butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid Ethyl Ester</h3><div class="NLM_p last">To a solution of 3-[1-(4-bromobenzyl)-3-<i>tert</i>-butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid ethyl ester (from step 1, 1.02 g, 1.51 mmol) in <i>p-</i>dioxane (15 mL) were added potassium acetate (443 mg, 4.52 mmol), bis(pinacolato)diboron (1.08 g, 4.25 mmol), and Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (125 mg, 0.15 mmol) in a sealable vessel. The mixture was sparged with nitrogen gas for 5 min, sealed, and heated to 90 °C for 12 h. After cooling, the reaction mixture was partitioned between EtOAc and water, the aqueous layer was extracted with EtOAc, and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified on silica gel (ISCO, 0–20% EtOAc in hexanes) to afford the title compound as off-white foam (910 mg, 84%) used without further analysis.</div></div><div id="sec3_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Step 3: 3-{3-<i>tert</i>-Butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid Ethyl Ester</h3><div class="NLM_p last">A solution of the product of step 2 (250 mg, 0.345 mmol), K<sub>2</sub>CO<sub>3</sub> (145 mg, 0.105 mmol), 5-bromo-2-methoxypyridine (91 mg, 0.484 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (55 mg, 0.048 mmol) in DME/H<sub>2</sub>O 2:1 (6 mL) was degassed via sparging with nitrogen and heated at 85 °C for 4 h. After cooling, the mixture was poured into water, extracted with EtOAc (×2) and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified using silica gel chromatography (ISCO, 0–15% EtOAc in hexanes) to afford 206 mg (85%) of the title ester. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.14 (s, 9H), 1.16 (t, 3H), 1.22 (s, 3H), 3.29 (s, 2H), 3.96 (s, 3H), 4.05 (q, 2H), 5.42 (s, 4H), 6.78 (d, 1H), 6.87 (d, 2H), 6.91 (d, 1H), 7.10 (d, 1H), 7.37–7.53 (m, 5H), 7.70 (d, 1H), 7.75 (d, 1H), 8.12 (m, 2H), 8.31 (d, 1H).</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Step 4: 3-{-3-<i>tert</i>-Butylsulfanyl-5-(6-fluoroquinolin-2-ylmethoxy)-1-[4-(6-methoxypyridine-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11c</b>)</h3><div class="NLM_p">To a solution of the ethyl ester from step 3 (206 mg, 0.304 mmol) in a mixture of THF (3 mL), MeOH (1.5 mL), and H<sub>2</sub>O (1.5 mL) was added LiOH·H<sub>2</sub>O (75 mg, 1.79 mmol), and the reaction mixture was heated to 60 °C for 4 h. After cooling, the reaction mixture was diluted with EtOAc and H<sub>2</sub>O, and solid citric acid was added to achieve an aqueous pH of ∼3. The organic phase was separated and the aqueous layer extracted with EtOAc. The combined organic phases were washed with water, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to afford the title compound as a colorless solid in quantitative yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.16 (s, 9H), 1.26 (s, 6H), 3.33 (s, 2H), 3.95 (s, 3H), 5.40 (s, 2H), 5.43 (s, 2H), 6.76 (d, 1H), 6.85 (d, 2H), 6.92 (d, 1H), 7.07 (d, 1H), 7.35 (d, 2H), 7.44 (m, 1H), 7.49 (m, 1H), 7.69 (d, 1H), 7.73 (d, 1H), 8.12 (m, 2H), 8.30 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 678; observed 678.</div><div class="NLM_p last">The following compounds were prepared using route A.</div></div><div id="secaa" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-{-3-<i>tert</i>-Butylsulfanyl-5-(7-fluoroquinolin-2-ylmethoxy)-1-[4-(6-methoxypyridine-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11d</b>)</h3><div class="NLM_p last">For step 1, <b>21</b> was used as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.16 (s, 9H), 1.26 (s, 3H), 3.34 (s, 2H), 3.95 (s, 3H), 5.41 (s, 2H), 5.54 (s, 2H), 6.76 (d, 1H), 6.85 (d, 2H), 6.91 (d, 1H), 7.07 (d, 1H), 7.36 (m, 4H), 7.67–7.83 (m, 4H), 8.16 (d, 1H), 8.30 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 678; observed 678.</div></div><div id="sec3_12_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-{-3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridine-3-yl)benzyl]-5-(6-methylquinolin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11e</b>)</h3><div class="NLM_p last">For step 1, the alkylation was performed at 45 °C in MeCN using <b>17</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.17 (s, 9H), 1.26 (s, 6H), 2.54 (s, 3H), 3.33 (s, 2H), 3.95 (s, 3H), 5.40 (s, 2H), 5.43 (s, 2H), 6.76 (d, 1H), 6.87 (d, 2H), 6.91 (d, 1H), 7.04 (d, 1H), 7.37 (m, 3H), 7.55 (m, 2H), 7.68 (m, 2H), 8.03 (d, 1H), 8.08 (d, 1H), 8.30 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 674; observed 674.</div></div><div id="sec3_12_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(imidazo[1,2-<i>a</i>]pyridine-2-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11f</b>)</h3><div class="NLM_p last">For step 1, the alkylation was performed at 55 °C in a 15:1 mixture of MeCN/DMF for 48 h using <b>22</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.24 (s, 9H), 1.28 (s, 6H), 3.34 (s, 2H), 3.95 (s, 3H), 5.29 (s, 2H), 5.43 (s, 2H), 6.75–6.83 (m, 5H), 6.94 (d, 1H), 7.20 (m, 1H), 7.30 (d, 2H), 7.38 (s, 1H), 7.64–7.73 (m, 3H), 8.07 (d, 1H), 8.28 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 649; observed 649.</div></div><div id="sec3_12_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(3-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11h</b>)</h3><div class="NLM_p last">For step 1, the alkylation was performed at ambient temperature using DMF as solvent with the addition of catalytic TBAI and <b>16a</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.26 (s, 15H), 2.44 (s, 3H), 3.35 (s, 2H), 3.94 (s, 3H), 5.24 (s, 2H), 5.42 (s, 2H), 6.76 (d, 1H), 6.83 (m, 3H), 6.96 (s, 1H), 7.22 (dd, 1H), 7.32 (d, 2H), 7.40 (d, 1H), 7.55 (d, 1H), 7.68 (dd, 1H), 8.30 (d, 1H), 8.50 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_12_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(4-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11i</b>)</h3><div class="NLM_p last">For step 1, the alkylation was performed at ambient temperature using DMF as solvent with the addition of catalytic TBAI using <b>16b</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (s, 9H), 1.27 (s, 6H), 2.37 (s, 3H), 3.34 (s, 2H), 3.95 (s, 3H), 5.20 (s, 2H), 5.43 (s, 2H), 6.76 (d, 1H), 6.86 (m, 3H), 7.03 (d, 1H), 7.06 (d, 1H), 7.34 (m, 3H), 7.43 (s, 1H), 7.68 (dd, 1H), 8.29 (d, 1H), 8.48 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_12_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-ethylpyridin-2ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11l</b>)</h3><div class="NLM_p last">For step 1, the alkylation was performed at 45 °C in MeCN with catalytic TBAI for 72 h with <b>16e</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (s, 9H), 1.26 (m, 9H), 2.65 (q, 2H), 3.34 (s, 2H), 3.95 (s, 3H), 5.20 (s, 2H), 5.43 (s, 2H), 6.76 (d, 1H), 6.83 (m, 3H), 7.01 (d, 1H), 7.33 (m, 3H), 7.54 (m, 2H), 7.68 (dd, 1H), 8.30 (d, 1H), 8.48 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 638; observed 638.</div></div><div id="sec3_12_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(3,5-dimethylpyridin-2ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11m</b>)</h3><div class="NLM_p last">For step 1, the alkylation reaction was performed at ambient temperature using DMF as solvent with catalytic TBAI and <b>16f</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.20 (s, 6H), 1.25 (s, 9H), 2.31 (s, 3H), 2.40 (s, 3H), 3.35 (s, 2H), 3.95 (s, 3H), 5.20 (s, 2H), 5.41 (s, 2H), 6.74–6.93 (m, 4H), 6.91 (d, 1H), 7.31 (d, 2H), 7.39 (m, 2H), 7.67 (dd, 1H), 8.28 (d, 1H), 8.30 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 638; observed 638.</div></div><div id="sec3_12_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(5-methylisoxazol-3-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11s</b>)</h3><div class="NLM_p last">For step 1, the alkylation reaction was carried out at 45 °C in MeCN for 12 h using <b>23</b> as alkylating reagent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.26 (s, 15H), 2.41 (s, 3H), 3.35 (s, 2H), 3.95 (s, 3H), 5.15 (s, 2H), 5.45 (s, 2H), 6.13 (s, 1H), 6.77 (d, 1H), 6.76–6.87 (m, 3H), 7.08 (d, 1H), 7.34 (m, 3H), 7.68 (dd, 1H), 8.31 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 614; observed 614.</div></div><div id="sec3_12_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(1,5-dimethyl-1<i>H</i>-pyrazol-3-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11t</b>)</h3><div class="NLM_p last">For step 1, the alkylation reaction was performed using MeCN as solvent with catalytic TBAI and <b>24</b> as alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.25 (s, 15H), 2.24 (s, 3H), 3.36 (s, 2H), 3.85 (s, 3H), 3.95 (s, 3H), 5.03 (s, 2H), 5.46 (s, 2H), 6.11 (s, 1H), 6.77 (d, 1H), 6.80 (dd, 1H), 6.84 (d, 2H), 7.07 (d, 1H), 7.36 (m, 3H), 7.71 (dd, 1H), 8.32 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 627; observed 627.</div></div><div id="sec3_12_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(2,5-dimethyl-2<i>H</i>-pyrazol-3-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11u</b>)</h3><div class="NLM_p">For step 1, the alkylation reaction was performed using MeCN as solvent with catalytic TBAI and <b>25</b> as alkylating reagent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.26 (s, 15H), 2.24 (s, 3H), 3.85 (s, 3H), 3.95 (s, 3H), 5.03 (s, 2H), 5.46 (s, 2H), 6.11 (s, 1H), 6.77 (d, 1H), 6.80 (dd, 1H), 6.84 (d, 2H), 7.07 (d, 1H), 7.36 (m, 3H), 7.71 (dd, 1H), 8.32 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 627; observed 627.</div><div class="NLM_p last">For the following compounds, step 1 was performed using <b>16c</b> as alkylating agent and the coupling partner in step 3 was chosen accordingly.</div></div><div id="sec3_12_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11v</b>)</h3><div class="NLM_p last">For step 3, 6-bromo-2-methoxypyridine was used as the cross-coupling partner. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.11 (s, 15H), 2.28 (s, 3H), 3.91 (s, 3H), 5.15 (s, 2H), 5.53 (s, 2H), 6.74 (d, 1H), 6.83 (dd, 1H), 6.93 (d, 2H), 7.10 (d, 1H), 7.35 (m, 2H), 7.49 (d, 1H), 7.60 (d, 1H), 7.74 (m, 1H), 7.97 (d, 2H), 8.41 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_12_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(2-ethoxythiazol-4-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11y</b>)</h3><div class="NLM_p last">For step 3, 4-bromo-2-ethoxythiazole was used as the cross-coupling partner. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.21 (s, 9H), 1.25 (s, 6H), 1.43 (t, 3H), 2.34 (s, 3H), 3.32 (s, 2H), 4.48 (q, 2H), 5.20 (s, 2H), 5.39 (s, 2H), 6.74 (s, 1H), 6.80 (m, 3H), 7.00 (d, 1H), 7.27 (d, 1H), 7.47 (d, 1H), 7.50 (d, 1H), 7.63 (d, 2H), 8.45 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 644; observed 644.</div></div><div id="sec3_12_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(6-trifluoromethylpyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11z</b>)</h3><div class="NLM_p last">For step 3, 5-bromo-2-trifluoromethylpyridine was used as the coupling partner. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.20 (s, 9H), 1.23 (s, 6H), 2.35 (s, 3H), 3.34 (s, 2H), 5.17 (s, 2H), 5.46 (s, 2H), 6.81 (dd, 1H), 6.90 (d, 2H), 6.95 (d, 1H), 7.32 (d, 1H), 7.41 (d, 2H), 7.47 (d, 1H), 7.54 (dd, 1H), 7.69 (d, 1H), 7.92 (dd, 1H), 8.47 (s, 1H), 8.83 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 662; observed 662.</div></div><div id="sec3_12_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(5-trifluoromethylpyridin-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11aa</b>)</h3><div class="NLM_p last">For step 3, 2-chloro-5-trifluoromethylpyridine was used as the coupling partner. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.20 (s, 9H), 1.23 (s, 6H), 2.34 (s, 3H), 3.34 (s, 2H), 5.20 (s, 2H), 5.46 (s, 2H), 6.81 (dd, 1H), 6.88 (d, 2H), 6.98 (d, 1H), 7.31 (d, 1H), 7.46 (d, 1H), 7.53 (d, 1H), 7.72 (d, 1H), 7.84 (d, 2H), 7.93 (dd. 1H), 8.45 (s, 1H), 8.90 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 662; observed 662.</div></div><div id="sec3_12_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(5-trifluoromethylpyridin-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11ee</b>)</h3><div class="NLM_p last">For step 3, 2-chloro-5-methylpyridine was used as the coupling partner. The title compound was purified using preparative HPLC and isolated as the trifluoromethanesulfonic acid salt. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.20 (s, 6H), 1.23 (s, 9H), 2.52 (s, 3H), 2.55 (s, 3H), 3.35 (s, 2H), 5,46 (s, 2H), 5.52 (s, 2H), 6.84 (d, 1H), 6.99 (m, 3H), 7.29 (m, 1H), 7.67 (d, 2H), 7.85 (d, 1H), 7.92 (d, 1H), 8.13 (m, 2H), 8.70 (s, 1H), 8.76 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 592; observed 592.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Route B. 3-{-3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridine-3-yl)benzyl]-5-(quinoxalin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11b</b>). Step 1: 3-{3-<i>tert</i>-Butylsulfanyl-5-hydroxy-1-[4-(4,4,5,5-tetramethyl-1-[1,3,2]dioxaborolan-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid Ethyl Ester (<b>12</b>)</h3><div class="NLM_p last">To a solution of 3-[1-(4-bromobenzyl)-3-<i>tert</i>-butylsulfanyl-5- hydroxyl-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid ethyl ester<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (35.0 g, 67.5 mmol) in <i>p</i>-dioxane (350 mL) were added potassium acetate (19.9 g, 202.7 mmol), bis(pinacolato)diboron (25.0 g, 98.4 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) dichloromethane complex (2.50 g, 3.1 mmol), and the solution was sparged with nitrogen for 30 min. The resulting mixture was heated under nitrogen at 85 °C for 12 h, after which the solvent volume was reduced to ∼100 mL in vacuo, the residue taken up in EtOAc (1 L), washed with water, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–15% EtOAc in hexanes) afforded 33.5 g (88%) of the title compound. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.16 (t, 3H), 1.21 (s, 6H), 1.25 (s, 9H), 1,31 (s, 12H), 3.25 (s, 2H), 4.04 (q, 2H), 4.69 (s, 1H), 5.37 (s, 2H), 6.65 (dd, 1H), 6.76 (d, 2H), 6.96 (d, 1H), 7.17 (d, 1H), 7.67 (d, 2H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 566; observed 566.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Step 2: 3-{3-<i>tert</i>-Butylsulfanyl-5-hydroxy-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid Ethyl Ester (<b>13</b>, R<sup>2</sup> = 6-Methoxypyridin-3-yl)</h3><div class="NLM_p last">To a solution of <b>12</b> (25.3 g, 44.8 mmol) in a mixture of 1,2-dimethoxyethane (300 mL) and water (150 mL) were added potassium carbonate (15.5 g, 112.1 mmol) and 5-bromo-2-methoxypyridine (10.9 g, 58.0 mmol). The mixture was degassed via sparging with nitrogen gas for 30 min and tetrakis(triphenylphosphine)palladium(0) (1.0 g, 0.86 mmol) and heated at 80 °C under nitrogen for 24 h. The reaction mixture was reduced in volume in vacuo and diluted in EtOAc and washed with water. The aqueous phase was extracted with EtOAc, and the combined organic phases were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified using silica gel chromatography (0–20% EtOAc in hexanes) to yield 23.7 g (96%) of the title compound as a colorless foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.17 (t, 3H), 1.23 (s, 6H), 1.28 (s, 9H), 3.29 (s, 2H), 3.97 (s, 3H), 4.04 (q, 2H), 5.40 (s, 2H), 6.70 (dd, 1H), 6.79 (d, 1H), 6.85 (d, 2H), 7.20 (d, 1H), 7.37 (d, 2H), 7.72 (dd, 1H), 8.31 (d, 1H).</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Step 3: 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(quinoxalin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid Ethyl Ester</h3><div class="NLM_p last">To the phenol isolated in step 2 (1.62 g, 2.96 mmol) in MeCN (45 mL) were added cesium carbonate (2.89 g, 8.87 mmol) and 2-chloromethylquinoxaline (<b>15</b>, 0.58 g, 3.25 mmol), and the suspension was stirred at ambient temperature for 12 h. The reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water, and the organic phase was separated, washed with water, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified using silica gel chromatography (ISCO, 0–5% EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to afford 1.84 g (90%) of the title ester as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.15 (s, 9H), 1.17 (t, 3H), 1.23 (s, 6H), 3.29 (s, 2H), 3.96 (s, 3H), 4.05 (q, 2H), 5.43 (s, 2H), 5.50 (s, 2H), 6.78 (d, 1H), 6.85 (d, 2H), 6.94 (dd, 1H), 7.10 (d, 1H), 7.37 (m, 3H), 7.72 (dd, 1H), 7.78 (m, 2H), 8.11 (m, 2H), 8.31 (d, 1H), 9.14 (s, 1H).</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Step 4: 3-{-3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridine-3-yl)benzyl]-5-(quinoxalin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid</h3><div class="NLM_p">To the ester isolated in step 3 (150 mg, 0.22 mmol) in a mixture of THF (4 mL), MeOH (1.3 mL), and water (1.3 mL) was added LiOH·H<sub>2</sub>O (45 mg, 1.07 mmol), and the solution was heated at 60 °C for 4 h. Upon completion of the reaction the mixture was diluted with EtOAc and water, solid citric acid was added to attain an aqueous pH of ∼3, and the aqueous phase was extracted with EtOAc. The organic phase was washed with water, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to yield 140 mg (97%) of the title compound. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.15 (s, 9H), 1.26 (s, 6H), 3.33 (s, 2H), 3.95 (s, 3H), 5.45 (s, 2H), 5.49 (s, 2H), 6.76 (d, 1H), 6.85 (d, 2H), 6.94 (dd, 1H), 7.10 (d, 1H), 7.38 (m, 3H), 7.70 (dd, 1H), 7.78 (m, 2H), 8.11 (m, 2H), 8.30 (d, 1H), 9.14 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 661; observed 661.</div><div class="NLM_p last">The following compounds were prepared according to route B using the intermediate prepared from step 2 (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, R<sup>2</sup> = 6-methoxy-pyridin-3-yl).</div></div><div id="sec3_16_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(quinolin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11a</b>)</h3><div class="NLM_p last">For step 3, 2-chloromethylquinoline hydrochloride was used as the alkylating agent with catalytic TBAI and DMF as solvent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.16 (s, 15H), 3.32 (s, 2H), 3.95 (s, 3H), 5.43 (s, 4H), 6.77 (d, 1H), 6.84 (d, 2H), 6.90 (dd, 1H), 7.07 (d, 1H), 7.36 (m, 3H), 7.54 (m, 1H), 7.70 (dd, 1H), 7.74 (d, 2H), 7.81 (d, 1H), 8.11 (d, 1H), 8.17 (d, 1H), 8.30 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 660; observed 660.</div></div><div id="sec3_16_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(1<i>H</i>-indol-2-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11g</b>)</h3><div class="NLM_p last">For step 3, 2-chloromethylindole-1-carboxylic acid <i>tert</i>-butyl ester (<b>28</b>) was used as the alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (s, 9H), 1.26 (s, 6H), 3.34 (s, 2H), 3.95 (s, 3H), 5.27 (s, 2H), 5.44 (s, 2H), 6.53 (s, 1H), 6.76 (d, 1H), 6.85 (m, 3H), 7.07 (d, 1H), 7.08 (m, 1H), 7.13 (m, 1H), 7.32–7.40 (m, 4H), 7.58 (d, 1H), 7.69 (dd, 1H), 8.31 (d, 1H), 8.46 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 648; observed 648</div></div><div id="sec3_16_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11j</b>)</h3><div class="NLM_p last">For step 3, 2-chloromethyl-5-methylpyridine hydrochloride (<b>16c</b>) was used as the alkylating agent at 55 °C for 24 h. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.27 (s, 6H), 2.35 (s, 3H), 3.33 (s, 2H), 3.95 (s, 3H), 5.21 (s, 2H), 5.43 (s, 2H), 6.76 (d, 1H), 6.82 (m, 3H), 6.99 (d, 1H), 7.33 (m, 3H), 7.49 (d, 1H), 7.56 (dd, 1H), 7.68 (dd, 1H), 8.28 (d, 1H), 8.47 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_16_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(6-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11k</b>)</h3><div class="NLM_p last">For step 3, <b>16d</b> was used as the alkylating agent using catalytic TBAI in DMF as solvent at 50 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.24 (s, 15H), 2.81 (s, 3H), 3.34 (s, 2H), 3.95 (s, 3H), 5.45 (s, 2H), 5.54 (s, 2H), 6.78 (d, 1H), 6.88 (m, 3H), 7.07 (d, 1H), 7.35 (m, 4H), 7.71 (m, 2H), 7.95 (m, 1H), 8.32 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_16_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5,6-dimethylpyridin-2ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11n</b>)</h3><div class="NLM_p last">For step 3, compound <b>26</b> was used as the alkylating agent at 35 °C for 12 h. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 2.28 (s, 3H), 2.53 (s, 3H), 3.33 (s, 2H), 3.95 (s, 3H), 5.18 (s, 2H), 5.43 (s, 2H), 6.76 (s, 1H), 6.85 (m, 3H), 7.03 (d, 1H), 7.32 (m, 4H), 7.42 (d, 1H), 7.69 (dd, 1H), 8.30 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 638; observed 638.</div></div><div id="sec3_16_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5-chloropyridin-2-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11o</b>)</h3><div class="NLM_p last">For step 3, compound <b>27</b> was used as the alkylating agent with catalytic TBAI in DMF as solvent for 12 h. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.27 (s, 6H), 3.35 (s, 2H), 3.96 (s, 3H), 5.24 (s, 2H), 5.45 (s, 2H), 6.78 (d, 1H), 6.87 (m, 3H), 7.08 (d, 1H), 7.30 (d, 1H), 7.37 (d, 2H), 7.54 (d, 1H), 7.69 (m, 2H), 8.30 (d, 1H), 8.57 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 644; observed 644.</div></div><div id="sec3_16_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(5-methoxypyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11p</b>)</h3><div class="NLM_p last">For step 3, compound <b>18</b> was used as the alkylating agent with catalytic TBAI and DMF as solvent for 12 h. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 3.86 (s, 3H), 3.94 (s, 3H), 5.18 (s, 2H), 5.43 (s, 2H), 6.75 (d, 1H), 6.84 (m, 3H), 7.02 (d, 1H), 7.23 (dd, 1H), 7.32 (m, 3H), 7.49 (d, 1H), 7.68 (dd, 1H), 8.29 (d, 1H), 8.32 (d, 1H).). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 641; observed 641.</div></div><div id="sec3_16_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5-carbamoylpyridin-2-ylmethoxy)-1-[4-(6-methoxypyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11q</b>)</h3><div class="NLM_p last">For step 3, compound <b>19</b> was used as the alkylating agent with catalytic TBAI and DMF as solvent for 12 h. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.14 (s, 15H), 3.26 (s, 2H), 3.89 (s, 3H), 5.24 (s, 2H), 5.56 (s, 2H), 6.92 (m, 4H), 7.11 (d, 1H), 7.38 (d, 1H), 7.58 (d, 2H), 7.66 (d, 1H), 7.99 (dd, 1H), 8.30 (dd, 1H), 8.46 (d, 1H), 9.10 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 654; observed 654.</div></div><div id="sec3_16_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxypyridin-3-yl)benzyl]-5-(5-methylpyrazin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11r</b>)</h3><div class="NLM_p">For step 3, compound <b>14</b> was used as the alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 2.58 (s, 3H), 3.34 (s, 2H), 3.95 (s, 3H), 5.27 (s, 2H), 5.45 (s, 2H), 6.77 (d, 1H), 6.87 (m, 3H), 7.08 (d, 1H), 7.33 (m, 3H), 7.70 (dd, 1H), 8.30 (d, 1H), 8.46 (s, 1H), 8.71 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 625; observed 625.</div><div class="NLM_p last">The following compounds were prepared according to route B but varying the cross-coupling partner in step 2 as described and using compound <b>16c</b> as the alkylating agent in step 3.</div></div><div id="sec3_16_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(3-methoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11w</b>)</h3><div class="NLM_p last">For step 2, 2-bromo-3-methoxypyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.98 (s, 6H), 1.05 (s, 9H), 2.29 (s, 3H), 3.20 (s, 2H), 3.61 (s, 3H), 5.15 (s, 2H), 5.34 (s, 2H), 6.74 (m, 3H), 6.89 (d, 1H), 7.08 (m, 2H), 7.22 (m, 1H), 7.41 (m, 2H), 7.59 (d, 2H), 8.11 (s, 1H), 8.39 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 624; observed 624.</div></div><div id="sec3_16_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(4-trifluoromethylpyridin-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11x</b>)</h3><div class="NLM_p last">For step 2, 2-chloro-4-trifluoromethylpyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.27 (s, 6H), 2.34 (s, 3H), 3.33 (s, 2H), 5.19 (s, 2H), 5.45 (s, 2H), 6.81 (dd, 1H), 6.84 (d, 2H), 6.96 (d, 1H), 7.31 (d, 1H), 7.41 (d, 1H), 7.47 (d, 1H), 7.52 (d, 1H), 7.82 (m, 3H), 8.46 (s, 1H), 8.32 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 662; observed 662.</div></div><div id="sec3_16_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(6-trifluoromethylpyridin-2-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11bb</b>)</h3><div class="NLM_p last">For step 2, 2-chloro-6-trifluoromethylpyridine was used as the coupling partner. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 2.33 (s, 3H), 3.34 (s, 2H), 5.19 (s, 2H), 5.44 (s, 2H), 6.81 (dd, 1H), 6.89 (d, 2H), 6.96 (d, 1H), 7.30 (d, 1H), 7.45 (d, 1H), 7.51 (dd, 1H), 7.56 (d, 1H), 7.77 (d, 1H), 7.84 (d, 1H), 7.87 (d, 2H), 8.44 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 662; observed 662.</div></div><div id="sec3_16_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (AM803, <b>11cc</b>)</h3><div class="NLM_p last">For step 2, 5-bromo-2-ethoxypyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.21 (s, 9H), 1.26 (s, 6H), 1.40 (t, 3H), 2.34 (s, 3H), 3.33 (s, 2H), 4.36 (q, 2H), 5.19 (s, 2H), 5.42 (s, 2H), 6.73 (d, 1H), 6.82 (m, 3H), 7.00 (d, 1H), 7.33 (m, 3H), 7.47 (d, 1H), 7.53 (dd, 1H), 7.67 (dd, 1H), 8.27 (d, 1H), 8.46 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 638; observed 638.</div></div><div id="sec3_16_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-ethoxypyridin-2-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11dd</b>)</h3><div class="NLM_p last">For step 2, 2-chloro-6-ethoxypyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 1.40 (t, 3H), 2.33 (s, 3H), 3.34 (s, 2H), 4.42 (q, 2H), 5.20 (s, 2H), 5.43 (s, 2H), 6.62 (d, 1H), 6.82 (dd, 1H), 6.86 (d, 2H), 7.00 (d, 1H), 7.20 (d, 1H), 7.31 (d, 1H), 7.45–7.58 (m, 3H), 7.85 (d, 2H), 8.45 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 638; observed 638.</div></div><div id="sec3_16_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(5-fluoropyridine-2-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11ff</b>)</h3><div class="NLM_p last">For step 2, 2-bromo-5-fluoropyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.26 (s, 6H), 2.34 (s, 3H), 3.33 (s, 2H), 5.20 (s, 2H), 5.43 (s, 2H), 6.83 (m, 3H), 6.99 (d, 1H), 7.31 (d, 1H), 7.38–7.54 (m, 3H), 7.60 (dd, 1H), 7.72 (d, 2H), 8.45 (s, 1H), 8.50 (d, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 612; observed 612.</div></div><div id="sec3_16_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(5-fluoropyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11gg</b>)</h3><div class="NLM_p last">For step 2, 3-bromo-5-fluoropyridine was used as the coupling partner. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.22 (s, 9H), 1.28 (s, 6H), 2.34 (s, 3H), 5.19 (s, 2H), 5.45 (s, 2H), 6.81 (dd, 1H), 6.88 (d, 2H), 6.96 (d, 1H), 7.32 (d, 1H), 7.36 (d, 2H), 7.49 (m, 3H), 8.40 (d, 1H), 8.47 (s, 1H), 8.53 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 612; observed 612.</div></div><div id="sec3_16_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-(4-pyridin-3-yl-benzyl)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11hh</b>)</h3><div class="NLM_p last">For step 2, 3-bromopyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.11 (s, 6H), 1.14 (s, 9H), 2.28 (s, 3H), 3.23 (s, 2H), 5.15 (s, 2H), 5.54 (s, 2H), 6.83 (dd, 1H), 6.93 (d, 2H), 7.11 (d, 1H), 7.33 (d, 1H), 7.38 (d, 1H), 7.42 (dd, 1H), 7.58 (d, 1H), 7.62 (d, 2H), 8.00 (d, 1H), 8.40 (s, 1H), 8.53 (d, 1H), 8.83 (d, 1H), 12.41 (br s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 594; observed 594.</div></div><div id="sec3_16_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 3-[3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-(4-pyridin-2-yl-benzyl)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11ii</b>)</h3><div class="NLM_p last">For step 2, 2-chloropyridine was used in the cross-coupling reaction. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13 (s, 15H), 2.28 (s, 3H), 3.22 (s, 2H), 5.15 (s, 2H), 5.54 (s, 2H), 6.83 (dd, 1H), 6.92 (d, 2H), 7.10 (d, 1H), 7.35 (m, 3H), 7.60 (dd, 1H), 7.80–7.98 (m, 4H), 8.41 (s, 1H), 8.61 (d, 1H), 12.42 (br s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 594; observed 594.</div></div><div id="sec3_16_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(5-methoxypyrimidin-2-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11kk</b>)</h3><div class="NLM_p last">For step 2, 2-chloro-5-fluoropyrimidine was used in the cross-coupling step. In step 4 (ester hydrolysis), the reaction time was prolonged to 72 h at 65 °C to force complete displacement of the fluoride with methoxide. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.21 (s, 9H), 1.26 (s, 6H), 2.33 (s, 3H), 3.33 (s, 2H), 3.92 (s, 3H), 5.21 (s, 2H), 5.44 (s, 2H), 6.81 (m, 3H), 6.99 (d, 1H), 7.30 (d, 1H), 7.46 (d, 1H), 7.52 (d, 1H), 8.12 (s, 1H), 8.15 (s, 1H), 8.43 (s, 2H), 8.45 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 625; observed 625.</div></div><div id="sec3_16_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methyl-1-oxypyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>11ll</b>)</h3><div class="NLM_p last">For step 2, 5-bromo-2-ethoxypyridine was used as the coupling partner, and in step 3 compound <b>16g</b> was used as the alkylating agent. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (s, 9H), 1.25 (s, 6H), 1.40 (t, 3H), 2.33 (s, 3H), 3.34 (s, 2H), 4.36 (q, 2H), 5.39 (s, 2H), 5.44 (s, 2H), 6.74 (d, 1H), 6.84 (m, 3H), 7.04 (d, 1H), 7.22 (d, 1H), 7.35 (m, 3H), 7.60 (d, 1H), 7.69 (dd, 1H), 8.29 (s, 2H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 654; observed 654.</div></div><div id="sec3_16_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 3-{3-<i>tert</i>-Butylsulfanyl-5-(5-methylpyridin-2-ylmethoxy)-1-[4-(6-oxo-1,6-dihydropyridin-3-yl)benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethylpropionic Acid (<b>11jj</b>)</h3><div class="NLM_p last">To the sodium salt of <b>11cc</b> (prepared through reaction of <b>11cc</b> with 1 equiv of NaOH in EtOH for 1 h and evaporation in vacuo; 700 mg, 1.06 mmol) in ethylene glycol (5 mL) was added LiOH·H<sub>2</sub>O (400 mg, 10 mmol) in a sealable vessel, and the mixture was heated to 165 °C for 1 week. LCMS analysis indicated incomplete reaction. The reaction mixture was allowed to cool and diluted with EtOAc. Water and solid citric acid were added until aqueous pH was ∼4. The aqueous layer was extracted with EtOAc and the organic phase dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified using silica gel chromatography (0–7% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (s, 15H), 2.33 (s, 3H), 3.56 (s, 2H), 5.23 (s, 2H), 5.59 (br s, 2H), 6.54 (d, 1H), 6.66 (d, 1H), 6.75 (dd, 1H), 6.94 (d, 2H), 7.01 (d, 2H), 7.13 (s, 1H), 7.31 (s, 1H), 7.44 (d, 1H), 7.51 (d, 1H), 7.63 (d, 1H), 8.42 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 610; observed 610.</div></div><div id="sec3_16_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 3-[1-[4-(6-Ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>29</b>)</h3><div class="NLM_p last">To an ice cooled suspension of anhydrous AlCl<sub>3</sub> (1.38 g, 10.34 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) was added water (138 μL, 7.66 mmol) dropwise, and the solution was allowed to attain ambient temperature. After 20 min the solution was recooled to 0 °C and a solution of the ethyl ester of <b>11cc</b> (isolated product from step 3 of route B; 1.70 g, 2.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) was added over a period of 5 min. After 1 h, TLC analysis indicated a 60:40 product/SM mixture. The mixture was cooled to 0 °C, and anhydrous AlCl<sub>3</sub> (1.25 g, 9.37 mmol) and water (125 μL, 6.94 mmol) were added sequentially. The mixture was stirred at ambient temperature for 1 h and the reaction quenched upon addition of 0.5 N aqueous sodium potassium tartrate solution with vigorous stirring for 1 h. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the organic phase was dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–35% EtOAc in hexanes) afforded 1.07 g (73%) of the ethyl ester of <b>29</b>. To the isolated ester (100 mg, 0.173 mmol) in a mixture of THF (3 mL), MeOH (1 mL) and water (1 mL) were added LiOH·H<sub>2</sub>O (35 mg, 0.833 mmol). The mixture was heated at 60 °C for 4 h. The mixture was diluted with EtOAc and water, and solid citric acid was added to acidify the aqueous layer to a pH of ∼3, after which the aqueous layer was extracted with EtOAc and the organic phase dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to yield the title compound as a colorless solid in quantitative yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.32 (s, 6H), 1.40 (t, 3H), 2.33 (s, 3H), 3.00 (s, 2H), 4.36 (q, 2H), 5.13 (s, 2H), 5.34 (s, 2H), 6.38 (s, 1H), 6.74 (d, 1H), 6.81 (dd, 1H), 6.90 (d, 2H), 6.99 (d, 1H), 7.03 (d, 1H), 7.33 (d, 2H), 7.46 (d, 1H), 7.53 (dd, 1H), 7.67 (dd, 1H), 8.27 (d, 1H), 8.45 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 550; observed 550.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>rac</i>-3-[1-[4-(6-Ethoxypyridin-3-yl)benzyl]-3-(2-methylpropane-2-sulfinyl)-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>30</b>)</h3><div class="NLM_p last">3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic acid <b>(11cc</b>, 75.0 mg, 0.118 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) and cooled to −20 °C. <i>m</i>-CPBA (29.0 mg, 0.118 mmol) was added and the solution slowly warmed to 0 °C. Upon completion of the reaction as judged by TLC analysis, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with water and the organic phase separated, dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded 65 mg (85%) of the title compound as a colorless solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.29 (s, 9H), 1.37 (s, 6H), 1.40 (t, 3H), 2.34 (s, 3H), 3.11 (d, 1H), 3.23 (d, 1H), 4.36 (q, 2H), 5.14 (app q, 2H), 5.29 (d, 1H), 5.47 (d, 1H), 6.74 (d, 1H), 6.80 (m, 3H), 7.00 (d, 1H), 7.38 (d, 2H), 7.43 (d, 1H), 7.53 (dd, 1H), 7.67 (dd, 1H), 7.78 (s, 1H), 8.26 (d, 1H), 8.45 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 654; observed 654.</div></div><div id="sec3_17_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 3-[3-(3,3-Dimethylbutyryl)-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>31a</b>)</h3><div class="NLM_p last">To a solution of the ethyl ester of <b>29</b> (150 mg, 0.26 mmol) in 1,2-dichloroethane were added anhydrous AlCl<sub>3</sub> (104 mg, 0.78 mmol) and <i>tert</i>-butylacetyl chloride (72 μL, 0.52 mmol), and the reaction mixture was heated to 65 °C under nitrogen for 1 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (25 mL) and 0.5 N aqueous sodium potassium tartrate solution added (25 mL). The mixture was vigorously stirred for 1 h. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> and the organic phase dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. Purification of the residue using silica gel chromatography (ISCO, 0–40% EtOAc in hexanes) afforded 114 mg (65%) of the ester of the title compound. The isolated ester (114 mg, 0.17 mmol) was dissolved in a mixture of THF (3 mL), MeOH (1 mL), and water (1 mL). LiOH·H<sub>2</sub>O (40 mg, 0.95 mmol) was added, and the mixture was heated to 60 °C. Upon completion of the hydrolysis (∼2 h) the mixture was allowed to cool and diluted with EtOAc and water. The aqueous pH was adjusted to ∼3 with the addition of solid citric acid, the mixture extracted with EtOAc, and the organic phase dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to yield the title compound as a colorless solid in quantitative yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.09 (s, 9H), 1.32 (s, 6H), 1.40 (t, 3H), 2.36 (s, 3H), 2,90 (s, 2H), 3.64 (s, 2H), 4.36 (q, 2H), 5.17 (s, 2H), 5.40 (s, 2H), 6.74 (d, 1H), 6.81 (dd, 1H), 6.85 (d, 2H), 6.99 (d, 1H), 7.33 (d, 2H), 7.47 (s, 1H), 7.49 (d, 1H), 7.57 (dd, 1H), 7.67 (dd, 1H), 8.26 (d, 1H), 8.48 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 648; observed 648.</div></div><div id="sec3_17_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 3-[1-[4-(6-Ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-3-phenylacetyl-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (<b>31b</b>)</h3><div class="NLM_p last"><b>31b</b> was prepared in the same manner as <b>31a</b> using phenylacetyl chloride as electrophile. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.29 (s, 6H), 1.40 (t, 3H), 2.35 (s, 3H), 3.66 (s, 2H), 4.33 (s, 2H), 4.36 (q, 2H), 5.08 (s, 2H), 5.36 (s, 2H), 6.74 (d, 1H), 6.79 (dd, 1H), 6.82 (d, 2H), 6.92 (d, 1H), 7.22–7.33 (m, 8H), 7.49 (s, 1H), 7.58 (dd, 1H), 7.65 (dd, 1H), 8.25 (d, 1H), 8.47 (s, 1H). [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calculated 668; observed 668.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/jm2008369">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Information for the characterization of final compounds <b>11b</b>, <b>11d</b>–<b>11z</b>, <b>11bb</b>–<b>11ll</b> and <b>29</b>, <b>30</b>, <b>31a</b>,<b>b</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2008369/suppl_file/jm2008369_si_006.pdf">jm2008369_si_006.pdf (1.31 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2008369" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas S. Stock</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0d637e79626e664d64636e687d796462637e6e64236e6260"><span class="__cf_email__" data-cfemail="a4cad7d0cbc7cfe4cdcac7c1d4d0cdcbcad7c7cd8ac7cbc9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gretchen Bain</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jasmine Zunic</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiwei Li</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeannie Ziff</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Roppe</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelina Santini</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janice Darlington</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pat Prodanovich</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher D. King</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Baccei</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Lee</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haojing Rong</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Chapman</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex Broadhead</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Lorrain</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucia Correa</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John H. Hutchinson</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jilly F. Evans</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peppi Prasit</span> - <span class="hlFld-Affiliation affiliation">Departments
of †Chemistry, ‡Biology, and §Drug Metabolism, Amira Pharmaceuticals, 9535 Waples Road,
Suite 100, San Diego, California 92121, United
States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d1623e4582-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Brian Stearns for assistance in preparing the tritiated FLAP ligand used in our binding studies.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i90" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i90"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> Abbreviations Used</h2><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">LT</td><td class="NLM_def"><p class="first last">leukotriene</p></td></tr><tr><td class="NLM_term">5-LO</td><td class="NLM_def"><p class="first last">5-lipoxygenase</p></td></tr><tr><td class="NLM_term">FLAP</td><td class="NLM_def"><p class="first last">five-lipoxygenase activating protein</p></td></tr><tr><td class="NLM_term">5-HpETE</td><td class="NLM_def"><p class="first last">(5S,6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-5-hydroperoxy-6,8,11,14-eicosatetraenoic acid</p></td></tr><tr><td class="NLM_term">5-oxo-ETE</td><td class="NLM_def"><p class="first last">5-oxo-(6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-6,8,11,14-eicosatetraenoic acid</p></td></tr><tr><td class="NLM_term">CysLT</td><td class="NLM_def"><p class="first last">cysteinyl leukotriene</p></td></tr><tr><td class="NLM_term">CVD</td><td class="NLM_def"><p class="first last">cardiovascular disease</p></td></tr><tr><td class="NLM_term">hLA</td><td class="NLM_def"><p class="first last">human leukocyte assay</p></td></tr><tr><td class="NLM_term">hWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration required to achieve 50% inhibition</p></td></tr><tr><td class="NLM_term">hSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arruda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee., C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors: development of 3-{3-<i>tert</i>-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5803</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900945d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5803-5815&author=J.+H.+Hutchinsonauthor=Y.+Liauthor=J.+M.+Arrudaauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+Lee.author=D.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=N.+Stockauthor=P.+Prasitauthor=J.+F.+Evans&title=5-Lipoxygenase-activating+protein+inhibitors%3A+development+of+3-%7B3-tert-butylsulfanyl-1-%5B4-%286-methoxy-pyridin-3-yl%29-benzyl%5D-5-%28pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethyl-propionic+acid+%28AM103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm900945d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900945d%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DArruda%26aufirst%3DJ.%2BM.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DLee.%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors%253A%2520development%2520of%25203-%257B3-tert-butylsulfanyl-1-%255B4-%25286-methoxy-pyridin-3-yl%2529-benzyl%255D-5-%2528pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM103%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5803%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((<i>S</i>)-1-Acetyl-2,3-dihydro-1<i>H</i>-indol-2-ylmethoxy)-3-<i>tert</i>-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—a potent FLAP inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=213-217&author=N.+Stockauthor=C.+Bacceiauthor=G.+Bainauthor=A.+Broadheadauthor=C.+Chapmanauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=Y.+Liauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=J.+Zunicauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=5-Lipoxygenase-activating+protein+inhibitors.+Part+2%3A+3-%7B5-%28%28S%29-1-Acetyl-2%2C3-dihydro-1H-indol-2-ylmethoxy%29-3-tert-butylsulfanyl-1-%5B4-%285-methoxy-pyrimidin-2-yl%29-benzyl%5D-1H-indol-2-yl%7D-2%2C2-dimethyl-propionic+acid+%28AM679%29%E2%80%94a+potent+FLAP+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DBroadhead%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DZunic%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors.%2520Part%25202%253A%25203-%257B5-%2528%2528S%2529-1-Acetyl-2%252C3-dihydro-1H-indol-2-ylmethoxy%2529-3-tert-butylsulfanyl-1-%255B4-%25285-methoxy-pyrimidin-2-yl%2529-benzyl%255D-1H-indol-2-yl%257D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM679%2529%25E2%2580%2594a%2520potent%2520FLAP%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D213%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-<i>tert</i>-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—a potent FLAP inhibitor suitable for topical administration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4598</span><span class="NLM_x">–</span> <span class="NLM_lpage">4601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4598-4601&author=N.+Stockauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=A.+Santiniauthor=K.+Schaabauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=5-Lipoxygenase-activating+protein+inhibitors.+Part+3%3A+3-%7B3-tert-Butylsulfanyl-1-%5B4-%285-methoxy-pyrimidin-2-yl%29-benzyl%5D-5-%285-methyl-pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethyl-propionic+acid+%28AM643%29%E2%80%94a+potent+FLAP+inhibitor+suitable+for+topical+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DSchaab%26aufirst%3DK.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors.%2520Part%25203%253A%25203-%257B3-tert-Butylsulfanyl-1-%255B4-%25285-methoxy-pyrimidin-2-yl%2529-benzyl%255D-5-%25285-methyl-pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM643%2529%25E2%2580%2594a%2520potent%2520FLAP%2520inhibitor%2520suitable%2520for%2520topical%2520administration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4598%26epage%3D4601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">The discovery of the leukotrienes</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">S2</span><span class="NLM_x">–</span> <span class="NLM_lpage">S6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2000&pages=S2-S6&author=B.+Samuelsson&title=The+discovery+of+the+leukotrienes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DThe%2520discovery%2520of%2520the%2520leukotrienes%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2000%26volume%3D161%26spage%3DS2%26epage%3DS6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">What’s all the FLAP about? 5-Lipoxygenase-activating protein inhibitors for inflammatory diseases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=72-78&author=J.+F.+Evansauthor=A.+D.+Fergusonauthor=R.+T.+Mosleyauthor=J.+H.+Hutchinson&title=What%E2%80%99s+all+the+FLAP+about%3F+5-Lipoxygenase-activating+protein+inhibitors+for+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DWhat%25E2%2580%2599s%2520all%2520the%2520FLAP%2520about%253F%25205-Lipoxygenase-activating%2520protein%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D72%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Grant, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, W. S.</span><span> </span><span class="NLM_article-title">5-Oxo-ETE and the OXE receptor</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2Fj.prostaglandins.2009.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=19450703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=98-104&author=E.+G.+Grantauthor=J.+Rokachauthor=W.+S.+Powell&title=5-Oxo-ETE+and+the+OXE+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">5-Oxo-ETE and the OXE receptor</span></div><div class="casAuthors">Grant, Gail E.; Rokach, Joshua; Powell, William S.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  5-Oxo-ETE is a product of the 5-lipoxygenase pathway that is formed by the oxidn. of 5-HETE by 5-hydroxyeicosanoid dehydrogenase (5-HEDH). 5-HEDH is a microsomal NADP+-dependent enzyme that is highly selective for 5-HETE. 5-Oxo-ETE synthesis is regulated by intracellular NADP+ levels and is dramatically increased under conditions that favor oxidn. of NADPH to NADP+ such as oxidative stress and the respiratory burst in phagocytic cells. 5-Oxo-ETE is a potent chemoattractant for eosinophils and has similar effects on neutrophils, basophils and monocytes.  It elicits infiltration of eosinophils and, to a lesser extent, neutrophils into the skin after intradermal injection in humans.  It also promotes the survival of tumor cells and has been shown to block the induction of apoptosis by 5-LO inhibitors. 5-Oxo-ETE acts by the Gi/o-coupled OXE receptor, which was also known as TG1019, R527 and hGPCR48.  Although the pathophysiol. role of 5-oxo-ETE is not well understood, it may play important roles in asthma and allergic diseases, cancer, and cardiovascular disease.  The availability of a selective antagonist would help to clarify the role of 5-oxo-ETE and may be of therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdkkS0fmsMLVg90H21EOLACvtfcHk0ljB21xjj6zxxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7nE&md5=d4175150c556c310c476bc9496b48766</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DE.%2BG.%26aulast%3DRokach%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DW.%2BS.%26atitle%3D5-Oxo-ETE%2520and%2520the%2520OXE%2520receptor%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2009%26volume%3D89%26spage%3D98%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Peters-Golden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, W. R.</span><span> </span><span class="NLM_article-title">Mechanisms of disease. Leukotrienes</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1056%2FNEJMra071371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17978293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=1841-1854&author=M.+Peters-Goldenauthor=W.+R.+Henderson&title=Mechanisms+of+disease.+Leukotrienes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotrienes</span></div><div class="casAuthors">Peters-Golden, Marc; Henderson, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1841-1854</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Leukotrienes comprise a family of products of the 5-lipoxygenase pathway of arachidonic acid metab.  The cysteinyl leukotrienes C4, D4, and E4 account for the biol. activity that was previously termed "slow-reacting substance of anaphylaxis", and the efficacy of antagonists to type 1 cysteinyl leukotriene receptor (CysLT1) in asthma validates the importance of cysteinyl leukotrienes and CysLT1 in this disease.  Here, the authors discuss: synthesis of leukotrienes; leukotriene receptors; blockade of leukotriene synthesis and leukotriene receptors; leukotrienes in disease; and leukotrienes in antimicrobial defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjehKHMPz2p7Vg90H21EOLACvtfcHk0ljB21xjj6zxxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM&md5=4e617e65cf4b1f55f595bc03344fdb55</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra071371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra071371%26sid%3Dliteratum%253Aachs%26aulast%3DPeters-Golden%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26atitle%3DMechanisms%2520of%2520disease.%2520Leukotrienes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D1841%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">BLT1 and BLT2: the leukotriene B4 receptors</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0952-3278%2803%2900073-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=12895595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=123-134&author=A.+M.+Tagerauthor=A.+D.+Luster&title=BLT1+and+BLT2%3A+the+leukotriene+B4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BLT1 and BLT2: the leukotriene B4 receptors</span></div><div class="casAuthors">Tager, Andrew M.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Two receptors for LTB4 have been molecularly identified: BLT1 and BLT2.  Both receptors are G protein-coupled 7 transmembrane domain receptors, whose genes are located in very close proximity to each other in the human and mouse genomes.  The 2 receptors differ in their affinity and specificity for LTB4: BLT1 is a high-affinity receptor specific for LTB4, whereas BLT2 is a low-affinity receptor that also binds other eicosanoids.  The 2 receptors also differ in their pattern of expression with BLT1 being expressed primarily in leukocytes, whereas BLT2 is expressed more ubiquitously.  By mediating the activities of LTB4, these receptors participate both in host immune responses and in the pathogenesis of inflammatory diseases.  Reduced disease severity in animal inflammatory models seen with LTB4 receptor antagonists and in mice with targeted deletion of BLT1 have revealed important roles for LTB4 and its receptors in regulating pathol. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fxBgFGg_3bVg90H21EOLACvtfcHk0ljB21xjj6zxxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbw%253D&md5=e60a4de33d9c99c03f2a30d8153757de</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0952-3278%2803%2900073-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-3278%252803%252900073-5%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DBLT1%2520and%2520BLT2%253A%2520the%2520leukotriene%2520B4%2520receptors%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2003%26volume%3D69%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooks, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene CysLT1 receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=789-793&author=K.+R.+Lynchauthor=G.+P.+O%E2%80%99Neillauthor=Q.+Liuauthor=D.-S.+Imauthor=N.+Sawyerauthor=K.+M.+Mettersauthor=N.+Coulombeauthor=M.+Abramovitzauthor=D.+J.+Figueroaauthor=Z.+Zengauthor=B.+M.+Connollyauthor=C.+Baiauthor=C.+P.+Austinauthor=A.+Chateauneufauthor=R.+Stoccoauthor=G.+M.+Greigauthor=S.+Kargmanauthor=S.+B.+Hooksauthor=E.+Hosfieldauthor=D.+L.+Williamsauthor=A.+W.+Ford-Hutchinsonauthor=C.+T.+Caskeyauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+CysLT1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DConnolly%26aufirst%3DB.%2BM.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DGreig%26aufirst%3DG.%2BM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DHosfield%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%2520CysLT1%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D789%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellefeuille, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene 2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30531</span><span class="NLM_x">–</span> <span class="NLM_lpage">30536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1074%2Fjbc.M003490200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=10851239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30531-30536&author=C.+E.+Heiseauthor=B.+F.+O%E2%80%99Dowdauthor=D.+J.+Figueroaauthor=N.+Sawyerauthor=T.+Nguyenauthor=D.-S.+Imauthor=R.+Stoccoauthor=J.+N.+Bellefeuilleauthor=M.+Abramovitzauthor=R.+Chengauthor=D.+L.+Williamsauthor=Z.+Zengauthor=Q.+Liuauthor=L.+Maauthor=M.+K.+Clementsauthor=N.+Coulombeauthor=Y.+Liuauthor=C.+P.+Austinauthor=S.+R.+Georgeauthor=G.+P.+O%E2%80%99Neillauthor=K.+M.+Mettersauthor=K.+R.+Lynchauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human cysteinyl leukotriene 2 receptor</span></div><div class="casAuthors">Heise, Christopher E.; O'Dowd, Brian F.; Figueroa, David J.; Sawyer, Nicole; Nguyen, Tuan; Im, Dong-Soon; Stocco, Rino; Bellefeuille, Julie N.; Abramovitz, Mark; Cheng, Regina; Williams, David L., Jr.; Zeng, Zhizhen; Liu, Qingyun; Ma, Lei; Clements, Michelle K.; Coulombe, Nathalie; Liu, Yuan; Austin, Christopher P.; George, Susan R.; O'Neill, Gary P.; Metters, Kathleen M.; Lynch, Kevin R.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30531-30536</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The contractile and inflammatory actions of the cysteinyl leukotrienes (CysLTs), LTC4, LTD4, and LTE4, are thought to be mediated through at least two distinct but related CysLT G protein-coupled receptors.  The human CysLT1 receptor has been recently cloned and characterized.  We describe here the cloning and characterization of the second cysteinyl leukotriene receptor, CysLT2, a 346-amino acid protein with 38% amino acid identity to the CysLT1 receptor.  The recombinant human CysLT2 receptor was expressed in Xenopus oocytes and HEK293T cells and shown to couple to elevation of intracellular calcium when activated by LTC4, LTD4, or LTE4.  Analyses of radiolabeled LTD4 binding to the recombinant CysLT2 receptor demonstrated high affinity binding and a rank order of potency for competition of LTC4 = LTD4 » LTE4.  In contrast to the dual CysLT1/CysLT2 antagonist, BAY u9773, the CysLT1 receptor-selective antagonists MK-571, montelukast, zafirlukast, and pranlukast exhibited low potency in competition for LTD4 binding and as antagonists of CysLT2 receptor signaling.  CysLT2 receptor mRNA was detected in lung macrophages and airway smooth muscle, cardiac Purkinje cells, adrenal medulla cells, peripheral blood leukocytes, and brain, and the receptor gene was mapped to chromosome 13q14, a region linked to atopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNARzHAjs1wLVg90H21EOLACvtfcHk0lhUSqkGQ3Texw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D&md5=a3c128d90e193664c2180e3029d8b96d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003490200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003490200%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DBellefeuille%26aufirst%3DJ.%2BN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%25202%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30531%26epage%3D30536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Beller, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, Y.</span><span> </span><span class="NLM_article-title">Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46129</span><span class="NLM_x">–</span> <span class="NLM_lpage">46134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46129-46134&author=T.+C.+Bellerauthor=A.+Maekawaauthor=D.+S.+Friendauthor=K.+F.+Austenauthor=Y.+Kanaoka&title=Targeted+gene+disruption+reveals+the+role+of+the+cysteinyl+leukotriene+2+receptor+in+increased+vascular+permeability+and+in+bleomycin-induced+pulmonary+fibrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeller%26aufirst%3DT.%2BC.%26aulast%3DMaekawa%26aufirst%3DA.%26aulast%3DFriend%26aufirst%3DD.%2BS.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DKanaoka%26aufirst%3DY.%26atitle%3DTargeted%2520gene%2520disruption%2520reveals%2520the%2520role%2520of%2520the%2520cysteinyl%2520leukotriene%25202%2520receptor%2520in%2520increased%2520vascular%2520permeability%2520and%2520in%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46129%26epage%3D46134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kamohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushime, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span> </span><span class="NLM_article-title">Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=1088-1092&author=M.+Kamoharaauthor=J.+Takasakiauthor=M.+Matsumotoauthor=S-i.+Matsumotoauthor=T.+Saitoauthor=T.+Sogaauthor=H.+Matsushimeauthor=K.+Furuichi&title=Functional+characterization+of+cysteinyl+leukotriene+CysLT2+receptor+on+human+coronary+artery+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamohara%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS-i.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DMatsushime%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26atitle%3DFunctional%2520characterization%2520of%2520cysteinyl%2520leukotriene%2520CysLT2%2520receptor%2520on%2520human%2520coronary%2520artery%2520smooth%2520muscle%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ciana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verderio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parravicini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelosa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcredito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sironi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovati, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span> </span><span class="NLM_article-title">The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=4615-4627&author=P.+Cianaauthor=M.+Fumagalliauthor=M.+L.+Trincavelliauthor=C.+Verderioauthor=P.+Rosaauthor=D.+Leccaauthor=S.+Ferrarioauthor=C.+Parraviciniauthor=V.+Capraauthor=P.+Gelosaauthor=U.+Guerriniauthor=S.+Belcreditoauthor=M.+Ciminoauthor=L.+Sironiauthor=E.+Tremoliauthor=G.+E.+Rovatiauthor=C.+Martiniauthor=M.+P.+Abbracchio&title=The+orphan+receptor+GPR17+identified+as+a+new+dual+uracil+nucleotides%2Fcysteinyl-leukotrienes+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiana%26aufirst%3DP.%26aulast%3DFumagalli%26aufirst%3DM.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DVerderio%26aufirst%3DC.%26aulast%3DRosa%26aufirst%3DP.%26aulast%3DLecca%26aufirst%3DD.%26aulast%3DFerrario%26aufirst%3DS.%26aulast%3DParravicini%26aufirst%3DC.%26aulast%3DCapra%26aufirst%3DV.%26aulast%3DGelosa%26aufirst%3DP.%26aulast%3DGuerrini%26aufirst%3DU.%26aulast%3DBelcredito%26aufirst%3DS.%26aulast%3DCimino%26aufirst%3DM.%26aulast%3DSironi%26aufirst%3DL.%26aulast%3DTremoli%26aufirst%3DE.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DThe%2520orphan%2520receptor%2520GPR17%2520identified%2520as%2520a%2520new%2520dual%2520uracil%2520nucleotides%252Fcysteinyl-leukotrienes%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramoto, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span> </span><span class="NLM_article-title">Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2005&pages=281-288&author=Y.+Nonakaauthor=T+Hiramotoauthor=N.+Fujita&title=Identification+of+endogenous+surrogate+ligands+for+human+P2Y12+receptors+by+in+silico+and+in+vitro+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DHiramoto%26aufirst%3DT%26aulast%3DFujita%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520endogenous%2520surrogate%2520ligands%2520for%2520human%2520P2Y12%2520receptors%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520methods%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D337%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Maekawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span> </span><span class="NLM_article-title">Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">16695</span><span class="NLM_x">–</span> <span class="NLM_lpage">16700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=16695-16700&author=A.+Maekawaauthor=Y.+Kanaokaauthor=X.+Xingauthor=K.+F.+Austen&title=Functional+recognition+of+a+distinct+receptor+preferential+for+leukotriene+E4+in+mice+lacking+the+cysteinyl+leukotriene+1+and+2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DA.%26aulast%3DKanaoka%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26atitle%3DFunctional%2520recognition%2520of%2520a%2520distinct%2520receptor%2520preferential%2520for%2520leukotriene%2520E4%2520in%2520mice%2520lacking%2520the%2520cysteinyl%2520leukotriene%25201%2520and%25202%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D16695%26epage%3D16700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Chandt, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, C. B.</span><span> </span><span class="NLM_article-title">Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1111%2Fj.1742-1241.2007.01320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17394438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=663-676&author=W.+Bergerauthor=M.+T.+De+Chandtauthor=C.+B.+Cairns&title=Zileuton%3A+clinical+implications+of+5-lipoxygenase+inhibition+in+severe+airway+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease</span></div><div class="casAuthors">Berger, W.; De Chandt, M. T. M.; Cairns, C. B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">663-676</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-Lipoxygenase pathway results in the formation of leukotrienes, including leukotriene B4 (LTB4), 5-oxo-6E,8Z,11Z,14Z-eicosatetranoic acid and the cysteinyl leukotrienes (LTC4, LTD4 and LTE4) and activates all four leukotriene receptors, BLT1, BLT2, cysLT1 and cysLT2.  Zileuton is the only com. available inhibitor of the 5-Lipoxygenase pathway.  In a no. of clin. trials, zileuton has been shown to improve airway function and inflammation, asthma symptom control and quality of life in asthmatics.  Given the important role that leukotrienes play in airway inflammation, zileuton provides an addnl. therapeutic option in the management of chronic, persistent asthma, particularly those asthmatics with more severe disease.  In addn., zileuton has shown promise in a no. of other conditions, including upper airway inflammatory conditions, dermatol. disease and chronic obstructive pulmonary disease.  The development of new formulations, including a controlled release tablet formulation for b.i.d. dosing and an i.v. prepn. for acute asthma exacerbations may enhance clin. utility and expand therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlBF2XBlKc5LVg90H21EOLACvtfcHk0li53-5IMcePrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KqsL8%253D&md5=49d295d1c310cb6e1f8b6e5ef75106f6</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2007.01320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2007.01320.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DDe%2BChandt%26aufirst%3DM.%2BT.%26aulast%3DCairns%26aufirst%3DC.%2BB.%26atitle%3DZileuton%253A%2520clinical%2520implications%2520of%25205-lipoxygenase%2520inhibition%2520in%2520severe%2520airway%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2007%26volume%3D61%26spage%3D663%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span> <span class="citation_source-book">Prescribing Information for ZYFLO CR</span>; <span class="NLM_publisher-name">Cornerstone Therapeutics, Inc</span>: <span class="NLM_publisher-loc">Lexington, MA</span>, May<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prescribing+Information+for+ZYFLO+CR%3B+Cornerstone+Therapeutics%2C+Inc%3A+Lexington%2C+MA%2C+May+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPrescribing%2520Information%2520for%2520ZYFLO%2520CR%26pub%3DCornerstone%2520Therapeutics%252C%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dahlen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterstrom, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlen, S. E.</span><span> </span><span class="NLM_article-title">Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005</span> <span class="citation_source-journal">Thorax</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1997&pages=342-347&author=B.+Dahlenauthor=M.+Kumlinauthor=E.+Ihreauthor=O.+Zetterstromauthor=S.+E.+Dahlen&title=Inhibition+of+allergen-induced+airway+obstruction+and+leukotriene+generation+in+atopic+asthmatic+subjects+by+the+leukotriene+biosynthesis+inhibitor+BAYx+1005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlen%26aufirst%3DB.%26aulast%3DKumlin%26aufirst%3DM.%26aulast%3DIhre%26aufirst%3DE.%26aulast%3DZetterstrom%26aufirst%3DO.%26aulast%3DDahlen%26aufirst%3DS.%2BE.%26atitle%3DInhibition%2520of%2520allergen-induced%2520airway%2520obstruction%2520and%2520leukotriene%2520generation%2520in%2520atopic%2520asthmatic%2520subjects%2520by%2520the%2520leukotriene%2520biosynthesis%2520inhibitor%2520BAYx%25201005%26jtitle%3DThorax%26date%3D1997%26volume%3D52%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Friedman, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buntinx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, P.</span><span> </span><span class="NLM_article-title">Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=8385430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A280%3ADyaK3s3itFSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1993&pages=839-844&author=B.+S.+Friedmanauthor=E.+H.+Belauthor=A.+Buntinxauthor=W.+Tanakaauthor=Y.+H.+Hanauthor=S.+Shingoauthor=R.+Spectorauthor=P.+Sterk&title=Oral+leukotriene+inhibitor+%28MK-886%29+blocks+allergen-induced+airway+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses</span></div><div class="casAuthors">Friedman B S; Bel E H; Buntinx A; Tanaka W; Han Y H; Shingo S; Spector R; Sterk P</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">839-44</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">To elucidate the role of leukotrienes (LT) in allergic asthma in humans the effect of MK-886, an LT biosynthesis inhibitor, was evaluated on antigen-induced early (EAR) and late (LAR) asthmatic reactions and bronchial responsiveness to histamine.  Eight atopic men participated in a two-part, double-blind, placebo-controlled, crossover trial.  MK-886 was administered in two oral doses of 500 mg and 250 mg, 1 h before and 2 h after allergen inhalation, respectively.  Biochemical effects of MK-886 were evaluated by the inhibition of urinary LTE4 excretion and calcium ionophore-stimulated LTB4 biosynthesis in whole blood ex vivo.  MK-886 significantly inhibited the EAR by 58.4% (AUC0-3 h) and the LAR by 43.6% (AUC3-7 h) when compared with placebo (p < 0.01).  There was no difference in PC20 histamine 30 h post allergen challenge between MK-886 and placebo (0.33 and 0.27 doubling doses, p > 0.1).  MK-886 inhibited calcium ionophore-stimulated LTB4 production in whole blood (54.2 +/- 25.6%) for up to 6 h post allergen challenge.  LTE4 excretion in urine was inhibited by 51.5% during the EAR by as much as 80% during the LAR.  This indicates that LT play a role in allergen-induced asthmatic reactions in humans in vivo and that LT synthesis inhibitors such as MK-886 should be further explored for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0hYXRy8PyYJI8NvIb08rbfW6udTcc2ebY4PfYCdtngLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3itFSitA%253D%253D&md5=c445dfbaa26091699c82144488aca55f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DB.%2BS.%26aulast%3DBel%26aufirst%3DE.%2BH.%26aulast%3DBuntinx%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DShingo%26aufirst%3DS.%26aulast%3DSpector%26aufirst%3DR.%26aulast%3DSterk%26aufirst%3DP.%26atitle%3DOral%2520leukotriene%2520inhibitor%2520%2528MK-886%2529%2520blocks%2520allergen-induced%2520airway%2520responses%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1993%26volume%3D147%26spage%3D839%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Diamant, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmers, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Veen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depré, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, P. J.</span><span> </span><span class="NLM_article-title">The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0091-6749%2895%2970151-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=7822663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK2MXptlaksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=42-51&author=Z.+Diamantauthor=M.+C.+Timmersauthor=H.+van+der+Veenauthor=B.+S.+Friedmanauthor=M.+De+Smetauthor=M.+Depr%C3%A9author=D.+Hilliardauthor=E.+H.+Belauthor=P.+J.+Sterk&title=The+effect+of+MK-0591%2C+a+novel+5-lipoxygenase+activating+protein+inhibitor%2C+on+leukotriene+biosynthesis+and+allergen-induced+airway+responses+in+asthmatic+subjects+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo</span></div><div class="casAuthors">Diamant, Zuzana; Timmers, Mieke C.; van der Veen, Hilly; Friedman, Beth S.; De Smet, Marina; Depre, Marleen; Hilliard, Deborah; Bel, Elisabeth H.; Sterk, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book</span>)
        </div><div class="casAbstract">The 5-lipoxygenase metabolites of arachidonic acid are likely to be involved in the pathophysiol. of atopic asthma.  We investigated the effect of pretreatment with MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on allergen-induced early asthmatic reactions (EARs) and late asthmatic reactions (LARs), and subsequent airway hyperresponsiveness to histamine.  Eight atopic men with mild to moderate asthma aged 19 to 31 yr, (forced expiratory vol. in 1 s [FEV1] ≥67% of predicted value, histamine provocative concn. causing a 20% fall in FEV1 [PC20] <4 mg/mL) and documented EAR and LAR to house dust mite ext. participated in a two-period, double-blind, placebo-controlled, crossover study.  During each study period histamine PC20 was measured 2 days before and 1 day after a standardized allergen inhalation challenge test.  MK-0591 was administered in 3 oral doses of 250 mg each at 24, 12, and 1.5 h before inhalation of allergen.  Biochem. activity of MK-0591 was detd. by calcium ionophore A-23187-stimulated leukotriene (LT)B4 biosynthesis in whole blood ex vivo and by urinary LTE4 excretion.  Airway response to allergen was measured by FEV1 (percent fall from baseline).  The EAR (0 to 3 h) and the LAR (3 to 8 h) were expressed as corresponding areas under the time-response curves.  MK-0591 and placebo did not differ in their effects on prechallenge FEV1 (p = 0.10).  As compared with the value before pretreatment, MK-0591 blocked LTB4 biosynthesis and LTE4 excretion by a mean of 98% (range, 96% to 99%; p < 0.002) and 87% (range, 84% to 96%; p < 0.046), resp., from 0 to 24 h after allergen challenge.  Both the EAR and the LAR were significantly reduced after administration of MK-0591 as compared with placebo, with a mean inhibition of 79% (p = 0.011) and 39% (p = 0.040), resp.  Allergen-induced airway hyperresponsiveness was not significantly different between the two pretreatment periods (p = 0.37).  In this study oral MK-0591 prevented leukotriene biosynthesis after allergen challenge in patients with mild to moderate asthma.  The results of our study indicate that 5-lipoxygenase products play an important role during the EAR, whereas their contribution to the pathophysiol. of the LAR seems to be of less importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1x0C2Od-G0LVg90H21EOLACvtfcHk0li1xXUDLZKZUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlaksb4%253D&md5=c4514925d708c4e4fd36d5547dc21aa4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0091-6749%2895%2970151-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-6749%252895%252970151-6%26sid%3Dliteratum%253Aachs%26aulast%3DDiamant%26aufirst%3DZ.%26aulast%3DTimmers%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BVeen%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DB.%2BS.%26aulast%3DDe%2BSmet%26aufirst%3DM.%26aulast%3DDepr%25C3%25A9%26aufirst%3DM.%26aulast%3DHilliard%26aufirst%3DD.%26aulast%3DBel%26aufirst%3DE.%2BH.%26aulast%3DSterk%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520effect%2520of%2520MK-0591%252C%2520a%2520novel%25205-lipoxygenase%2520activating%2520protein%2520inhibitor%252C%2520on%2520leukotriene%2520biosynthesis%2520and%2520allergen-induced%2520airway%2520responses%2520in%2520asthmatic%2520subjects%2520in%2520vivo%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D1995%26volume%3D95%26spage%3D42%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piechuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, W. M.</span><span> </span><span class="NLM_article-title">Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(<i>t</i>-butylthio)-5-(quinolin-2-ylmethoxy)-indol-2-yl]-2,2-dimethylpropanoic acid), a potent, orally active leukotriene biosynthesis inhibitor</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1139%2Fy92-107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=1330258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1GqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=799-807&author=C.+Brideauauthor=C.+Chanauthor=S.+Charlesonauthor=D.+Denisauthor=J.+F.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=J.+H.+Hutchinsonauthor=T.+R.+Jonesauthor=S.+L%C3%A9gerauthor=J.+A.+Manciniauthor=C.+S.+McFarlaneauthor=C.+Pickettauthor=H.+Piechutaauthor=P.+Prasitauthor=D.+Riendeauauthor=C.+A.+Rouzerauthor=P.+Tagariauthor=P.+J.+Vickersauthor=R.+N.+Youngauthor=W.+M.+Abraham&title=Pharmacology+of+MK-0591+%283-%5B1-%284-chlorobenzyl%29-3-%28t-butylthio%29-5-%28quinolin-2-ylmethoxy%29-indol-2-yl%5D-2%2C2-dimethylpropanoic+acid%29%2C+a+potent%2C+orally+active+leukotriene+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor</span></div><div class="casAuthors">Brideau, C.; Chan, C.; Charleson, S.; Denis, D.; Evans, J. F.; Ford-Hutchinson, A. W.; Fortin, R.; Gillard, J. W.; Guay, J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-807</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">MK-0591 (I, previously L-686,708) is a potent inhibitor of leukotriene (LT) biosynthesis in intact human and elicited rat polymorphonuclear leukocytes (PMNLs) (IC50 values 3.1 and 6.1 nM, resp.) and in human, squirrel monkey, and rat whole blood (IC50 values 510, 69, and 9 nM, resp).  MK-0591 had no effect on rat 5-lipoxygenase.  MK-0591 has a high affinity for 5-lipoxygenase activating protein (FLAP) as evidenced by an IC50 value of 1.6 nM in a FLAP binding assay and inhibition of the photoaffinity labeling of FLAP by two different photoaffinity ligands.  Inhibition of activation of 5-lipoxygenase was shown through inhibition of the translocation of the enzyme from the cytosol to the membrane in human PMNLs.  MK-0591 was a potent inhibitor of LT biosynthesis in vivo, first, following ex vivo challenge of blood obtained from treated rats and squirrel monkeys, second, in rat pleurisy model, and, third, as monitored by inhibition of the urinary excretion of the LTE4 in antigen-challenged allergic sheep.  Inhibition of antigen-induced bronchoconstriction by MK-0951 was obsd. in inbred rats pretreated with methysergide, Ascaris-challenged squirrel monkeys, and Ascaris-challenged sheep (early and late phase response).  These results indicate that MK-0591 is a potent inhibitor of LT biosynthesis, both in vitro and in vivo, indicating that the compd will be suitable for assessing the role of leukotrienes in pathol. situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36suu6bJUo7Vg90H21EOLACvtfcHk0li1xXUDLZKZUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1GqsLg%253D&md5=c6159363af5cdbb670de65dc5bbcd2f3</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1139%2Fy92-107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy92-107%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DMcFarlane%26aufirst%3DC.%2BS.%26aulast%3DPickett%26aufirst%3DC.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DVickers%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26atitle%3DPharmacology%2520of%2520MK-0591%2520%25283-%255B1-%25284-chlorobenzyl%2529-3-%2528t-butylthio%2529-5-%2528quinolin-2-ylmethoxy%2529-indol-2-yl%255D-2%252C2-dimethylpropanoic%2520acid%2529%252C%2520a%2520potent%252C%2520orally%2520active%2520leukotriene%2520biosynthesis%2520inhibitor%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1992%26volume%3D70%26spage%3D799%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_contrib-group">Young, R. N.</span><span> </span><span class="NLM_article-title">Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be realized?</span> <span class="citation_source-journal">Eur. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0223-5234%2899%2900225-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK1MXntVWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=671-685&author=R.+N.+Young&title=Inhibitors+of+5-lipoxygenase%3A+a+therapeutic+potential+yet+to+be+realized%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?</span></div><div class="casAuthors">Young, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-685</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review, with 113 refs.  Inhibition of leukotriene biosynthesis has been extensively studied as a potential for the development of novel therapies for inflammation and respiratory diseases and, in particular, for asthma.  Many compds. have been identified which inhibit the key enzyme, 5-lipoxygenase.  Four distinct classes of compds. have been identified, namely, (1) redox inhibitors (alternative substrates), (2) iron chelating inhibitors, (3) competitive reversible inhibitors, and (4) inhibitors of the 5-lipoxygenase activating protein.  Experience over the past two decades with redox inhibitors has been disappointing and although a no. of potent compds. have been identified, they have often been assocd. with ancillary toxicity and non-specificity due to their redox activity.  Iron chelating inhibitors have been more successful and one compd., Zileuton, has reached the market.  However, more potent analogs have often encountered toxicity problems.  Competitive inhibitors have been identified by a no. of research groups but, as yet, none has been successful.  Inhibitors of the 5-lipoxygenase activating protein (FLAP) have been identified and compds. such as MK-0591 and BaY-X-1005 have shown efficacy in asthma trials.  To date, however, no clear advantage for inhibitors of lipoxygenase has been demonstrated relative to the leukotriene D4 receptor antagonists such as Singulair and Accolate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhHdZOxWRr6LVg90H21EOLACvtfcHk0li1xXUDLZKZUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVWrsLs%253D&md5=05331bc54e417589ea8bb23e6fa24261</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2900225-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252900225-1%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DInhibitors%2520of%25205-lipoxygenase%253A%2520a%2520therapeutic%2520potential%2520yet%2520to%2520be%2520realized%253F%26jtitle%3DEur.%2520J.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D671%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Helgadottir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorleifsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretarsdottir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteindottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveinbjornsdottir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdimarsson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthiasson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsdottir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorhallsdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigge, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudnason, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulcher, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fng1311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=14770184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=233-239&author=A.+Helgadottirauthor=A.+Manolescuauthor=G.+Thorleifssonauthor=S.+Gretarsdottirauthor=H.+Jonsdottirauthor=U.+Thorsteindottirauthor=N.+J.+Samaniauthor=G.+Gudmundssonauthor=S.+F.+A.+Grantauthor=G.+Thorgeirssonauthor=S.+Sveinbjornsdottirauthor=E.+M.+Valdimarssonauthor=S.+E.+Matthiassonauthor=H.+Johannssonauthor=O.+Gudmundsdottirauthor=M.+E.+Guerneyauthor=J.+Sainzauthor=M.+Thorhallsdottirauthor=M.+Andresdottirauthor=M.+L.+Friggeauthor=E.+J.+Topolauthor=A.+Kongauthor=V.+Gudnasonauthor=H.+Hakonarsonauthor=J.+R.+Gulcherauthor=K.+Stefansson&title=The+gene+encoding+5-lipoxygenase+activating+protein+confers+risk+of+myocardial+infarction+and+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke</span></div><div class="casAuthors">Helgadottir, Anna; Manolescu, Andrei; Thorleifsson, Gudmar; Gretarsdottir, Solveig; Jonsdottir, Helga; Thorsteinsdottir, Unnur; Samani, Nilesh J.; Gudmundsson, Gudmundur; Grant, Struan F. A.; Thorgeirsson, Gudmundur; Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.; Matthiasson, Stefan E.; Johannsson, Halldor; Gudmundsdottir, Olof; Gurney, Mark E.; Sainz, Jesus; Thorhallsdottir, Margret; Andresdottir, Margret; Frigge, Michael L.; Topol, Eric J.; Kong, Augustine; Gudnason, Vilmundur; Hakonarson, Hakon; Gulcher, Jeffrey R.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13.  A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is assocd. with a two times greater risk of myocardial infarction in Iceland.  This haplotype also confers almost two times greater risk of stroke.  Another ALOX5AP haplotype is assocd. with myocardial infarction in individuals from the UK.  Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype.  We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene prodn. and inflammation in the arterial wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwmL2IOUxmmbVg90H21EOLACvtfcHk0lgYKKwklJacSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOnsL4%253D&md5=876af51d8d672d28e02be75e53bb24d2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fng1311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1311%26sid%3Dliteratum%253Aachs%26aulast%3DHelgadottir%26aufirst%3DA.%26aulast%3DManolescu%26aufirst%3DA.%26aulast%3DThorleifsson%26aufirst%3DG.%26aulast%3DGretarsdottir%26aufirst%3DS.%26aulast%3DJonsdottir%26aufirst%3DH.%26aulast%3DThorsteindottir%26aufirst%3DU.%26aulast%3DSamani%26aufirst%3DN.%2BJ.%26aulast%3DGudmundsson%26aufirst%3DG.%26aulast%3DGrant%26aufirst%3DS.%2BF.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DSveinbjornsdottir%26aufirst%3DS.%26aulast%3DValdimarsson%26aufirst%3DE.%2BM.%26aulast%3DMatthiasson%26aufirst%3DS.%2BE.%26aulast%3DJohannsson%26aufirst%3DH.%26aulast%3DGudmundsdottir%26aufirst%3DO.%26aulast%3DGuerney%26aufirst%3DM.%2BE.%26aulast%3DSainz%26aufirst%3DJ.%26aulast%3DThorhallsdottir%26aufirst%3DM.%26aulast%3DAndresdottir%26aufirst%3DM.%26aulast%3DFrigge%26aufirst%3DM.%2BL.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DGudnason%26aufirst%3DV.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DGulcher%26aufirst%3DJ.%2BR.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DThe%2520gene%2520encoding%25205-lipoxygenase%2520activating%2520protein%2520confers%2520risk%2520of%2520myocardial%2520infarction%2520and%2520stroke%26jtitle%3DNat.%2520Genet.%26date%3D2004%26volume%3D36%26spage%3D233%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Kajimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoike, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, N.</span><span> </span><span class="NLM_article-title">Validation of the association between gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population</span> <span class="citation_source-journal">Circ. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1253%2Fcircj.69.1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=16127181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGntLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=1029-1034&author=K.+Kajimotoauthor=K.+Shiojiauthor=C.+Ishidaauthor=Y.+Iwanagaauthor=Y.+Kokuboauthor=H.+Tomoikeauthor=S.-i.+Miyazakiauthor=H.+Nonogiauthor=Y.+Gotoauthor=N.+Iwai&title=Validation+of+the+association+between+gene+encoding+5-lipoxygenase-activating+protein+and+myocardial+infarction+in+a+Japanese+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population</span></div><div class="casAuthors">Kajimoto, Kazuaki; Shioji, Keisuke; Ishida, Chisaki; Iwanaga, Yoshitaka; Kokubo, Yoshihiro; Tomoike, Hitonobu; Miyazaki, Shun-ichi; Nonogi, Hiroshi; Goto, Yoichi; Iwai, Naoharu</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1029-1034</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">Background Recently, the 5-lipoxygenase activating protein gene (ALOX5AP) was reported to confer a risk of myocardial infarction (MI) and stroke, independent of conventional risk factors.  The purpose of the present study was to validate those findings in a Japanese population.  Methods and Results The study population consisted of 1,875 subjects (males 871, females 1,004) recruited from the Suita study (control group) and 353 subjects (males 306, females 47) with MI.  The promoter, all of the exons, and 3'UTR regions of ALOX5AP were sequenced in 96 subjects, and 8 polymorphisms were found.  There were significant differences in the frequencies of the haplotypes constructed from the 2 SNPs (A162C and T8733A) between the control and MI groups.  Multiple logistic anal. indicated that the homozygous genotype of the (CA) haplotype was significantly assocd. with a reduced risk for MI.  Conclusion The hypothesis that ALOX5AP contributes to susceptibility for MI was validated in a Japanese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCftA-YseObrVg90H21EOLACvtfcHk0lgYKKwklJacSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGntLfI&md5=ce7bc88f5e53765bf24ae8131f554d6d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1253%2Fcircj.69.1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.69.1029%26sid%3Dliteratum%253Aachs%26aulast%3DKajimoto%26aufirst%3DK.%26aulast%3DShioji%26aufirst%3DK.%26aulast%3DIshida%26aufirst%3DC.%26aulast%3DIwanaga%26aufirst%3DY.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DTomoike%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DS.-i.%26aulast%3DNonogi%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DIwai%26aufirst%3DN.%26atitle%3DValidation%2520of%2520the%2520association%2520between%2520gene%2520encoding%25205-lipoxygenase-activating%2520protein%2520and%2520myocardial%2520infarction%2520in%2520a%2520Japanese%2520population%26jtitle%3DCirc.%2520J.%26date%3D2005%26volume%3D69%26spage%3D1029%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_contrib-group">Girelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallari, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malerba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco Pignatti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrocher, R.</span><span> </span><span class="NLM_article-title"><i>ALOX5AP</i> gene variants and risk of coronary artery disease: an angiography-based study</span> <span class="citation_source-journal">Eur. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fsj.ejhg.5201854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17505527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVaqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=959-966&author=D.+Girelliauthor=N.+Martinelliauthor=E.+Trabettiauthor=O.+Olivieriauthor=U.+Cavallariauthor=G.+Malerbaauthor=F.+Bustiauthor=S.+Frisoauthor=F.+Pizzoloauthor=P.+Franco+Pignattiauthor=R.+Corrocher&title=ALOX5AP+gene+variants+and+risk+of+coronary+artery+disease%3A+an+angiography-based+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study</span></div><div class="casAuthors">Girelli, Domenico; Martinelli, Nicola; Trabetti, Elisabetta; Olivieri, Oliviero; Cavallari, Ugo; Malerba, Giovanni; Busti, Fabiana; Friso, Simonetta; Pizzolo, Francesca; Pignatti, Pier Franco; Corrocher, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">959-966</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of this study was to explore the role of variants of the gene encoding arachidonate 5-lipoxygenase-activating protein (ALOX5AP) as possible susceptibility factors for coronary artery disease (CAD) and myocardial infarction (MI) in patients with or without angiog. proven CAD.  A total of 1431 patients with or without angiog. documented CAD were examd. simultaneously for seven ALOX5AP single-nucleotide polymorphisms, allowing reconstruction of the at-risk haplotypes (HapA and HapB) previously identified in the Icelandic and British populations.  Using a haplotype-based approach, HapA was not assocd. with either CAD or MI.  On the other hand, HapB and another haplotype within the same region (that we named HapC) were significantly more represented in CAD vs. CAD-free patients, and these assocns. remained significant after adjustment for traditional cardiovascular risk factors by logistic regression (HapB: odds ratio (OR) 1.67, 95% confidence interval (CI) 1.04-2.67; P = 0.032; HapC: OR 2.41, 95% CI 1.09-5.32; P = 0.030).  No difference in haplotype distributions was obsd. between CAD subjects with or without a previously documented MI.  Our angiog.-based study suggests a possible modest role of ALOX5AP in the development of the atheroma rather than in its late thrombotic complications such as MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0g1VKKLrDjbVg90H21EOLACvtfcHk0lgBGjEfg1akcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVaqsrg%253D&md5=474d70a2f9611a18572a812bf22cd0ca</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejhg.5201854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejhg.5201854%26sid%3Dliteratum%253Aachs%26aulast%3DGirelli%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DN.%26aulast%3DTrabetti%26aufirst%3DE.%26aulast%3DOlivieri%26aufirst%3DO.%26aulast%3DCavallari%26aufirst%3DU.%26aulast%3DMalerba%26aufirst%3DG.%26aulast%3DBusti%26aufirst%3DF.%26aulast%3DFriso%26aufirst%3DS.%26aulast%3DPizzolo%26aufirst%3DF.%26aulast%3DFranco%2BPignatti%26aufirst%3DP.%26aulast%3DCorrocher%26aufirst%3DR.%26atitle%3DALOX5AP%2520gene%2520variants%2520and%2520risk%2520of%2520coronary%2520artery%2520disease%253A%2520an%2520angiography-based%2520study%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2007%26volume%3D15%26spage%3D959%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_contrib-group">Kaushal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haverbusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissela, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindorfer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, D.</span><span> </span><span class="NLM_article-title">Association of <i>ALOX5AP</i> with ischemic stroke: a population-based case-control study</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1007%2Fs00439-007-0338-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17387518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFKisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=601-607&author=R.+Kaushalauthor=P.+Palauthor=K.+Alwellauthor=M.+Haverbuschauthor=M.+Flahertyauthor=C.+Moomawauthor=P.+Sekarauthor=B.+Kisselaauthor=D.+Kleindorferauthor=R.+Chakrabortyauthor=J.+Broderickauthor=R.+Dekaauthor=D.+Woo&title=Association+of+ALOX5AP+with+ischemic+stroke%3A+a+population-based+case-control+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Association of ALOX5AP with ischemic stroke: a population-based case-control study</span></div><div class="casAuthors">Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Arachidonate 5-lipoxygenase activating protein (ALOX5AP) has been reported to demonstrate linkage and assocn. with ischemic stroke and myocardial infarction.  However, replication studies have been conflicting and to date, a significant proportion of blacks have not been studied.  We prospectively recruited cases of ischemic stroke from all 16 hospitals in the Greater Cincinnati/Northern Kentucky region and demog. matched them to stroke-free population-based controls.  Single nucleotide polymorphisms (SNPs) were selected based on assocn. with ischemic stroke in prior studies.  Allelic, genotypic and haplotypic assocn. testing was performed using HAPLOVIEW.  Multiple logistic regression was used to control for the presence of traditional risk factors including hypertension, diabetes, hypercholesterolemia and smoking.  A total of 357 cases and 482 controls were genotyped.  The SNPs, rs9579646 and rs4769874 were found to be significantly assocd. at both allelic (P = 0.019 and P < 10-4, resp.) and genotypic level with ischemic stroke among whites after correction for multiple testing.  Haplotype assocn. was identified with ischemic stroke as well as ischemic stroke subtypes among whites.  Although an overall haplotype assocn. with ischemic stroke was identified among blacks no evidence of assocn. among individual haplotypes, alleles or genotypes were obsd.  Allele frequencies for the SNPs examd. were markedly different among whites and blacks.  In conclusion, we report significant assocn. of variants of ALOX5AP with ischemic stroke and ischemic stroke subtypes among whites.  No significant assocn. was identified among blacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW57iGMmXNebVg90H21EOLACvtfcHk0lgBGjEfg1akcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFKisb4%253D&md5=30a111ce3c4dacf56b3ee3a9ed12adfb</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1007%2Fs00439-007-0338-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-007-0338-y%26sid%3Dliteratum%253Aachs%26aulast%3DKaushal%26aufirst%3DR.%26aulast%3DPal%26aufirst%3DP.%26aulast%3DAlwell%26aufirst%3DK.%26aulast%3DHaverbusch%26aufirst%3DM.%26aulast%3DFlaherty%26aufirst%3DM.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DSekar%26aufirst%3DP.%26aulast%3DKissela%26aufirst%3DB.%26aulast%3DKleindorfer%26aufirst%3DD.%26aulast%3DChakraborty%26aufirst%3DR.%26aulast%3DBroderick%26aufirst%3DJ.%26aulast%3DDeka%26aufirst%3DR.%26aulast%3DWoo%26aufirst%3DD.%26atitle%3DAssociation%2520of%2520ALOX5AP%2520with%2520ischemic%2520stroke%253A%2520a%2520population-based%2520case-control%2520study%26jtitle%3DHum.%2520Genet.%26date%3D2007%26volume%3D121%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_contrib-group">Lohmussar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschwendtner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Org, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, M.</span><span> </span><span class="NLM_article-title">ALOX5AP gene and the PDE4D gene in a central european population of stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=731-736&author=E.+Lohmussarauthor=A.+Gschwendtnerauthor=J.+C.+Muellerauthor=T.+Orgauthor=E.+Wichmannauthor=G.+Hamannauthor=T.+Meitingerauthor=M.+Dichgans&title=ALOX5AP+gene+and+the+PDE4D+gene+in+a+central+european+population+of+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmussar%26aufirst%3DE.%26aulast%3DGschwendtner%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DJ.%2BC.%26aulast%3DOrg%26aufirst%3DT.%26aulast%3DWichmann%26aufirst%3DE.%26aulast%3DHamann%26aufirst%3DG.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DDichgans%26aufirst%3DM.%26atitle%3DALOX5AP%2520gene%2520and%2520the%2520PDE4D%2520gene%2520in%2520a%2520central%2520european%2520population%2520of%2520stroke%2520patients%26jtitle%3DStroke%26date%3D2005%26volume%3D36%26spage%3D731%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tsai, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, N. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=487-491&author=A.+K.+Tsaiauthor=N.+Liauthor=N.+Q.+Hansonauthor=M.+Y.+Tsaiauthor=W.+Tang&title=Associations+of+genetic+polymorphisms+of+arachidonate+5-lipoxygenase-activating+protein+with+risk+of+coronary+artery+disease+in+a+European-American+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DA.%2BK.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHanson%26aufirst%3DN.%2BQ.%26aulast%3DTsai%26aufirst%3DM.%2BY.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DAssociations%2520of%2520genetic%2520polymorphisms%2520of%2520arachidonate%25205-lipoxygenase-activating%2520protein%2520with%2520risk%2520of%2520coronary%2520artery%2520disease%2520in%2520a%2520European-American%2520population%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D207%26spage%3D487%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_contrib-group">Mehrabian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allayee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaposhnik, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusis, A. J.</span><span> </span><span class="NLM_article-title">Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=120-126&author=M.+Mehrabianauthor=H.+Allayeeauthor=J.+Wongauthor=W.+Shihauthor=X.-P.+Wangauthor=Z.+Shaposhnikauthor=C.+D.+Funkauthor=A.+J.+Lusis&title=Identification+of+5-lipoxygenase+as+a+major+gene+contributing+to+atherosclerosis+susceptibility+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMehrabian%26aufirst%3DM.%26aulast%3DAllayee%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.-P.%26aulast%3DShaposhnik%26aufirst%3DZ.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%25205-lipoxygenase%2520as%2520a%2520major%2520gene%2520contributing%2520to%2520atherosclerosis%2520susceptibility%2520in%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, M. P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräbner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pédrono, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanbroek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lötzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habenicht, A. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span> </span><span class="NLM_article-title">The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fnm1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=15322539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=966-973&author=L.+Zhaoauthor=M.+P.+W.+Moosauthor=R.+Gr%C3%A4bnerauthor=F.+P%C3%A9dronoauthor=J.+Fanauthor=B.+Kaiserauthor=N.+Johnauthor=S.+Schmidtauthor=R.+Spanbroekauthor=K.+L%C3%B6tzerauthor=L.+Huangauthor=J.+Cuiauthor=D.+Raderauthor=J.+F.+Evansauthor=A.+J.+R.+Habenichtauthor=C.+D.+Funk&title=The+5-lipoxygenase+pathway+promotes+pathogenesis+of+hyperlipidemia-dependent+aortic+aneurysm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm</span></div><div class="casAuthors">Zhao, Lei; Moos, Michael P. W.; Graebner, Rolf; Pedrono, Frederique; Fan, Jinjin; Kaiser, Brigitte; John, Nicole; Schmidt, Sandra; Spanbroek, Rainer; Loetzer, Katharina; Huang, Li; Cui, Jisong; Rader, Daniel J.; Evans, Jilly F.; Habenicht, Andreas J. R.; Funk, Colin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">966-973</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the 5-lipoxygenase (5-LO) pathway leads to the biosynthesis of proinflammatory leukotriene lipid mediators.  Genetic studies have assocd. 5-LO and its accessory protein, 5-LO-activating protein, with cardiovascular disease, myocardial infarction and stroke.  Here we show that 5-LO-pos. macrophages localize to the adventitia of diseased mouse and human arteries in areas of neoangiogenesis and that these cells constitute a main component of aortic aneurysms induced by an atherogenic diet contg. cholate in mice deficient in apolipoprotein E.  5-LO deficiency markedly attenuates the formation of these aneurysms and is assocd. with reduced matrix metalloproteinase-2 activity and diminished plasma macrophage inflammatory protein-1α (MIP-1α; also called CCL3), but only minimally affects the formation of lipid-rich lesions.  The leukotriene LTD4 strongly stimulates expression of MIP-1α in macrophages and MIP-2 (also called CXCL2) in endothelial cells.  These data link the 5-LO pathway to hyperlipidemia-dependent inflammation of the arterial wall and to pathogenesis of aortic aneurysms through a potential chemokine intermediary route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTVY7nl9JpzLVg90H21EOLACvtfcHk0lixjWkCrkrxYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSktLw%253D&md5=db42c20964c5c2bead459cd9198e061c</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1038%2Fnm1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1099%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DMoos%26aufirst%3DM.%2BP.%2BW.%26aulast%3DGr%25C3%25A4bner%26aufirst%3DR.%26aulast%3DP%25C3%25A9drono%26aufirst%3DF.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DB.%26aulast%3DJohn%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSpanbroek%26aufirst%3DR.%26aulast%3DL%25C3%25B6tzer%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DRader%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHabenicht%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26atitle%3DThe%25205-lipoxygenase%2520pathway%2520promotes%2520pathogenesis%2520of%2520hyperlipidemia-dependent%2520aortic%2520aneurysm%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D966%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Jawien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateuszuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszanecki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzik, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichocki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlopicki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korbut, R.</span><span> </span><span class="NLM_article-title">Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases artherosclerosis in apoE/LDLR-double knockout mice</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=141-146&author=J.+Jawienauthor=M.+Gajdaauthor=M.+Rudlingauthor=L.+Mateuszukauthor=R.+Olszaneckiauthor=T.+J.+Guzikauthor=T.+Cichockiauthor=S.+Chlopickiauthor=R.+Korbut&title=Inhibition+of+five+lipoxygenase+activating+protein+%28FLAP%29+by+MK-886+decreases+artherosclerosis+in+apoE%2FLDLR-double+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJawien%26aufirst%3DJ.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DRudling%26aufirst%3DM.%26aulast%3DMateuszuk%26aufirst%3DL.%26aulast%3DOlszanecki%26aufirst%3DR.%26aulast%3DGuzik%26aufirst%3DT.%2BJ.%26aulast%3DCichocki%26aufirst%3DT.%26aulast%3DChlopicki%26aufirst%3DS.%26aulast%3DKorbut%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520five%2520lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520by%2520MK-886%2520decreases%2520artherosclerosis%2520in%2520apoE%252FLDLR-double%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D36%26spage%3D141%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_contrib-group">Tardiff, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L’Allier, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olukotun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R.</span><span> </span><span class="NLM_article-title">Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients with recent acute coronary syndrome</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1260&author=J.-C.+Tardiffauthor=P.+L.+L%E2%80%99Allierauthor=R.+Ibrahimauthor=J.+C.+Gregoireauthor=A.+Hegedusauthor=J.+Francauthor=J.+Blueauthor=M.+Cooperauthor=A.+Olukotunauthor=R.+Taub&title=Three+months+of+treatment+with+5-lipoxygenase+inhibitor+VIA-2291+in+patients+with+recent+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTardiff%26aufirst%3DJ.-C.%26aulast%3DL%25E2%2580%2599Allier%26aufirst%3DP.%2BL.%26aulast%3DIbrahim%26aufirst%3DR.%26aulast%3DGregoire%26aufirst%3DJ.%2BC.%26aulast%3DHegedus%26aufirst%3DA.%26aulast%3DFranc%26aufirst%3DJ.%26aulast%3DBlue%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DOlukotun%26aufirst%3DA.%26aulast%3DTaub%26aufirst%3DR.%26atitle%3DThree%2520months%2520of%2520treatment%2520with%25205-lipoxygenase%2520inhibitor%2520VIA-2291%2520in%2520patients%2520with%2520recent%2520acute%2520coronary%2520syndrome%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_contrib-group">Brotz, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Blasis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson-Shea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olukotun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R.</span><span> </span><span class="NLM_article-title">Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients scheduled for elective carotid endarterectomy surgery</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1261&author=T.+M.+Brotzauthor=G.+De+Blasisauthor=L.+Carbonariauthor=M.+S.+Perryauthor=E.+Chiangauthor=A.+Hansson-Sheaauthor=M.+Cooperauthor=A.+Olukotunauthor=F.+Cipolloneauthor=R.+Taub&title=Three+months+of+treatment+with+5-lipoxygenase+inhibitor+VIA-2291+in+patients+scheduled+for+elective+carotid+endarterectomy+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrotz%26aufirst%3DT.%2BM.%26aulast%3DDe%2BBlasis%26aufirst%3DG.%26aulast%3DCarbonari%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DM.%2BS.%26aulast%3DChiang%26aufirst%3DE.%26aulast%3DHansson-Shea%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DOlukotun%26aufirst%3DA.%26aulast%3DCipollone%26aufirst%3DF.%26aulast%3DTaub%26aufirst%3DR.%26atitle%3DThree%2520months%2520of%2520treatment%2520with%25205-lipoxygenase%2520inhibitor%2520VIA-2291%2520in%2520patients%2520scheduled%2520for%2520elective%2520carotid%2520endarterectomy%2520surgery%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorvaldsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helgadottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zink, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnar, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnarsson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottskalksson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adalsteinsdottir, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristjansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardarson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristinsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2005&pages=2277-2279&author=H.+Hakonarsonauthor=S.+Thorvaldssonauthor=H.+Helgadottirauthor=D.+Gudbjartssonauthor=F.+Zinkauthor=M.+Andresdottirauthor=A.+Manolescuauthor=D.+O.+Arnarauthor=K.+Andersenauthor=A.+Sigurdssonauthor=G.+Thorgeirssonauthor=A.+Jonssonauthor=U.+Agnarssonauthor=H.+Bjornsdottirauthor=G.+Gottskalkssonauthor=A.+Einarssonauthor=H.+Gudmundsdottirauthor=A.+E.+Adalsteinsdottirauthor=K.+Gudmundssonauthor=K.+Kristjanssonauthor=T.+Hardarsonauthor=A.+Kristinssonauthor=E.+J.+Topolauthor=J.+Gulcherauthor=A.+Kongauthor=M.+Gurneyauthor=G.+Thorgeirssonauthor=K.+Stefansson&title=Effects+of+a+5-lipoxygenase-activating+protein+inhibitor+on+biomarkers+associated+with+risk+of+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DThorvaldsson%26aufirst%3DS.%26aulast%3DHelgadottir%26aufirst%3DH.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DAndresdottir%26aufirst%3DM.%26aulast%3DManolescu%26aufirst%3DA.%26aulast%3DArnar%26aufirst%3DD.%2BO.%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DSigurdsson%26aufirst%3DA.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DJonsson%26aufirst%3DA.%26aulast%3DAgnarsson%26aufirst%3DU.%26aulast%3DBjornsdottir%26aufirst%3DH.%26aulast%3DGottskalksson%26aufirst%3DG.%26aulast%3DEinarsson%26aufirst%3DA.%26aulast%3DGudmundsdottir%26aufirst%3DH.%26aulast%3DAdalsteinsdottir%26aufirst%3DA.%2BE.%26aulast%3DGudmundsson%26aufirst%3DK.%26aulast%3DKristjansson%26aufirst%3DK.%26aulast%3DHardarson%26aufirst%3DT.%26aulast%3DKristinsson%26aufirst%3DA.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DGulcher%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DGurney%26aufirst%3DM.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DEffects%2520of%2520a%25205-lipoxygenase-activating%2520protein%2520inhibitor%2520on%2520biomarkers%2520associated%2520with%2520risk%2520of%2520myocardial%2520infarction%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2005%26volume%3D293%26spage%3D2277%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulkower, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malo, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. D. W.</span><span> </span><span class="NLM_article-title">Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsV2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=690-705&author=T.+Kolasaauthor=D.+E.+Gunnauthor=P.+Bhatiaauthor=K.+W.+Woodsauthor=T.+Ganeauthor=A.+O.+Stewartauthor=J.+B.+Bouskaauthor=R.+R.+Harrisauthor=K.+I.+Hulkowerauthor=P.+E.+Maloauthor=R.+L.+Bellauthor=G.+W.+Carterauthor=C.+D.+W.+Brooks&title=Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic+acids+as+leukotriene+biosynthesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors</span></div><div class="casAuthors">Kolasa, Teodozyj; Gunn, David E.; Bhatia, Pramila; Woods, Keith W.; Gane, Todd; Stewart, Andrew O.; Bouska, Jennifer B.; Harris, Richard R.; Hulkower, Keren I.; Malo, Peter E.; Bell, Randy L.; Carter, George W.; Brooks, Clint D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">690-705</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids was studied as leukotriene biosynthesis inhibitors.  The hypothesis of structure-activity optimization by insertion of an oxime moiety was investigated using REV-5901 as a starting point.  A systematic structure-activity optimization showed that the spatial arrangement and stereochem. of the oxime insertion unit proved to be important for inhibitory activity.  A promising lead inhibited LTB4 biosynthesis in the intact human neutrophil with IC50 of 8 nM and had superior oral activity in vivo, in a rat pleurisy model (ED50 = 0.14 mg/kg) and rat anaphylaxis model (ED50 = 0.13 mg/kg).  Spa.  In a model of lung inflammation, the compd. blocked LTE4 biosynthesis (ED50 of 0.1 mg/kg) and eosinophil influx (ED50 of 0.2 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG88LL4q8nJrVg90H21EOLACvtfcHk0lgvCnoTWSJoaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsV2gtQ%253D%253D&md5=5df5b791b96d1690456a976dea72155b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9904102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904102%26sid%3Dliteratum%253Aachs%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGane%26aufirst%3DT.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BB.%26aulast%3DHarris%26aufirst%3DR.%2BR.%26aulast%3DHulkower%26aufirst%3DK.%2BI.%26aulast%3DMalo%26aufirst%3DP.%2BE.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%2BW.%26atitle%3DHeteroarylmethoxyphenylalkoxyiminoalkylcarboxylic%2520acids%2520as%2520leukotriene%2520biosynthesis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D690%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Freed, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magomedov, N. A.</span><span> </span><span class="NLM_article-title">Trapping of the putative cationic intermediate in the morin rearrangement with carbon nucleophiles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0013406" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=839-852&author=J.+D.+Freedauthor=D.+J.+Hartauthor=N.+A.+Magomedov&title=Trapping+of+the+putative+cationic+intermediate+in+the+morin+rearrangement+with+carbon+nucleophiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo0013406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0013406%26sid%3Dliteratum%253Aachs%26aulast%3DFreed%26aufirst%3DJ.%2BD.%26aulast%3DHart%26aufirst%3DD.%2BJ.%26aulast%3DMagomedov%26aufirst%3DN.%2BA.%26atitle%3DTrapping%2520of%2520the%2520putative%2520cationic%2520intermediate%2520in%2520the%2520morin%2520rearrangement%2520with%2520carbon%2520nucleophiles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D839%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Prasit, P.; Fortin, R.; Hutchinson, J. H.; Belley, M. L.; Leger, S.; Frenette, R.; Gillard, J.</span> U.S. Patent 5,272,145, Dec 21,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prasit%2C+P.%3B+Fortin%2C+R.%3B+Hutchinson%2C+J.+H.%3B+Belley%2C+M.+L.%3B+Leger%2C+S.%3B+Frenette%2C+R.%3B+Gillard%2C+J.+U.S.+Patent+5%2C272%2C145%2C+Dec+21%2C+1993."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=1588922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK38XlvVCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1992&pages=873-879&author=S.+Charlesonauthor=P.+Prasitauthor=S.+Legerauthor=J.+W.+Gillardauthor=P.+J.+Vickersauthor=J.+A.+Manciniauthor=P.+Charlesonauthor=J.+Guayauthor=A.+W.+Ford-Hutchinsonauthor=J.+F.+Evans&title=Characterization+of+a+5-lipoxygenase-activating+protein+binding+assay%3A+correlation+of+affinity+for+5-lipoxygenase-activating+protein+with+leukotriene+synthesis+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a 5-lipoxygenase-activating protein binding assay:  Correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition</span></div><div class="casAuthors">Charleson, Stella; Prasit, Petpiboon; Leger, Serge; Gillard, John W.; Vickers, Philip J.; Mancini, Joseph A.; Charleson, Peter; Guay, Jocelyne; Ford-Hutchinson, Anthony W.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-9</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">A binding assay has been developed to measure the affinity of leukotriene synthesis inhibitors for 5-lipoxygenase-activating protein (FLAP), using human leukocyte membranes as the source of FLAP and a radioiodinated leukotriene synthesis inhibitor, 125IL-691,831, as ligand.  Linearity of specific binding of radiolabeled ligand was demonstrated with increasing protein and ligand concns.  Satn. anal. of radioligand binding showed a Kd of 6 nM and a Bmax that, depending on the membrane prepn., varied between 8 and 53 pmol/mg of protein.  An excellent correlation was shown between affinity for FLAP in the binding assay and inhibition of leukotriene synthesis in human polymorphonuclear leukocytes for compds. from two structurally distinct classes, namely indoles and quinolines.  A large no. of membrane-active compds. did not compete with 125I-L-691,831 binding to FLAP.  In addn., direct 5-lipoxygenase inhibitors and a selection of eicosanoids were unable to compete for FLAP binding.  This study validates a selective binding assay for leukotriene synthesis inhibitors whose protein target is FLAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5FEWpt5XUsrVg90H21EOLACvtfcHk0lgvCnoTWSJoaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVCqu7w%253D&md5=957d4c75d28d36cd8e12814cc5cdb1b5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DGillard%26aufirst%3DJ.%2BW.%26aulast%3DVickers%26aufirst%3DP.%2BJ.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DCharleson%26aufirst%3DP.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520a%25205-lipoxygenase-activating%2520protein%2520binding%2520assay%253A%2520correlation%2520of%2520affinity%2520for%25205-lipoxygenase-activating%2520protein%2520with%2520leukotriene%2520synthesis%2520inhibition%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D41%26spage%3D873%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span> </span><span class="NLM_article-title">Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=510-512&author=A.+D.+Fergusonauthor=B.+M.+McKeeverauthor=S.+Xuauthor=D.+Wisniewskiauthor=D.+K.+Millerauthor=T.+Yaminauthor=R.+H.+Spencerauthor=L.+Chuauthor=F.+Ujjainwallaauthor=B.+R.+Cunninghamauthor=J.+F.+Evansauthor=J.+W.+Becker&title=Crystal+structure+of+inhibitor-bound+human+5-lipoxygenase-activating+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DYamin%26aufirst%3DT.%26aulast%3DSpencer%26aufirst%3DR.%2BH.%26aulast%3DChu%26aufirst%3DL.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DCunningham%26aufirst%3DB.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26atitle%3DCrystal%2520structure%2520of%2520inhibitor-bound%2520human%25205-lipoxygenase-activating%2520protein%26jtitle%3DScience%26date%3D2007%26volume%3D27%26spage%3D510%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D<sub>2</sub> receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1036-1040&author=N.+Stockauthor=D.+Volkotsauthor=K.+Stebbinsauthor=A.+Broadheadauthor=B.+Stearnsauthor=J.+Roppeauthor=T.+Parrauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=A.+Santiniauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=Sodium+%5B2%E2%80%B2-%5B%28cyclopropanecarbonyl-ethyl-amino%29-methyl%5D-4%E2%80%B2-%286-ethoxy-pyridin-3-yl%29-6-methoxy-biphenyl-3-yl%5D-acetate+%28AM432%29%3A+a+potent%2C+selective+prostaglandin+D2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DVolkots%26aufirst%3DD.%26aulast%3DStebbins%26aufirst%3DK.%26aulast%3DBroadhead%26aufirst%3DA.%26aulast%3DStearns%26aufirst%3DB.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DT.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DSodium%2520%255B2%25E2%2580%25B2-%255B%2528cyclopropanecarbonyl-ethyl-amino%2529-methyl%255D-4%25E2%2580%25B2-%25286-ethoxy-pyridin-3-yl%2529-6-methoxy-biphenyl-3-yl%255D-acetate%2520%2528AM432%2529%253A%2520a%2520potent%252C%2520selective%2520prostaglandin%2520D2%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1036%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Smith, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span> </span><span class="NLM_article-title">Characterization of 5-lipoxygenase inhibitors in biochemical and functional in vivo assays</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1332</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=8531100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK28XhvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=1332-1338&author=W.+G.+Smithauthor=A.+F.+Shafferauthor=J.+L.+Currieauthor=J.+M.+Thompsonauthor=S.+Kimauthor=T.+Raoauthor=P.+C.+Isakson&title=Characterization+of+5-lipoxygenase+inhibitors+in+biochemical+and+functional+in+vivo+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 5-lipoxygenase inhibitors in biochemical and function in vivo assays</span></div><div class="casAuthors">Smith, Walter G.; Shaffer, Alex F.; Currie, Jerry L.; Thompson, Janice M.; Kim, Suzanne; Rao, Tadimeti; Isakson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1332-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Several potent and selective inhibitors of 5-lipoxygenase (5-LO) have been recently developed with excellent activity in certain in vivo assays of leukotriene prodn.  The efficacy of three such inhibitors that have been in clin. trials (zileuton, A-78773 and ZD2138) were evaluated in: (1) ex vivo whole blood assay, (2) dermal Arthus reaction, and (3) functional airway response.  In addn., a model of eicosanoid prodn. in rat lung was developed that provides a simple assay for evaluation of the biochem. efficacy of 5-LO inhibitors in the lung.  Bronchoalveolar lavage of rat lung with calcium ionophore A23187 resulted in rapid and robust prodn. of PGE2, 6-keto-PGF1α, thromboxane (TxB2), and leukotriene B4 (LTB4).  Supplementation of lavage fluid with arachidonic acid markedly augmented prodn. of all eicosanoids except LTB4.  All three inhibitors were potent and selective blockers of LTB4 prodn. in the ex vivo whole blood assay and in the dermal Arthus reaction.  In contrast, higher doses of inhibitor were needed to block LTB4 prodn. in the rat lung lavage model than were needed to block ex vivo whole blood LTB4 prodn. when both end points were measured in the same animal.  Similarly, zileuton and A-78733 were less effective in suppressing the functional airway response to antigen in sensitized guinea pigs, whereas both inhibitors were effective in suppressing LTB4 prodn. in the ex vivo whole blood assay.  These results demonstrate that different 5-LO inhibitors have markedly distinct efficacy for inhibition of leukotriene prodn., depending on the animal model.  The results also suggest that the lung is relatively resistant to treatment by the current 5-LO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFSnaUV_BdIrVg90H21EOLACvtfcHk0ljWVjENFyh0Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVyrsQ%253D%253D&md5=1f14c1313202d6c03e1a3d6294fa6215</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BG.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DCurrie%26aufirst%3DJ.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26atitle%3DCharacterization%2520of%25205-lipoxygenase%2520inhibitors%2520in%2520biochemical%2520and%2520functional%2520in%2520vivo%2520assays%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D1332%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Walsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Validated assays for human cytochrome P450 activities</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1124%2Fdmd.32.6.647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=15155557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=647-660&author=R.+L.+Walskyauthor=R.+S.+Obach&title=Validated+assays+for+human+cytochrome+P450+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Validated assays for human cytochrome P450 activities</span></div><div class="casAuthors">Walsky, Robert L.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-660</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The measurement of the effect of new chem. entities on human cytochrome P 450 marker activities using in vitro experimentation represents an important exptl. approach in drug development.  In vitro drug interaction data can be used in guiding the design of clin. drug interaction studies, or, when no effect is obsd. in vitro, the data can be used in place of an in vivo study to claim that no interaction will occur in vivo.  To make such a claim, it must be assured that the in vitro expts. are performed with abs. confidence in the methods used and data obtained.  To meet this need, 12 semiautomated assays for human P 450 marker substrate activities have been developed and validated using approaches described in the GLP (good lab. practices) as per the code of U.S. Federal Regulations.  The assays that were validated are: phenacetin O-deethylase (CYP1A2), coumarin 7-hydroxylase (CYP2A6), bupropion hydroxylase (CYP2B6), amodiaquine N-deethylase (CYP2C8), diclofenac 4'-hydroxylase and tolbutamide methylhydroxylase (CYP2C9), (S)-mephenytoin 4'-hydroxylase (CYP2C19), dextromethorphan O-demethylase (CYP2D6), chlorzoxazone 6-hydroxylase (CYP2E1), felodipine dehydrogenase, testosterone 6β-hydroxylase, and midazolam 1'-hydroxylase (CYP3A4 and CYP3A5).  High-pressure liq. chromatog.-tandem mass spectrometry, using stable isotope-labeled internal stds., has been applied as the anal. method.  This anal. approach, through its high sensitivity and selectivity, has permitted the use of very low incubation concns. of microsomal protein (0.01-0.2 mg/mL).  Anal. assay accuracy and precision values were excellent.  Enzyme kinetic and inhibition parameters obtained using these methods demonstrated high precision and were within the range of values previously reported in the scientific literature.  These methods should prove useful in the routine assessments of the potential for new drug candidates to elicit pharmacokinetic drug interactions via inhibition of cytochrome P 450 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF04TGeyYbbVg90H21EOLACvtfcHk0ljWVjENFyh0Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D&md5=35532b907c15f1053aa8233dab2ec581</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DValidated%2520assays%2520for%2520human%2520cytochrome%2520P450%2520activities%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D647%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hao Li, Hong-Cheng Xia, Fang-Yuan Nie, <span class="NLM_string-name hlFld-ContribAuthor">Qin-Hua Song</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid and Effective Reaction of 2-Methylpyridin-N-oxides with Triphosgene via a [3,3]-Sigmatropic Rearrangement: Mechanism and Applications. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (12)
                                     , 8308-8318. <a href="https://doi.org/10.1021/acs.joc.1c00749" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00749%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRapid%252Band%252BEffective%252BReaction%252Bof%252B2-Methylpyridin-N-oxides%252Bwith%252BTriphosgene%252Bvia%252Ba%252B%25255B3%25252C3%25255D-Sigmatropic%252BRearrangement%25253A%252BMechanism%252Band%252BApplications%26aulast%3DLi%26aufirst%3DHao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31032021%26date%3D27052021%26volume%3D86%26issue%3D12%26spage%3D8308%26epage%3D8318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Ni, Arunika Ekanayake, Bianca Espinosa, Caiqun Yu, Jacob N. Sanders, John Perino, K. N. Houk, <span class="NLM_string-name hlFld-ContribAuthor">Chao Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Target Identification of a Novel Electrophilic Warhead, 2-Chloromethylquinoline. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (24)
                                     , 2715-2719. <a href="https://doi.org/10.1021/acs.biochem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DSynthesis%252Band%252BTarget%252BIdentification%252Bof%252Ba%252BNovel%252BElectrophilic%252BWarhead%25252C%252B2-Chloromethylquinoline%26aulast%3DNi%26aufirst%3DFeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21042019%26date%3D29052019%26date%3D07062019%26date%3D04062019%26volume%3D58%26issue%3D24%26spage%3D2715%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Pettersen, Johan Broddefalk, Hans Emtenäs, Martin A. Hayes, Malin Lemurell, Marianne Swanson, Johan Ulander, Carl Whatling, Carl Amilon, Hans Ericsson, Annika Westin Eriksson, Kenneth Granberg, Alleyn T. Plowright, Igor Shamovsky, Anita Dellsèn, Monica Sundqvist, Mats Någård, <span class="NLM_string-name hlFld-ContribAuthor">Eva-Lotte Lindstedt</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4312-4324. <a href="https://doi.org/10.1021/acs.jmedchem.8b02004" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b02004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b02004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b02004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BDevelopment%252Bof%252Ban%252BInhibitor%252Bof%252B5-Lipoxygenase%252BActivating%252BProtein%252B%252528AZD5718%252529%252Bfor%252BTreatment%252Bof%252BCoronary%252BArtery%252BDisease%26aulast%3DPettersen%26aufirst%3DDaniel%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21122018%26date%3D26032019%26date%3D14032019%26volume%3D62%26issue%3D9%26spage%3D4312%26epage%3D4324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Malin Lemurell, Johan Ulander, Hans Emtenäs, Susanne Winiwarter, Johan Broddefalk, Marianne Swanson, Martin A. Hayes, Luna Prieto Garcia, Annika Westin Eriksson, Johan Meuller, Johan Cassel, Gabrielle Saarinen, Zhong-Qing Yuan, Christian Löfberg, Staffan Karlsson, Monica Sundqvist, <span class="NLM_string-name hlFld-ContribAuthor">Carl Whatling</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4325-4349. <a href="https://doi.org/10.1021/acs.jmedchem.8b02012" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b02012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b02012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b02012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BChemical%252BSeries%252Bof%252B5-Lipoxygenase-Activating%252BProtein%252BInhibitors%252Bfor%252BTreatment%252Bof%252BCoronary%252BArtery%252BDisease%26aulast%3DLemurell%26aufirst%3DMalin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D23122018%26date%3D15042019%26date%3D30032019%26volume%3D62%26issue%3D9%26spage%3D4325%26epage%3D4349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kokila Ranasinghe, Patricia A. Marzilli, Svetlana Pakhomova, <span class="NLM_string-name hlFld-ContribAuthor">Luigi G. Marzilli</span>. </span><span class="cited-content_cbyCitation_article-title">Linear Bidentate Ligands (L) with Two Terminal Pyridyl N-Donor Groups Forming Pt(II)LCl2 Complexes with Rare Eight-Membered Chelate Rings. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (20)
                                     , 12756-12768. <a href="https://doi.org/10.1021/acs.inorgchem.8b01943" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b01943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b01943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b01943%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DLinear%252BBidentate%252BLigands%252B%252528L%252529%252Bwith%252BTwo%252BTerminal%252BPyridyl%252BN-Donor%252BGroups%252BForming%252BPt%252528II%252529LCl2%252BComplexes%252Bwith%252BRare%252BEight-Membered%252BChelate%252BRings%26aulast%3DRanasinghe%26aufirst%3DKokila%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D03102018%26volume%3D57%26issue%3D20%26spage%3D12756%26epage%3D12768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason A.  Mulder</span>, <span class="hlFld-ContribAuthor ">Joe  Gao</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Xingzhong  Zeng</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Nitinchandra D.  Patel</span>, <span class="hlFld-ContribAuthor ">Zhibin  Li</span>, <span class="hlFld-ContribAuthor ">Sonia  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Jon C.  Lorenz</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Shengli  Ma</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Nelu  Grinberg</span>, <span class="hlFld-ContribAuthor ">Heewon  Lee</span>, <span class="hlFld-ContribAuthor ">Todd  Bosanac</span>, <span class="hlFld-ContribAuthor ">Hidenori  Takahashi</span>, <span class="hlFld-ContribAuthor ">Zhidong  Chen</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Peter  Nemoto</span>, <span class="hlFld-ContribAuthor ">Carl A.  Busacca</span>, <span class="hlFld-ContribAuthor ">Jinhua J.  Song</span>, <span class="hlFld-ContribAuthor ">Nathan K.  Yee</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, and <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>  . </span><span class="cited-content_cbyCitation_article-title">Early Development Scale-Up of a Structurally-Challenging 5-Lipoxygenase Activating Protein (FLAP) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 1427-1434. <a href="https://doi.org/10.1021/acs.oprd.7b00202" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00202%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEarly%252BDevelopment%252BScale-Up%252Bof%252Ba%252BStructurally-Challenging%252B5-Lipoxygenase%252BActivating%252BProtein%252B%252528FLAP%252529%252BInhibitor%26aulast%3DMulder%26aufirst%3DJason%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09062017%26date%3D18072017%26date%3D15092017%26date%3D30062017%26volume%3D21%26issue%3D9%26spage%3D1427%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Pascal  Heitel</span>, <span class="hlFld-ContribAuthor ">Lena  Kalinowsky</span>, and <span class="hlFld-ContribAuthor ">Daniel  Merk</span>  . </span><span class="cited-content_cbyCitation_article-title">Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5235-5266. <a href="https://doi.org/10.1021/acs.jmedchem.6b01287" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01287%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Band%252BChallenges%252Bfor%252BFatty%252BAcid%252BMimetics%252Bin%252BDrug%252BDiscovery%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D25082016%26date%3D27032017%26date%3D13072017%26date%3D02032017%26volume%3D60%26issue%3D13%26spage%3D5235%26epage%3D5266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Hidenori    Takahashi </span><span class="hlFld-ContribAuthor "> Alessandra    Bartolozzi </span><span class="hlFld-ContribAuthor "> Thomas    Simpson </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the Novel Oxadiazole-Containing 5-Lipoxygenase Activating Protein (FLAP) Inhibitor BI 665915. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 101-119. <a href="https://doi.org/10.1021/bk-2016-1239.ch004" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch004%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bthe%252BNovel%252BOxadiazole-Containing%252B5-Lipoxygenase%252BActivating%252BProtein%252B%252528FLAP%252529%252BInhibitor%252BBI%252B665915%26aulast%3DTakahashi%26aufirst%3DHidenori%26date%3D2016%26date%3D2016%26spage%3D101%26epage%3D119%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidenori  Takahashi</span>, <span class="hlFld-ContribAuthor ">Doris  Riether</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Todd  Bosanac</span>, <span class="hlFld-ContribAuthor ">Valentina  Berger</span>, <span class="hlFld-ContribAuthor ">Ralph  Binetti</span>, <span class="hlFld-ContribAuthor ">John  Broadwater</span>, <span class="hlFld-ContribAuthor ">Zhidong  Chen</span>, <span class="hlFld-ContribAuthor ">Rebecca  Crux</span>, <span class="hlFld-ContribAuthor ">Stéphane  De Lombaert</span>, <span class="hlFld-ContribAuthor ">Rajvee  Dave</span>, <span class="hlFld-ContribAuthor ">Jonathon A.  Dines</span>, <span class="hlFld-ContribAuthor ">Tazmeen  Fadra-Khan</span>, <span class="hlFld-ContribAuthor ">Adam  Flegg</span>, <span class="hlFld-ContribAuthor ">Michael  Garrigou</span>, <span class="hlFld-ContribAuthor ">Ming-Hong  Hao</span>, <span class="hlFld-ContribAuthor ">John  Huber</span>, <span class="hlFld-ContribAuthor ">J. Matthew  Hutzler</span>, <span class="hlFld-ContribAuthor ">Steven  Kerr</span>, <span class="hlFld-ContribAuthor ">Adrian  Kotey</span>, <span class="hlFld-ContribAuthor ">Weimin  Liu</span>, <span class="hlFld-ContribAuthor ">Ho Yin  Lo</span>, <span class="hlFld-ContribAuthor ">Pui Leng  Loke</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Tina M.  Morwick</span>, <span class="hlFld-ContribAuthor ">Spencer  Napier</span>, <span class="hlFld-ContribAuthor ">Alan  Olague</span>, <span class="hlFld-ContribAuthor ">Edward  Pack</span>, <span class="hlFld-ContribAuthor ">Anil K.  Padyana</span>, <span class="hlFld-ContribAuthor ">David S.  Thomson</span>, <span class="hlFld-ContribAuthor ">Heather  Tye</span>, <span class="hlFld-ContribAuthor ">Lifen  Wu</span>, <span class="hlFld-ContribAuthor ">Renee M.  Zindell</span>, <span class="hlFld-ContribAuthor ">Asitha  Abeywardane</span>, and <span class="hlFld-ContribAuthor ">Thomas  Simpson</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, SAR, and Series Evolution of Novel Oxadiazole-Containing 5-Lipoxygenase Activating Protein Inhibitors: Discovery of 2-[4-(3-{(R)-1-[4-(2-Amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1669-1690. <a href="https://doi.org/10.1021/jm501185j" title="DOI URL">https://doi.org/10.1021/jm501185j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501185j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501185j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BSAR%25252C%252Band%252BSeries%252BEvolution%252Bof%252BNovel%252BOxadiazole-Containing%252B5-Lipoxygenase%252BActivating%252BProtein%252BInhibitors%25253A%252BDiscovery%252Bof%252B2-%25255B4-%2525283-%25257B%252528R%252529-1-%25255B4-%2525282-Amino-pyrimidin-5-yl%252529-phenyl%25255D-1-cyclopropyl-ethyl%25257D-%25255B1%25252C2%25252C4%25255Doxadiazol-5-yl%252529-pyrazol-1-yl%25255D-N%25252CN-dimethyl-acetamide%252B%252528BI%252B665915%252529%26aulast%3DTakahashi%26aufirst%3DHidenori%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01082014%26date%3D11022015%26date%3D26022015%26date%3D14012015%26volume%3D58%26issue%3D4%26spage%3D1669%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Jason A.  Mulder</span>, <span class="hlFld-ContribAuthor ">Nitinchandra D.  Patel</span>, <span class="hlFld-ContribAuthor ">Joe  Gao</span>, <span class="hlFld-ContribAuthor ">Michael  Konrad</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Archer</span>, <span class="hlFld-ContribAuthor ">Frederic G.  Buono</span>, <span class="hlFld-ContribAuthor ">Adil  Duran</span>, <span class="hlFld-ContribAuthor ">Rolf  Schmid</span>, <span class="hlFld-ContribAuthor ">Juergen  Daeubler</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Xingzhong  Zeng</span>, <span class="hlFld-ContribAuthor ">Sonia  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Shengli  Ma</span>, <span class="hlFld-ContribAuthor ">Bo  Qu</span>, <span class="hlFld-ContribAuthor ">Zhibin  Li</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Nelu  Grinberg</span>, <span class="hlFld-ContribAuthor ">Heewon  Lee</span>, <span class="hlFld-ContribAuthor ">Todd  Bosanac</span>, <span class="hlFld-ContribAuthor ">Hidenori  Takahashi</span>, <span class="hlFld-ContribAuthor ">Zhidong  Chen</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Peter  Nemoto</span>, <span class="hlFld-ContribAuthor ">Carl A.  Busacca</span>, <span class="hlFld-ContribAuthor ">Jinhua J.  Song</span>, <span class="hlFld-ContribAuthor ">Nathan K.  Yee</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, and <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of an Asymmetric Synthesis of a Chiral Quaternary FLAP Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (3)
                                     , 1651-1660. <a href="https://doi.org/10.1021/jo502550h" title="DOI URL">https://doi.org/10.1021/jo502550h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502550h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502550h%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ban%252BAsymmetric%252BSynthesis%252Bof%252Ba%252BChiral%252BQuaternary%252BFLAP%252BInhibitor%26aulast%3DFandrick%26aufirst%3DKeith%2BR.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12112014%26date%3D22012015%26date%3D06022015%26date%3D06012015%26volume%3D80%26issue%3D3%26spage%3D1651%26epage%3D1660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thoria  Donia</span>, <span class="hlFld-ContribAuthor ">Abeer  Khamis</span>. </span><span class="cited-content_cbyCitation_article-title">Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges. </span><span class="cited-content_cbyCitation_journal-name">Environmental Science and Pollution Research</span><span> <strong>2021,</strong> <em>28 </em>
                                    (26)
                                     , 34121-34153. <a href="https://doi.org/10.1007/s11356-021-14109-9" title="DOI URL">https://doi.org/10.1007/s11356-021-14109-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11356-021-14109-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11356-021-14109-9%26sid%3Dliteratum%253Aachs%26jtitle%3DEnvironmental%2520Science%2520and%2520Pollution%2520Research%26atitle%3DManagement%252Bof%252Boxidative%252Bstress%252Band%252Binflammation%252Bin%252Bcardiovascular%252Bdiseases%25253A%252Bmechanisms%252Band%252Bchallenges%26aulast%3DDonia%26aufirst%3DThoria%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D26%26spage%3D34121%26epage%3D34153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichandran  Veerasamy</span>, <span class="hlFld-ContribAuthor ">Anitha  Roy</span>, <span class="hlFld-ContribAuthor ">Rohini  Karunakaran</span>, <span class="hlFld-ContribAuthor ">Harish  Rajak</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Analysis of Benzimidazoles as Emerging Anti-Inflammatory Agents: An Overview. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 663. <a href="https://doi.org/10.3390/ph14070663" title="DOI URL">https://doi.org/10.3390/ph14070663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070663%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalysis%252Bof%252BBenzimidazoles%252Bas%252BEmerging%252BAnti-Inflammatory%252BAgents%25253A%252BAn%252BOverview%26aulast%3DVeerasamy%26aufirst%3DRavichandran%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph D.  Ho</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Charles T.  Rauch</span>, <span class="hlFld-ContribAuthor ">Kristen  Aznavour</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Park</span>, <span class="hlFld-ContribAuthor ">John G.  Luz</span>, <span class="hlFld-ContribAuthor ">Stephen  Antonysamy</span>, <span class="hlFld-ContribAuthor ">Bradley  Condon</span>, <span class="hlFld-ContribAuthor ">Milan  Maletic</span>, <span class="hlFld-ContribAuthor ">Aiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Norman E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Srinivasan  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Ashley V.  Sloan</span>, <span class="hlFld-ContribAuthor ">Karen  Gooding</span>, <span class="hlFld-ContribAuthor ">Anita  Harvey</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  Yu</span>, <span class="hlFld-ContribAuthor ">Steven D.  Kahl</span>, <span class="hlFld-ContribAuthor ">Bryan H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP). </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2021,</strong> <em>1865 </em>
                                    (2)
                                     , 129800. <a href="https://doi.org/10.1016/j.bbagen.2020.129800" title="DOI URL">https://doi.org/10.1016/j.bbagen.2020.129800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2020.129800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2020.129800%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DStructure-based%25252C%252Bmulti-targeted%252Bdrug%252Bdiscovery%252Bapproach%252Bto%252Beicosanoid%252Binhibition%25253A%252BDual%252Binhibitors%252Bof%252BmPGES-1%252Band%252B5-lipoxygenase%252Bactivating%252Bprotein%252B%252528FLAP%252529%26aulast%3DHo%26aufirst%3DJoseph%2BD.%26date%3D2021%26volume%3D1865%26issue%3D2%26spage%3D129800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Tu</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Donghui  Huo</span>, <span class="hlFld-ContribAuthor ">Shengde  Zhang</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Fingerprint‐based computational models of 5‐lipo‐oxygenase activating protein inhibitors: Activity prediction and structure clustering. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (3)
                                     , 931-947. <a href="https://doi.org/10.1111/cbdd.13657" title="DOI URL">https://doi.org/10.1111/cbdd.13657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13657%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DFingerprint%2525E2%252580%252590based%252Bcomputational%252Bmodels%252Bof%252B5%2525E2%252580%252590lipo%2525E2%252580%252590oxygenase%252Bactivating%252Bprotein%252Binhibitors%25253A%252BActivity%252Bprediction%252Band%252Bstructure%252Bclustering%26aulast%3DTu%26aufirst%3DGuiping%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D3%26spage%3D931%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahsa  Mousavi</span>, <span class="hlFld-ContribAuthor ">Majid M.  Heravi</span>, <span class="hlFld-ContribAuthor ">Javad  Tajabadi</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot nitrodebromination and methyl bi-functionalization of 5-bromo 6-methylpyrimidines: a unique simultaneous transformation. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2020,</strong> <em>151 </em>
                                    (9)
                                     , 1395-1401. <a href="https://doi.org/10.1007/s00706-020-02658-7" title="DOI URL">https://doi.org/10.1007/s00706-020-02658-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02658-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02658-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DOne-pot%252Bnitrodebromination%252Band%252Bmethyl%252Bbi-functionalization%252Bof%252B5-bromo%252B6-methylpyrimidines%25253A%252Ba%252Bunique%252Bsimultaneous%252Btransformation%26aulast%3DMousavi%26aufirst%3DMahsa%26date%3D2020%26date%3D2020%26volume%3D151%26issue%3D9%26spage%3D1395%26epage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Sinha</span>, <span class="hlFld-ContribAuthor ">Mukesh  Doble</span>, <span class="hlFld-ContribAuthor ">S.L.  Manju</span>. </span><span class="cited-content_cbyCitation_article-title">5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (17)
                                     , 3745-3759. <a href="https://doi.org/10.1016/j.bmc.2019.06.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D5-Lipoxygenase%252Bas%252Ba%252Bdrug%252Btarget%25253A%252BA%252Breview%252Bon%252Btrends%252Bin%252Binhibitors%252Bstructural%252Bdesign%25252C%252BSAR%252Band%252Bmechanism%252Bbased%252Bapproach%26aulast%3DSinha%26aufirst%3DShweta%26date%3D2019%26volume%3D27%26issue%3D17%26spage%3D3745%26epage%3D3759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehra Tuğçe  Gür</span>, <span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Erden  Banoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>153 </em>, 34-48. <a href="https://doi.org/10.1016/j.ejmech.2017.07.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252Bdiscovery%252Bapproaches%252Btargeting%252B5-lipoxygenase-activating%252Bprotein%252B%252528FLAP%252529%252Bfor%252Binhibition%252Bof%252Bcellular%252Bleukotriene%252Bbiosynthesis%26aulast%3DG%25C3%25BCr%26aufirst%3DZehra%2BTu%25C4%259F%25C3%25A7e%26date%3D2018%26volume%3D153%26spage%3D34%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehra Tuğçe  Gür</span>, <span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">UIrike  Garscha</span>, <span class="hlFld-ContribAuthor ">Abdurrahman  Olgaç</span>, <span class="hlFld-ContribAuthor ">Ulrich S.  Schubert</span>, <span class="hlFld-ContribAuthor ">Jana  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Erden  Banoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 876-899. <a href="https://doi.org/10.1016/j.ejmech.2018.03.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bmulti-target%252Binhibitors%252Bof%252Bleukotriene%252Band%252Bprostaglandin%252BE2%252Bbiosynthesis%252Bby%252Bstructural%252Btuning%252Bof%252Bthe%252BFLAP%252Binhibitor%252BBRP-7%26aulast%3DG%25C3%25BCr%26aufirst%3DZehra%2BTu%25C4%259F%25C3%25A7e%26date%3D2018%26volume%3D150%26spage%3D876%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen Zhu  Bi</span>, <span class="hlFld-ContribAuthor ">Chen  Qu</span>, <span class="hlFld-ContribAuthor ">Xiao Lan  Chen</span>, <span class="hlFld-ContribAuthor ">Sheng Kai  Wei</span>, <span class="hlFld-ContribAuthor ">Ling Bo  Qu</span>, <span class="hlFld-ContribAuthor ">Shu Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Kai  Sun</span>, <span class="hlFld-ContribAuthor ">Yu Fen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(II) catalyzed heterobenzylic C(sp3)-H activation: Two efficient halogenation methodologies towards heterobenzyl halides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (15)
                                     , 1908-1917. <a href="https://doi.org/10.1016/j.tet.2018.02.058" title="DOI URL">https://doi.org/10.1016/j.tet.2018.02.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.02.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.02.058%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper%252528II%252529%252Bcatalyzed%252Bheterobenzylic%252BC%252528sp3%252529-H%252Bactivation%25253A%252BTwo%252Befficient%252Bhalogenation%252Bmethodologies%252Btowards%252Bheterobenzyl%252Bhalides%26aulast%3DBi%26aufirst%3DWen%2BZhu%26date%3D2018%26volume%3D74%26issue%3D15%26spage%3D1908%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha  Saroj Devi</span>, <span class="hlFld-ContribAuthor ">Rajasekar  Shanmugam</span>, <span class="hlFld-ContribAuthor ">Jayanta  Ghorai</span>, <span class="hlFld-ContribAuthor ">Meera  Ramanan</span>, <span class="hlFld-ContribAuthor ">Pazhamalai  Anbarasan</span>, <span class="hlFld-ContribAuthor ">Mukesh  Doble</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2018,</strong> <em>37 </em>
                                    (3)
                                     , 1700073. <a href="https://doi.org/10.1002/minf.201700073" title="DOI URL">https://doi.org/10.1002/minf.201700073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201700073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201700073%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DLigand-based%252BModeling%252Bfor%252Bthe%252BPrediction%252Bof%252BPharmacophore%252BFeatures%252Bfor%252BMulti-targeted%252BInhibition%252Bof%252Bthe%252BArachidonic%252BAcid%252BCascade%26aulast%3DSaroj%25E2%2580%2585Devi%26aufirst%3DNisha%26date%3D2018%26date%3D2017%26volume%3D37%26issue%3D3%26spage%3D1700073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaoyu  Hu</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of lipoxygenase inhibitors as anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 212-225. <a href="https://doi.org/10.1039/C7MD00390K" title="DOI URL">https://doi.org/10.1039/C7MD00390K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00390K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00390K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Bdevelopment%252Bof%252Blipoxygenase%252Binhibitors%252Bas%252Banti-inflammatory%252Bagents%26aulast%3DHu%26aufirst%3DChaoyu%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D212%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kumar Bhaskar  Pal</span>, <span class="hlFld-ContribAuthor ">Mukul  Mahanti</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Stella  Persson</span>, <span class="hlFld-ContribAuthor ">Anders P.  Sundin</span>, <span class="hlFld-ContribAuthor ">Fredrik R.  Zetterberg</span>, <span class="hlFld-ContribAuthor ">Stina  Oredsson</span>, <span class="hlFld-ContribAuthor ">Hakon  Leffler</span>, <span class="hlFld-ContribAuthor ">Ulf J.  Nilsson</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline–galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (34)
                                     , 6295-6305. <a href="https://doi.org/10.1039/C8OB01354C" title="DOI URL">https://doi.org/10.1039/C8OB01354C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01354C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01354C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DQuinoline%2525E2%252580%252593galactose%252Bhybrids%252Bbind%252Bselectively%252Bwith%252Bhigh%252Baffinity%252Bto%252Ba%252Bgalectin-8%252BN-terminal%252Bdomain%26aulast%3DPal%26aufirst%3DKumar%2BBhaskar%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D34%26spage%3D6295%26epage%3D6305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Asitha  Abeywardane</span>, <span class="hlFld-ContribAuthor ">Todd  Bosanac</span>, <span class="hlFld-ContribAuthor ">John A.  Broadwater</span>, <span class="hlFld-ContribAuthor ">Zhidong  Chen</span>, <span class="hlFld-ContribAuthor ">J. Matthew  Hutzler</span>, <span class="hlFld-ContribAuthor ">John D.  Huber</span>, <span class="hlFld-ContribAuthor ">Peter  Nemoto</span>, <span class="hlFld-ContribAuthor ">Alan  Olague</span>, <span class="hlFld-ContribAuthor ">Doris  Riether</span>, <span class="hlFld-ContribAuthor ">Tom  Simpson</span>, <span class="hlFld-ContribAuthor ">Hidenori  Takahashi</span>, <span class="hlFld-ContribAuthor ">Lifen  Wu</span>, <span class="hlFld-ContribAuthor ">Yunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Renee M.  Zindell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of oxadiazole-based FLAP inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4652-4659. <a href="https://doi.org/10.1016/j.bmcl.2017.09.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Boxadiazole-based%252BFLAP%252Binhibitors%26aulast%3DBartolozzi%26aufirst%3DAlessandra%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4652%26epage%3D4659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Jana  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">Ulrike  Garscha</span>. </span><span class="cited-content_cbyCitation_article-title">Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 607-620. <a href="https://doi.org/10.1080/13543776.2017.1276568" title="DOI URL">https://doi.org/10.1080/13543776.2017.1276568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1276568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1276568%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252Bleukotriene%252Bbiosynthesis%252Binhibitors%252B%2525282012-2016%252529%252Bas%252Banti-inflammatory%252Bagents%26aulast%3DWerz%26aufirst%3DOliver%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D607%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulrike  Garscha</span>, <span class="hlFld-ContribAuthor ">Susanna  Voelker</span>, <span class="hlFld-ContribAuthor ">Simona  Pace</span>, <span class="hlFld-ContribAuthor ">Jana  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">Besa  Emini</span>, <span class="hlFld-ContribAuthor ">Stefanie  Liening</span>, <span class="hlFld-ContribAuthor ">Antonietta  Rossi</span>, <span class="hlFld-ContribAuthor ">Christina  Weinigel</span>, <span class="hlFld-ContribAuthor ">Silke  Rummler</span>, <span class="hlFld-ContribAuthor ">Ulrich S.  Schubert</span>, <span class="hlFld-ContribAuthor ">Gerhard K.E.  Scriba</span>, <span class="hlFld-ContribAuthor ">Erşan  Çelikoğlu</span>, <span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Erden  Banoglu</span>, <span class="hlFld-ContribAuthor ">Lidia  Sautebin</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>. </span><span class="cited-content_cbyCitation_article-title">BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2016,</strong> <em>119 </em>, 17-26. <a href="https://doi.org/10.1016/j.bcp.2016.08.023" title="DOI URL">https://doi.org/10.1016/j.bcp.2016.08.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2016.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2016.08.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DBRP-187%25253A%252BA%252Bpotent%252Binhibitor%252Bof%252Bleukotriene%252Bbiosynthesis%252Bthat%252Bacts%252Bthrough%252Bimpeding%252Bthe%252Bdynamic%252B5-lipoxygenase%25252F5-lipoxygenase-activating%252Bprotein%252B%252528FLAP%252529%252Bcomplex%252Bassembly%26aulast%3DGarscha%26aufirst%3DUlrike%26date%3D2016%26volume%3D119%26spage%3D17%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bibiana  Rius</span>, <span class="hlFld-ContribAuthor ">Joan  Clària</span>. </span><span class="cited-content_cbyCitation_article-title">Principles, Mechanisms of Action, and Future Prospects of Anti-inflammatory Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 17-34. <a href="https://doi.org/10.1007/978-3-319-33889-7_2" title="DOI URL">https://doi.org/10.1007/978-3-319-33889-7_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-33889-7_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-33889-7_2%26sid%3Dliteratum%253Aachs%26atitle%3DPrinciples%25252C%252BMechanisms%252Bof%252BAction%25252C%252Band%252BFuture%252BProspects%252Bof%252BAnti-inflammatory%252BDrugs%26aulast%3DRius%26aufirst%3DBibiana%26date%3D2016%26date%3D2016%26spage%3D17%26epage%3D34%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNSAIDs%252Band%252BAspirin%26aulast%3DLanas%26aufirst%3DAngel%26date%3D2016%26volume%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Hanke</span>, <span class="hlFld-ContribAuthor ">Daniel  Merk</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Gerd  Geisslinger</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules with anti-inflammatory properties in clinical development. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2016,</strong> <em>157 </em>, 163-187. <a href="https://doi.org/10.1016/j.pharmthera.2015.11.011" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DSmall%252Bmolecules%252Bwith%252Banti-inflammatory%252Bproperties%252Bin%252Bclinical%252Bdevelopment%26aulast%3DHanke%26aufirst%3DThomas%26date%3D2016%26volume%3D157%26spage%3D163%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Pettersen</span>, <span class="hlFld-ContribAuthor ">Öjvind  Davidsson</span>, <span class="hlFld-ContribAuthor ">Carl  Whatling</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances for FLAP inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (13)
                                     , 2607-2612. <a href="https://doi.org/10.1016/j.bmcl.2015.04.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.04.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.04.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.04.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bfor%252BFLAP%252Binhibitors%26aulast%3DPettersen%26aufirst%3DDaniel%26date%3D2015%26volume%3D25%26issue%3D13%26spage%3D2607%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Feng  Zou</span>, <span class="hlFld-ContribAuthor ">Wei-Sheng  Huang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Zheng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhan-Jiang  Zheng</span>, <span class="hlFld-ContribAuthor ">Ke-Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Wen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">DMSO as oxidant and sulfenylating agent for metal-free oxidation and methylthiolation of alcohol-containing indoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (38)
                                     , 30389-30393. <a href="https://doi.org/10.1039/C5RA03606B" title="DOI URL">https://doi.org/10.1039/C5RA03606B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA03606B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA03606B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDMSO%252Bas%252Boxidant%252Band%252Bsulfenylating%252Bagent%252Bfor%252Bmetal-free%252Boxidation%252Band%252Bmethylthiolation%252Bof%252Balcohol-containing%252Bindoles%26aulast%3DZou%26aufirst%3DJin-Feng%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D38%26spage%3D30389%26epage%3D30393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabina Antonela  Antoniu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2014,</strong> <em>18 </em>
                                    (11)
                                     , 1285-1292. <a href="https://doi.org/10.1517/14728222.2014.945425" title="DOI URL">https://doi.org/10.1517/14728222.2014.945425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2014.945425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2014.945425%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252B5-lipoxygenase-activating%252Bprotein%252Bin%252Basthma%252Band%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DAntoniu%26aufirst%3DSabina%2BAntonela%26date%3D2014%26date%3D2014%26volume%3D18%26issue%3D11%26spage%3D1285%26epage%3D1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">Christina  Weinigel</span>, <span class="hlFld-ContribAuthor ">Dagmar  Barz</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Ulrike  Garscha</span>. </span><span class="cited-content_cbyCitation_article-title">An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2014,</strong> <em>1840 </em>
                                    (9)
                                     , 2961-2969. <a href="https://doi.org/10.1016/j.bbagen.2014.05.016" title="DOI URL">https://doi.org/10.1016/j.bbagen.2014.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2014.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DAn%252Bexperimental%252Bcell-based%252Bmodel%252Bfor%252Bstudying%252Bthe%252Bcell%252Bbiology%252Band%252Bmolecular%252Bpharmacology%252Bof%252B5-lipoxygenase-activating%252Bprotein%252Bin%252Bleukotriene%252Bbiosynthesis%26aulast%3DGerstmeier%26aufirst%3DJana%26date%3D2014%26volume%3D1840%26issue%3D9%26spage%3D2961%26epage%3D2969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Lehuan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted α-halogenation of 2-methylquinolines with tetrabutylammonium iodide and 1,2-dichloroethane (1,2-dibromoethane). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (29)
                                     , 3892-3895. <a href="https://doi.org/10.1016/j.tetlet.2014.04.023" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMicrowave-assisted%252B%2525CE%2525B1-halogenation%252Bof%252B2-methylquinolines%252Bwith%252Btetrabutylammonium%252Biodide%252Band%252B1%25252C2-dichloroethane%252B%2525281%25252C2-dibromoethane%252529%26aulast%3DXie%26aufirst%3DYuanyuan%26date%3D2014%26volume%3D55%26issue%3D29%26spage%3D3892%26epage%3D3895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C  Pergola</span>, <span class="hlFld-ContribAuthor ">J  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">B  Mönch</span>, <span class="hlFld-ContribAuthor ">B  Çalışkan</span>, <span class="hlFld-ContribAuthor ">S  Luderer</span>, <span class="hlFld-ContribAuthor ">C  Weinigel</span>, <span class="hlFld-ContribAuthor ">D  Barz</span>, <span class="hlFld-ContribAuthor ">J  Maczewsky</span>, <span class="hlFld-ContribAuthor ">S  Pace</span>, <span class="hlFld-ContribAuthor ">A  Rossi</span>, <span class="hlFld-ContribAuthor ">L  Sautebin</span>, <span class="hlFld-ContribAuthor ">E  Banoglu</span>, <span class="hlFld-ContribAuthor ">O  Werz</span>. </span><span class="cited-content_cbyCitation_article-title">The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis
              in vitro
              and
              in vivo
              by targeting 5-lipoxygenase-activating protein (FLAP). </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2014,</strong> <em>171 </em>
                                    (12)
                                     , 3051-3064. <a href="https://doi.org/10.1111/bph.12625" title="DOI URL">https://doi.org/10.1111/bph.12625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12625%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252Bnovel%252Bbenzimidazole%252Bderivative%252BBRP-7%252Binhibits%252Bleukotriene%252Bbiosynthesis%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bby%252Btargeting%252B5-lipoxygenase-activating%252Bprotein%252B%252528FLAP%252529%26aulast%3DPergola%26aufirst%3DC%26date%3D2014%26date%3D2014%26volume%3D171%26issue%3D12%26spage%3D3051%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Gaba</span>, <span class="hlFld-ContribAuthor ">Sarbjot  Singh</span>, <span class="hlFld-ContribAuthor ">Chander  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 494-505. <a href="https://doi.org/10.1016/j.ejmech.2014.01.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%25253A%252BAn%252Bemerging%252Bscaffold%252Bfor%252Banalgesic%252Band%2525C2%2525A0anti-inflammatory%252Bagents%26aulast%3DGaba%26aufirst%3DMonika%26date%3D2014%26volume%3D76%26spage%3D494%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Search for Novel 5-Lipoxygenase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Basic & Clinical Pharmacology & Toxicology</span><span> <strong>2014,</strong> <em>114 </em>
                                    (1)
                                     , 70-77. <a href="https://doi.org/10.1111/bcpt.12114" title="DOI URL">https://doi.org/10.1111/bcpt.12114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcpt.12114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcpt.12114%26sid%3Dliteratum%253Aachs%26jtitle%3DBasic%2520%2526%2520Clinical%2520Pharmacology%2520%2526%2520Toxicology%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSearch%252Bfor%252BNovel%252B5-Lipoxygenase%252BInhibitors%26aulast%3DSteinhilber%26aufirst%3DDieter%26date%3D2014%26date%3D2013%26volume%3D114%26issue%3D1%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>. </span><span class="cited-content_cbyCitation_article-title">5-Lipoxygenase inhibitors: a review of recent patents (2010 – 2012). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 895-909. <a href="https://doi.org/10.1517/13543776.2013.791678" title="DOI URL">https://doi.org/10.1517/13543776.2013.791678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.791678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.791678%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D5-Lipoxygenase%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatents%252B%2525282010%252B%2525E2%252580%252593%252B2012%252529%26aulast%3DHofmann%26aufirst%3DBettina%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D895%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Erden  Banoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of recent drug discovery approaches for new generation leukotriene A
              4
              hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (1)
                                     , 49-63. <a href="https://doi.org/10.1517/17460441.2013.735228" title="DOI URL">https://doi.org/10.1517/17460441.2013.735228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.735228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.735228%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DOverview%252Bof%252Brecent%252Bdrug%252Bdiscovery%252Bapproaches%252Bfor%252Bnew%252Bgeneration%252Bleukotriene%252BA%252B4%252Bhydrolase%252Binhibitors%26aulast%3D%25C3%2587al%25C4%25B1%25C5%259Fkan%26aufirst%3DBurcu%26date%3D2013%26date%3D2012%26volume%3D8%26issue%3D1%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erden  Banoglu</span>, <span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Susann  Luderer</span>, <span class="hlFld-ContribAuthor ">Gökçen  Eren</span>, <span class="hlFld-ContribAuthor ">Yagmur  Özkan</span>, <span class="hlFld-ContribAuthor ">Wolfram  Altenhofen</span>, <span class="hlFld-ContribAuthor ">Christina  Weinigel</span>, <span class="hlFld-ContribAuthor ">Dagmar  Barz</span>, <span class="hlFld-ContribAuthor ">Jana  Gerstmeier</span>, <span class="hlFld-ContribAuthor ">Carlo  Pergola</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (12)
                                     , 3728-3741. <a href="https://doi.org/10.1016/j.bmc.2012.04.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.04.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.04.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.04.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bbenzimidazole%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bleukotriene%252Bbiosynthesis%252Bby%252Bvirtual%252Bscreening%252Btargeting%252B5-lipoxygenase-activating%252Bprotein%252B%252528FLAP%252529%26aulast%3DBanoglu%26aufirst%3DErden%26date%3D2012%26volume%3D20%26issue%3D12%26spage%3D3728%26epage%3D3741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Di Gennaro</span>, <span class="hlFld-ContribAuthor ">Jesper Z.  Haeggström</span>. </span><span class="cited-content_cbyCitation_article-title">The Leukotrienes: Immune-Modulating Lipid Mediators of Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 51-92. <a href="https://doi.org/10.1016/B978-0-12-394300-2.00002-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-394300-2.00002-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-394300-2.00002-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-394300-2.00002-8%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLeukotrienes%25253A%252BImmune-Modulating%252BLipid%252BMediators%252Bof%252BDisease%26aulast%3DDi%2BGennaro%26aufirst%3DAntonio%26date%3D2012%26spage%3D51%26epage%3D92%26pub%3DElsevier%26atitle%3DAdvances%252Bin%252BImmunology%252BVolume%252B116%26date%3D2012%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert O.  Hughes</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Hidenori  Takahashi</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammatory Targets for the Treatment of Atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 223-235. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00015-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00015-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00015-1%26sid%3Dliteratum%253Aachs%26atitle%3DInflammatory%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BAtherosclerosis%26aulast%3DHughes%26aufirst%3DRobert%2BO.%26date%3D2012%26spage%3D223%26epage%3D235%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Leukotriene biosynthesis pathway and associated GPCRs (in italics).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of leukotriene pathway inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>CH<sub>2</sub>Br (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), Cs<sub>2</sub>CO<sub>3</sub>, MeCN or DMF, room temp to 60 °C; (b) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (cat.), bis(pinacolato)diboron, KOAc, <i>p</i>-dioxane, 85 °C; (c) heteroaryl-X, Pd(PPh<sub>3</sub>)<sub>4</sub> (cat.), DME/H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 80–85 °C; (d) LiOH·H<sub>2</sub>O, THF, H<sub>2</sub>O, MeOH, 60 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Alkylating Agents<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Chlorosuccinimide, C<sub>6</sub>H<sub>6</sub>, (PhCO)<sub>2</sub>, reflux; (b) trichloroisocyanuric acid, CHCl<sub>3</sub>, reflux; (c) <i>m</i>-CPBA, CHCl<sub>3</sub>; (d) Ac<sub>2</sub>O, 100 °C to reflux; (e) HCl (conc), reflux; (f) SOCl<sub>2</sub>, reflux; (g) <i>N</i>-bromosuccinimide, C<sub>6</sub>H<sub>6</sub>, (PhCO)<sub>2</sub>, reflux; (h) TMSCH<sub>2</sub>N<sub>2</sub>, toluene, MeOH; (i) TMSCN, Et<sub>2</sub>NC(O)Cl, CH<sub>2</sub>Cl<sub>2</sub>; (j) HCl (g), MeOH; (k) DIBAl-H, THF, −78 °C; (l) BH<sub>3</sub>·THF, THF, 0 °C; (m) Boc<sub>2</sub>O, DMAP, MeCN; (n) DIBAl-H, toluene, −40 °C; (o) LiBr, CH<sub>3</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. SAR at 3-Position of the Indole and Preparation of Pyridinone <b>11jj</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) LiOH·H<sub>2</sub>O, MeOH, THF, H<sub>2</sub>O, 60 °C; (b) <i>m</i>-CPBA (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, −20 to 0 °C; (c) AlCl<sub>3</sub>, H<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to room temp; (d) RC(O)Cl, AlCl<sub>3</sub>, DCE, 65 °C; (e) 1 N NaOH, EtOH; (f) LiOH·H<sub>2</sub>O, ethylene glycol, 165 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/medium/jm-2011-008369_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. On-rates and off-rates for radiolabeled compounds <b>1</b> and <b>11a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008369/production/images/large/jm-2011-008369_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2008369&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arruda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee., C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors: development of 3-{3-<i>tert</i>-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5803</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900945d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5803-5815&author=J.+H.+Hutchinsonauthor=Y.+Liauthor=J.+M.+Arrudaauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+Lee.author=D.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=N.+Stockauthor=P.+Prasitauthor=J.+F.+Evans&title=5-Lipoxygenase-activating+protein+inhibitors%3A+development+of+3-%7B3-tert-butylsulfanyl-1-%5B4-%286-methoxy-pyridin-3-yl%29-benzyl%5D-5-%28pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethyl-propionic+acid+%28AM103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm900945d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900945d%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DArruda%26aufirst%3DJ.%2BM.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DLee.%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors%253A%2520development%2520of%25203-%257B3-tert-butylsulfanyl-1-%255B4-%25286-methoxy-pyridin-3-yl%2529-benzyl%255D-5-%2528pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM103%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5803%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((<i>S</i>)-1-Acetyl-2,3-dihydro-1<i>H</i>-indol-2-ylmethoxy)-3-<i>tert</i>-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1<i>H</i>-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—a potent FLAP inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=213-217&author=N.+Stockauthor=C.+Bacceiauthor=G.+Bainauthor=A.+Broadheadauthor=C.+Chapmanauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=Y.+Liauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=J.+Zunicauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=5-Lipoxygenase-activating+protein+inhibitors.+Part+2%3A+3-%7B5-%28%28S%29-1-Acetyl-2%2C3-dihydro-1H-indol-2-ylmethoxy%29-3-tert-butylsulfanyl-1-%5B4-%285-methoxy-pyrimidin-2-yl%29-benzyl%5D-1H-indol-2-yl%7D-2%2C2-dimethyl-propionic+acid+%28AM679%29%E2%80%94a+potent+FLAP+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DBroadhead%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DZunic%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors.%2520Part%25202%253A%25203-%257B5-%2528%2528S%2529-1-Acetyl-2%252C3-dihydro-1H-indol-2-ylmethoxy%2529-3-tert-butylsulfanyl-1-%255B4-%25285-methoxy-pyrimidin-2-yl%2529-benzyl%255D-1H-indol-2-yl%257D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM679%2529%25E2%2580%2594a%2520potent%2520FLAP%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D213%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-<i>tert</i>-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—a potent FLAP inhibitor suitable for topical administration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4598</span><span class="NLM_x">–</span> <span class="NLM_lpage">4601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4598-4601&author=N.+Stockauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=A.+Santiniauthor=K.+Schaabauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=5-Lipoxygenase-activating+protein+inhibitors.+Part+3%3A+3-%7B3-tert-Butylsulfanyl-1-%5B4-%285-methoxy-pyrimidin-2-yl%29-benzyl%5D-5-%285-methyl-pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethyl-propionic+acid+%28AM643%29%E2%80%94a+potent+FLAP+inhibitor+suitable+for+topical+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DSchaab%26aufirst%3DK.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3D5-Lipoxygenase-activating%2520protein%2520inhibitors.%2520Part%25203%253A%25203-%257B3-tert-Butylsulfanyl-1-%255B4-%25285-methoxy-pyrimidin-2-yl%2529-benzyl%255D-5-%25285-methyl-pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethyl-propionic%2520acid%2520%2528AM643%2529%25E2%2580%2594a%2520potent%2520FLAP%2520inhibitor%2520suitable%2520for%2520topical%2520administration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4598%26epage%3D4601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">The discovery of the leukotrienes</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">S2</span><span class="NLM_x">–</span> <span class="NLM_lpage">S6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2000&pages=S2-S6&author=B.+Samuelsson&title=The+discovery+of+the+leukotrienes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DThe%2520discovery%2520of%2520the%2520leukotrienes%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2000%26volume%3D161%26spage%3DS2%26epage%3DS6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">What’s all the FLAP about? 5-Lipoxygenase-activating protein inhibitors for inflammatory diseases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=72-78&author=J.+F.+Evansauthor=A.+D.+Fergusonauthor=R.+T.+Mosleyauthor=J.+H.+Hutchinson&title=What%E2%80%99s+all+the+FLAP+about%3F+5-Lipoxygenase-activating+protein+inhibitors+for+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DWhat%25E2%2580%2599s%2520all%2520the%2520FLAP%2520about%253F%25205-Lipoxygenase-activating%2520protein%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D72%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Grant, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, W. S.</span><span> </span><span class="NLM_article-title">5-Oxo-ETE and the OXE receptor</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2Fj.prostaglandins.2009.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=19450703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=98-104&author=E.+G.+Grantauthor=J.+Rokachauthor=W.+S.+Powell&title=5-Oxo-ETE+and+the+OXE+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">5-Oxo-ETE and the OXE receptor</span></div><div class="casAuthors">Grant, Gail E.; Rokach, Joshua; Powell, William S.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  5-Oxo-ETE is a product of the 5-lipoxygenase pathway that is formed by the oxidn. of 5-HETE by 5-hydroxyeicosanoid dehydrogenase (5-HEDH). 5-HEDH is a microsomal NADP+-dependent enzyme that is highly selective for 5-HETE. 5-Oxo-ETE synthesis is regulated by intracellular NADP+ levels and is dramatically increased under conditions that favor oxidn. of NADPH to NADP+ such as oxidative stress and the respiratory burst in phagocytic cells. 5-Oxo-ETE is a potent chemoattractant for eosinophils and has similar effects on neutrophils, basophils and monocytes.  It elicits infiltration of eosinophils and, to a lesser extent, neutrophils into the skin after intradermal injection in humans.  It also promotes the survival of tumor cells and has been shown to block the induction of apoptosis by 5-LO inhibitors. 5-Oxo-ETE acts by the Gi/o-coupled OXE receptor, which was also known as TG1019, R527 and hGPCR48.  Although the pathophysiol. role of 5-oxo-ETE is not well understood, it may play important roles in asthma and allergic diseases, cancer, and cardiovascular disease.  The availability of a selective antagonist would help to clarify the role of 5-oxo-ETE and may be of therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdkkS0fmsMLVg90H21EOLACvtfcHk0li4MKrTWehXBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7nE&md5=d4175150c556c310c476bc9496b48766</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DE.%2BG.%26aulast%3DRokach%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DW.%2BS.%26atitle%3D5-Oxo-ETE%2520and%2520the%2520OXE%2520receptor%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2009%26volume%3D89%26spage%3D98%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Peters-Golden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, W. R.</span><span> </span><span class="NLM_article-title">Mechanisms of disease. Leukotrienes</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1056%2FNEJMra071371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17978293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=1841-1854&author=M.+Peters-Goldenauthor=W.+R.+Henderson&title=Mechanisms+of+disease.+Leukotrienes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotrienes</span></div><div class="casAuthors">Peters-Golden, Marc; Henderson, William R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1841-1854</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Leukotrienes comprise a family of products of the 5-lipoxygenase pathway of arachidonic acid metab.  The cysteinyl leukotrienes C4, D4, and E4 account for the biol. activity that was previously termed "slow-reacting substance of anaphylaxis", and the efficacy of antagonists to type 1 cysteinyl leukotriene receptor (CysLT1) in asthma validates the importance of cysteinyl leukotrienes and CysLT1 in this disease.  Here, the authors discuss: synthesis of leukotrienes; leukotriene receptors; blockade of leukotriene synthesis and leukotriene receptors; leukotrienes in disease; and leukotrienes in antimicrobial defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjehKHMPz2p7Vg90H21EOLACvtfcHk0li4MKrTWehXBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitL%252FM&md5=4e617e65cf4b1f55f595bc03344fdb55</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra071371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra071371%26sid%3Dliteratum%253Aachs%26aulast%3DPeters-Golden%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26atitle%3DMechanisms%2520of%2520disease.%2520Leukotrienes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D1841%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">BLT1 and BLT2: the leukotriene B4 receptors</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0952-3278%2803%2900073-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=12895595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=123-134&author=A.+M.+Tagerauthor=A.+D.+Luster&title=BLT1+and+BLT2%3A+the+leukotriene+B4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BLT1 and BLT2: the leukotriene B4 receptors</span></div><div class="casAuthors">Tager, Andrew M.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Two receptors for LTB4 have been molecularly identified: BLT1 and BLT2.  Both receptors are G protein-coupled 7 transmembrane domain receptors, whose genes are located in very close proximity to each other in the human and mouse genomes.  The 2 receptors differ in their affinity and specificity for LTB4: BLT1 is a high-affinity receptor specific for LTB4, whereas BLT2 is a low-affinity receptor that also binds other eicosanoids.  The 2 receptors also differ in their pattern of expression with BLT1 being expressed primarily in leukocytes, whereas BLT2 is expressed more ubiquitously.  By mediating the activities of LTB4, these receptors participate both in host immune responses and in the pathogenesis of inflammatory diseases.  Reduced disease severity in animal inflammatory models seen with LTB4 receptor antagonists and in mice with targeted deletion of BLT1 have revealed important roles for LTB4 and its receptors in regulating pathol. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fxBgFGg_3bVg90H21EOLACvtfcHk0li4MKrTWehXBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbw%253D&md5=e60a4de33d9c99c03f2a30d8153757de</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0952-3278%2803%2900073-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-3278%252803%252900073-5%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DBLT1%2520and%2520BLT2%253A%2520the%2520leukotriene%2520B4%2520receptors%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2003%26volume%3D69%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooks, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene CysLT1 receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=789-793&author=K.+R.+Lynchauthor=G.+P.+O%E2%80%99Neillauthor=Q.+Liuauthor=D.-S.+Imauthor=N.+Sawyerauthor=K.+M.+Mettersauthor=N.+Coulombeauthor=M.+Abramovitzauthor=D.+J.+Figueroaauthor=Z.+Zengauthor=B.+M.+Connollyauthor=C.+Baiauthor=C.+P.+Austinauthor=A.+Chateauneufauthor=R.+Stoccoauthor=G.+M.+Greigauthor=S.+Kargmanauthor=S.+B.+Hooksauthor=E.+Hosfieldauthor=D.+L.+Williamsauthor=A.+W.+Ford-Hutchinsonauthor=C.+T.+Caskeyauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+CysLT1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DConnolly%26aufirst%3DB.%2BM.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DGreig%26aufirst%3DG.%2BM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DHosfield%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%2520CysLT1%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D789%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellefeuille, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene 2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30531</span><span class="NLM_x">–</span> <span class="NLM_lpage">30536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1074%2Fjbc.M003490200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=10851239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30531-30536&author=C.+E.+Heiseauthor=B.+F.+O%E2%80%99Dowdauthor=D.+J.+Figueroaauthor=N.+Sawyerauthor=T.+Nguyenauthor=D.-S.+Imauthor=R.+Stoccoauthor=J.+N.+Bellefeuilleauthor=M.+Abramovitzauthor=R.+Chengauthor=D.+L.+Williamsauthor=Z.+Zengauthor=Q.+Liuauthor=L.+Maauthor=M.+K.+Clementsauthor=N.+Coulombeauthor=Y.+Liuauthor=C.+P.+Austinauthor=S.+R.+Georgeauthor=G.+P.+O%E2%80%99Neillauthor=K.+M.+Mettersauthor=K.+R.+Lynchauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human cysteinyl leukotriene 2 receptor</span></div><div class="casAuthors">Heise, Christopher E.; O'Dowd, Brian F.; Figueroa, David J.; Sawyer, Nicole; Nguyen, Tuan; Im, Dong-Soon; Stocco, Rino; Bellefeuille, Julie N.; Abramovitz, Mark; Cheng, Regina; Williams, David L., Jr.; Zeng, Zhizhen; Liu, Qingyun; Ma, Lei; Clements, Michelle K.; Coulombe, Nathalie; Liu, Yuan; Austin, Christopher P.; George, Susan R.; O'Neill, Gary P.; Metters, Kathleen M.; Lynch, Kevin R.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30531-30536</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The contractile and inflammatory actions of the cysteinyl leukotrienes (CysLTs), LTC4, LTD4, and LTE4, are thought to be mediated through at least two distinct but related CysLT G protein-coupled receptors.  The human CysLT1 receptor has been recently cloned and characterized.  We describe here the cloning and characterization of the second cysteinyl leukotriene receptor, CysLT2, a 346-amino acid protein with 38% amino acid identity to the CysLT1 receptor.  The recombinant human CysLT2 receptor was expressed in Xenopus oocytes and HEK293T cells and shown to couple to elevation of intracellular calcium when activated by LTC4, LTD4, or LTE4.  Analyses of radiolabeled LTD4 binding to the recombinant CysLT2 receptor demonstrated high affinity binding and a rank order of potency for competition of LTC4 = LTD4 » LTE4.  In contrast to the dual CysLT1/CysLT2 antagonist, BAY u9773, the CysLT1 receptor-selective antagonists MK-571, montelukast, zafirlukast, and pranlukast exhibited low potency in competition for LTD4 binding and as antagonists of CysLT2 receptor signaling.  CysLT2 receptor mRNA was detected in lung macrophages and airway smooth muscle, cardiac Purkinje cells, adrenal medulla cells, peripheral blood leukocytes, and brain, and the receptor gene was mapped to chromosome 13q14, a region linked to atopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNARzHAjs1wLVg90H21EOLACvtfcHk0li2qlHt_FouCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D&md5=a3c128d90e193664c2180e3029d8b96d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003490200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003490200%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DBellefeuille%26aufirst%3DJ.%2BN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%25202%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30531%26epage%3D30536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Beller, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, Y.</span><span> </span><span class="NLM_article-title">Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46129</span><span class="NLM_x">–</span> <span class="NLM_lpage">46134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46129-46134&author=T.+C.+Bellerauthor=A.+Maekawaauthor=D.+S.+Friendauthor=K.+F.+Austenauthor=Y.+Kanaoka&title=Targeted+gene+disruption+reveals+the+role+of+the+cysteinyl+leukotriene+2+receptor+in+increased+vascular+permeability+and+in+bleomycin-induced+pulmonary+fibrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeller%26aufirst%3DT.%2BC.%26aulast%3DMaekawa%26aufirst%3DA.%26aulast%3DFriend%26aufirst%3DD.%2BS.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DKanaoka%26aufirst%3DY.%26atitle%3DTargeted%2520gene%2520disruption%2520reveals%2520the%2520role%2520of%2520the%2520cysteinyl%2520leukotriene%25202%2520receptor%2520in%2520increased%2520vascular%2520permeability%2520and%2520in%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46129%26epage%3D46134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kamohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushime, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span> </span><span class="NLM_article-title">Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=1088-1092&author=M.+Kamoharaauthor=J.+Takasakiauthor=M.+Matsumotoauthor=S-i.+Matsumotoauthor=T.+Saitoauthor=T.+Sogaauthor=H.+Matsushimeauthor=K.+Furuichi&title=Functional+characterization+of+cysteinyl+leukotriene+CysLT2+receptor+on+human+coronary+artery+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamohara%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS-i.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DMatsushime%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26atitle%3DFunctional%2520characterization%2520of%2520cysteinyl%2520leukotriene%2520CysLT2%2520receptor%2520on%2520human%2520coronary%2520artery%2520smooth%2520muscle%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ciana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verderio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrario, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parravicini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelosa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcredito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sironi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovati, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span> </span><span class="NLM_article-title">The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=4615-4627&author=P.+Cianaauthor=M.+Fumagalliauthor=M.+L.+Trincavelliauthor=C.+Verderioauthor=P.+Rosaauthor=D.+Leccaauthor=S.+Ferrarioauthor=C.+Parraviciniauthor=V.+Capraauthor=P.+Gelosaauthor=U.+Guerriniauthor=S.+Belcreditoauthor=M.+Ciminoauthor=L.+Sironiauthor=E.+Tremoliauthor=G.+E.+Rovatiauthor=C.+Martiniauthor=M.+P.+Abbracchio&title=The+orphan+receptor+GPR17+identified+as+a+new+dual+uracil+nucleotides%2Fcysteinyl-leukotrienes+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiana%26aufirst%3DP.%26aulast%3DFumagalli%26aufirst%3DM.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DVerderio%26aufirst%3DC.%26aulast%3DRosa%26aufirst%3DP.%26aulast%3DLecca%26aufirst%3DD.%26aulast%3DFerrario%26aufirst%3DS.%26aulast%3DParravicini%26aufirst%3DC.%26aulast%3DCapra%26aufirst%3DV.%26aulast%3DGelosa%26aufirst%3DP.%26aulast%3DGuerrini%26aufirst%3DU.%26aulast%3DBelcredito%26aufirst%3DS.%26aulast%3DCimino%26aufirst%3DM.%26aulast%3DSironi%26aufirst%3DL.%26aulast%3DTremoli%26aufirst%3DE.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DThe%2520orphan%2520receptor%2520GPR17%2520identified%2520as%2520a%2520new%2520dual%2520uracil%2520nucleotides%252Fcysteinyl-leukotrienes%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramoto, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span> </span><span class="NLM_article-title">Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2005&pages=281-288&author=Y.+Nonakaauthor=T+Hiramotoauthor=N.+Fujita&title=Identification+of+endogenous+surrogate+ligands+for+human+P2Y12+receptors+by+in+silico+and+in+vitro+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DHiramoto%26aufirst%3DT%26aulast%3DFujita%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520endogenous%2520surrogate%2520ligands%2520for%2520human%2520P2Y12%2520receptors%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520methods%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D337%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Maekawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span> </span><span class="NLM_article-title">Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">16695</span><span class="NLM_x">–</span> <span class="NLM_lpage">16700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=16695-16700&author=A.+Maekawaauthor=Y.+Kanaokaauthor=X.+Xingauthor=K.+F.+Austen&title=Functional+recognition+of+a+distinct+receptor+preferential+for+leukotriene+E4+in+mice+lacking+the+cysteinyl+leukotriene+1+and+2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DA.%26aulast%3DKanaoka%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26atitle%3DFunctional%2520recognition%2520of%2520a%2520distinct%2520receptor%2520preferential%2520for%2520leukotriene%2520E4%2520in%2520mice%2520lacking%2520the%2520cysteinyl%2520leukotriene%25201%2520and%25202%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D16695%26epage%3D16700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Chandt, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, C. B.</span><span> </span><span class="NLM_article-title">Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1111%2Fj.1742-1241.2007.01320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17394438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=663-676&author=W.+Bergerauthor=M.+T.+De+Chandtauthor=C.+B.+Cairns&title=Zileuton%3A+clinical+implications+of+5-lipoxygenase+inhibition+in+severe+airway+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease</span></div><div class="casAuthors">Berger, W.; De Chandt, M. T. M.; Cairns, C. B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">663-676</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-Lipoxygenase pathway results in the formation of leukotrienes, including leukotriene B4 (LTB4), 5-oxo-6E,8Z,11Z,14Z-eicosatetranoic acid and the cysteinyl leukotrienes (LTC4, LTD4 and LTE4) and activates all four leukotriene receptors, BLT1, BLT2, cysLT1 and cysLT2.  Zileuton is the only com. available inhibitor of the 5-Lipoxygenase pathway.  In a no. of clin. trials, zileuton has been shown to improve airway function and inflammation, asthma symptom control and quality of life in asthmatics.  Given the important role that leukotrienes play in airway inflammation, zileuton provides an addnl. therapeutic option in the management of chronic, persistent asthma, particularly those asthmatics with more severe disease.  In addn., zileuton has shown promise in a no. of other conditions, including upper airway inflammatory conditions, dermatol. disease and chronic obstructive pulmonary disease.  The development of new formulations, including a controlled release tablet formulation for b.i.d. dosing and an i.v. prepn. for acute asthma exacerbations may enhance clin. utility and expand therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlBF2XBlKc5LVg90H21EOLACvtfcHk0lj12AJCW3RD0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KqsL8%253D&md5=49d295d1c310cb6e1f8b6e5ef75106f6</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2007.01320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2007.01320.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DDe%2BChandt%26aufirst%3DM.%2BT.%26aulast%3DCairns%26aufirst%3DC.%2BB.%26atitle%3DZileuton%253A%2520clinical%2520implications%2520of%25205-lipoxygenase%2520inhibition%2520in%2520severe%2520airway%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2007%26volume%3D61%26spage%3D663%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span> <span class="citation_source-book">Prescribing Information for ZYFLO CR</span>; <span class="NLM_publisher-name">Cornerstone Therapeutics, Inc</span>: <span class="NLM_publisher-loc">Lexington, MA</span>, May<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prescribing+Information+for+ZYFLO+CR%3B+Cornerstone+Therapeutics%2C+Inc%3A+Lexington%2C+MA%2C+May+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPrescribing%2520Information%2520for%2520ZYFLO%2520CR%26pub%3DCornerstone%2520Therapeutics%252C%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dahlen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterstrom, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlen, S. E.</span><span> </span><span class="NLM_article-title">Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005</span> <span class="citation_source-journal">Thorax</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1997&pages=342-347&author=B.+Dahlenauthor=M.+Kumlinauthor=E.+Ihreauthor=O.+Zetterstromauthor=S.+E.+Dahlen&title=Inhibition+of+allergen-induced+airway+obstruction+and+leukotriene+generation+in+atopic+asthmatic+subjects+by+the+leukotriene+biosynthesis+inhibitor+BAYx+1005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlen%26aufirst%3DB.%26aulast%3DKumlin%26aufirst%3DM.%26aulast%3DIhre%26aufirst%3DE.%26aulast%3DZetterstrom%26aufirst%3DO.%26aulast%3DDahlen%26aufirst%3DS.%2BE.%26atitle%3DInhibition%2520of%2520allergen-induced%2520airway%2520obstruction%2520and%2520leukotriene%2520generation%2520in%2520atopic%2520asthmatic%2520subjects%2520by%2520the%2520leukotriene%2520biosynthesis%2520inhibitor%2520BAYx%25201005%26jtitle%3DThorax%26date%3D1997%26volume%3D52%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Friedman, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buntinx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shingo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, P.</span><span> </span><span class="NLM_article-title">Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=8385430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A280%3ADyaK3s3itFSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1993&pages=839-844&author=B.+S.+Friedmanauthor=E.+H.+Belauthor=A.+Buntinxauthor=W.+Tanakaauthor=Y.+H.+Hanauthor=S.+Shingoauthor=R.+Spectorauthor=P.+Sterk&title=Oral+leukotriene+inhibitor+%28MK-886%29+blocks+allergen-induced+airway+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses</span></div><div class="casAuthors">Friedman B S; Bel E H; Buntinx A; Tanaka W; Han Y H; Shingo S; Spector R; Sterk P</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">839-44</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">To elucidate the role of leukotrienes (LT) in allergic asthma in humans the effect of MK-886, an LT biosynthesis inhibitor, was evaluated on antigen-induced early (EAR) and late (LAR) asthmatic reactions and bronchial responsiveness to histamine.  Eight atopic men participated in a two-part, double-blind, placebo-controlled, crossover trial.  MK-886 was administered in two oral doses of 500 mg and 250 mg, 1 h before and 2 h after allergen inhalation, respectively.  Biochemical effects of MK-886 were evaluated by the inhibition of urinary LTE4 excretion and calcium ionophore-stimulated LTB4 biosynthesis in whole blood ex vivo.  MK-886 significantly inhibited the EAR by 58.4% (AUC0-3 h) and the LAR by 43.6% (AUC3-7 h) when compared with placebo (p < 0.01).  There was no difference in PC20 histamine 30 h post allergen challenge between MK-886 and placebo (0.33 and 0.27 doubling doses, p > 0.1).  MK-886 inhibited calcium ionophore-stimulated LTB4 production in whole blood (54.2 +/- 25.6%) for up to 6 h post allergen challenge.  LTE4 excretion in urine was inhibited by 51.5% during the EAR by as much as 80% during the LAR.  This indicates that LT play a role in allergen-induced asthmatic reactions in humans in vivo and that LT synthesis inhibitors such as MK-886 should be further explored for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0hYXRy8PyYJI8NvIb08rbfW6udTcc2ebyAfQ20wgEOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3itFSitA%253D%253D&md5=c445dfbaa26091699c82144488aca55f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DB.%2BS.%26aulast%3DBel%26aufirst%3DE.%2BH.%26aulast%3DBuntinx%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DShingo%26aufirst%3DS.%26aulast%3DSpector%26aufirst%3DR.%26aulast%3DSterk%26aufirst%3DP.%26atitle%3DOral%2520leukotriene%2520inhibitor%2520%2528MK-886%2529%2520blocks%2520allergen-induced%2520airway%2520responses%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1993%26volume%3D147%26spage%3D839%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Diamant, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmers, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Veen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depré, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, P. J.</span><span> </span><span class="NLM_article-title">The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0091-6749%2895%2970151-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=7822663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK2MXptlaksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=42-51&author=Z.+Diamantauthor=M.+C.+Timmersauthor=H.+van+der+Veenauthor=B.+S.+Friedmanauthor=M.+De+Smetauthor=M.+Depr%C3%A9author=D.+Hilliardauthor=E.+H.+Belauthor=P.+J.+Sterk&title=The+effect+of+MK-0591%2C+a+novel+5-lipoxygenase+activating+protein+inhibitor%2C+on+leukotriene+biosynthesis+and+allergen-induced+airway+responses+in+asthmatic+subjects+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo</span></div><div class="casAuthors">Diamant, Zuzana; Timmers, Mieke C.; van der Veen, Hilly; Friedman, Beth S.; De Smet, Marina; Depre, Marleen; Hilliard, Deborah; Bel, Elisabeth H.; Sterk, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book</span>)
        </div><div class="casAbstract">The 5-lipoxygenase metabolites of arachidonic acid are likely to be involved in the pathophysiol. of atopic asthma.  We investigated the effect of pretreatment with MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on allergen-induced early asthmatic reactions (EARs) and late asthmatic reactions (LARs), and subsequent airway hyperresponsiveness to histamine.  Eight atopic men with mild to moderate asthma aged 19 to 31 yr, (forced expiratory vol. in 1 s [FEV1] ≥67% of predicted value, histamine provocative concn. causing a 20% fall in FEV1 [PC20] <4 mg/mL) and documented EAR and LAR to house dust mite ext. participated in a two-period, double-blind, placebo-controlled, crossover study.  During each study period histamine PC20 was measured 2 days before and 1 day after a standardized allergen inhalation challenge test.  MK-0591 was administered in 3 oral doses of 250 mg each at 24, 12, and 1.5 h before inhalation of allergen.  Biochem. activity of MK-0591 was detd. by calcium ionophore A-23187-stimulated leukotriene (LT)B4 biosynthesis in whole blood ex vivo and by urinary LTE4 excretion.  Airway response to allergen was measured by FEV1 (percent fall from baseline).  The EAR (0 to 3 h) and the LAR (3 to 8 h) were expressed as corresponding areas under the time-response curves.  MK-0591 and placebo did not differ in their effects on prechallenge FEV1 (p = 0.10).  As compared with the value before pretreatment, MK-0591 blocked LTB4 biosynthesis and LTE4 excretion by a mean of 98% (range, 96% to 99%; p < 0.002) and 87% (range, 84% to 96%; p < 0.046), resp., from 0 to 24 h after allergen challenge.  Both the EAR and the LAR were significantly reduced after administration of MK-0591 as compared with placebo, with a mean inhibition of 79% (p = 0.011) and 39% (p = 0.040), resp.  Allergen-induced airway hyperresponsiveness was not significantly different between the two pretreatment periods (p = 0.37).  In this study oral MK-0591 prevented leukotriene biosynthesis after allergen challenge in patients with mild to moderate asthma.  The results of our study indicate that 5-lipoxygenase products play an important role during the EAR, whereas their contribution to the pathophysiol. of the LAR seems to be of less importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1x0C2Od-G0LVg90H21EOLACvtfcHk0lhc5ZrzS9NppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlaksb4%253D&md5=c4514925d708c4e4fd36d5547dc21aa4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0091-6749%2895%2970151-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-6749%252895%252970151-6%26sid%3Dliteratum%253Aachs%26aulast%3DDiamant%26aufirst%3DZ.%26aulast%3DTimmers%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BVeen%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DB.%2BS.%26aulast%3DDe%2BSmet%26aufirst%3DM.%26aulast%3DDepr%25C3%25A9%26aufirst%3DM.%26aulast%3DHilliard%26aufirst%3DD.%26aulast%3DBel%26aufirst%3DE.%2BH.%26aulast%3DSterk%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520effect%2520of%2520MK-0591%252C%2520a%2520novel%25205-lipoxygenase%2520activating%2520protein%2520inhibitor%252C%2520on%2520leukotriene%2520biosynthesis%2520and%2520allergen-induced%2520airway%2520responses%2520in%2520asthmatic%2520subjects%2520in%2520vivo%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D1995%26volume%3D95%26spage%3D42%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piechuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, W. M.</span><span> </span><span class="NLM_article-title">Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(<i>t</i>-butylthio)-5-(quinolin-2-ylmethoxy)-indol-2-yl]-2,2-dimethylpropanoic acid), a potent, orally active leukotriene biosynthesis inhibitor</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1139%2Fy92-107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=1330258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1GqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=799-807&author=C.+Brideauauthor=C.+Chanauthor=S.+Charlesonauthor=D.+Denisauthor=J.+F.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=J.+H.+Hutchinsonauthor=T.+R.+Jonesauthor=S.+L%C3%A9gerauthor=J.+A.+Manciniauthor=C.+S.+McFarlaneauthor=C.+Pickettauthor=H.+Piechutaauthor=P.+Prasitauthor=D.+Riendeauauthor=C.+A.+Rouzerauthor=P.+Tagariauthor=P.+J.+Vickersauthor=R.+N.+Youngauthor=W.+M.+Abraham&title=Pharmacology+of+MK-0591+%283-%5B1-%284-chlorobenzyl%29-3-%28t-butylthio%29-5-%28quinolin-2-ylmethoxy%29-indol-2-yl%5D-2%2C2-dimethylpropanoic+acid%29%2C+a+potent%2C+orally+active+leukotriene+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor</span></div><div class="casAuthors">Brideau, C.; Chan, C.; Charleson, S.; Denis, D.; Evans, J. F.; Ford-Hutchinson, A. W.; Fortin, R.; Gillard, J. W.; Guay, J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-807</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">MK-0591 (I, previously L-686,708) is a potent inhibitor of leukotriene (LT) biosynthesis in intact human and elicited rat polymorphonuclear leukocytes (PMNLs) (IC50 values 3.1 and 6.1 nM, resp.) and in human, squirrel monkey, and rat whole blood (IC50 values 510, 69, and 9 nM, resp).  MK-0591 had no effect on rat 5-lipoxygenase.  MK-0591 has a high affinity for 5-lipoxygenase activating protein (FLAP) as evidenced by an IC50 value of 1.6 nM in a FLAP binding assay and inhibition of the photoaffinity labeling of FLAP by two different photoaffinity ligands.  Inhibition of activation of 5-lipoxygenase was shown through inhibition of the translocation of the enzyme from the cytosol to the membrane in human PMNLs.  MK-0591 was a potent inhibitor of LT biosynthesis in vivo, first, following ex vivo challenge of blood obtained from treated rats and squirrel monkeys, second, in rat pleurisy model, and, third, as monitored by inhibition of the urinary excretion of the LTE4 in antigen-challenged allergic sheep.  Inhibition of antigen-induced bronchoconstriction by MK-0951 was obsd. in inbred rats pretreated with methysergide, Ascaris-challenged squirrel monkeys, and Ascaris-challenged sheep (early and late phase response).  These results indicate that MK-0591 is a potent inhibitor of LT biosynthesis, both in vitro and in vivo, indicating that the compd will be suitable for assessing the role of leukotrienes in pathol. situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36suu6bJUo7Vg90H21EOLACvtfcHk0lhc5ZrzS9NppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1GqsLg%253D&md5=c6159363af5cdbb670de65dc5bbcd2f3</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1139%2Fy92-107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy92-107%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DMcFarlane%26aufirst%3DC.%2BS.%26aulast%3DPickett%26aufirst%3DC.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DVickers%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26atitle%3DPharmacology%2520of%2520MK-0591%2520%25283-%255B1-%25284-chlorobenzyl%2529-3-%2528t-butylthio%2529-5-%2528quinolin-2-ylmethoxy%2529-indol-2-yl%255D-2%252C2-dimethylpropanoic%2520acid%2529%252C%2520a%2520potent%252C%2520orally%2520active%2520leukotriene%2520biosynthesis%2520inhibitor%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1992%26volume%3D70%26spage%3D799%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_contrib-group">Young, R. N.</span><span> </span><span class="NLM_article-title">Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be realized?</span> <span class="citation_source-journal">Eur. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1016%2FS0223-5234%2899%2900225-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK1MXntVWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=671-685&author=R.+N.+Young&title=Inhibitors+of+5-lipoxygenase%3A+a+therapeutic+potential+yet+to+be+realized%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?</span></div><div class="casAuthors">Young, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-685</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review, with 113 refs.  Inhibition of leukotriene biosynthesis has been extensively studied as a potential for the development of novel therapies for inflammation and respiratory diseases and, in particular, for asthma.  Many compds. have been identified which inhibit the key enzyme, 5-lipoxygenase.  Four distinct classes of compds. have been identified, namely, (1) redox inhibitors (alternative substrates), (2) iron chelating inhibitors, (3) competitive reversible inhibitors, and (4) inhibitors of the 5-lipoxygenase activating protein.  Experience over the past two decades with redox inhibitors has been disappointing and although a no. of potent compds. have been identified, they have often been assocd. with ancillary toxicity and non-specificity due to their redox activity.  Iron chelating inhibitors have been more successful and one compd., Zileuton, has reached the market.  However, more potent analogs have often encountered toxicity problems.  Competitive inhibitors have been identified by a no. of research groups but, as yet, none has been successful.  Inhibitors of the 5-lipoxygenase activating protein (FLAP) have been identified and compds. such as MK-0591 and BaY-X-1005 have shown efficacy in asthma trials.  To date, however, no clear advantage for inhibitors of lipoxygenase has been demonstrated relative to the leukotriene D4 receptor antagonists such as Singulair and Accolate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhHdZOxWRr6LVg90H21EOLACvtfcHk0lhc5ZrzS9NppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVWrsLs%253D&md5=05331bc54e417589ea8bb23e6fa24261</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2900225-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252900225-1%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DInhibitors%2520of%25205-lipoxygenase%253A%2520a%2520therapeutic%2520potential%2520yet%2520to%2520be%2520realized%253F%26jtitle%3DEur.%2520J.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D671%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Helgadottir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorleifsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretarsdottir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteindottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveinbjornsdottir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdimarsson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthiasson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsdottir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorhallsdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigge, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudnason, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulcher, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fng1311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=14770184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=233-239&author=A.+Helgadottirauthor=A.+Manolescuauthor=G.+Thorleifssonauthor=S.+Gretarsdottirauthor=H.+Jonsdottirauthor=U.+Thorsteindottirauthor=N.+J.+Samaniauthor=G.+Gudmundssonauthor=S.+F.+A.+Grantauthor=G.+Thorgeirssonauthor=S.+Sveinbjornsdottirauthor=E.+M.+Valdimarssonauthor=S.+E.+Matthiassonauthor=H.+Johannssonauthor=O.+Gudmundsdottirauthor=M.+E.+Guerneyauthor=J.+Sainzauthor=M.+Thorhallsdottirauthor=M.+Andresdottirauthor=M.+L.+Friggeauthor=E.+J.+Topolauthor=A.+Kongauthor=V.+Gudnasonauthor=H.+Hakonarsonauthor=J.+R.+Gulcherauthor=K.+Stefansson&title=The+gene+encoding+5-lipoxygenase+activating+protein+confers+risk+of+myocardial+infarction+and+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke</span></div><div class="casAuthors">Helgadottir, Anna; Manolescu, Andrei; Thorleifsson, Gudmar; Gretarsdottir, Solveig; Jonsdottir, Helga; Thorsteinsdottir, Unnur; Samani, Nilesh J.; Gudmundsson, Gudmundur; Grant, Struan F. A.; Thorgeirsson, Gudmundur; Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.; Matthiasson, Stefan E.; Johannsson, Halldor; Gudmundsdottir, Olof; Gurney, Mark E.; Sainz, Jesus; Thorhallsdottir, Margret; Andresdottir, Margret; Frigge, Michael L.; Topol, Eric J.; Kong, Augustine; Gudnason, Vilmundur; Hakonarson, Hakon; Gulcher, Jeffrey R.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13.  A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is assocd. with a two times greater risk of myocardial infarction in Iceland.  This haplotype also confers almost two times greater risk of stroke.  Another ALOX5AP haplotype is assocd. with myocardial infarction in individuals from the UK.  Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype.  We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene prodn. and inflammation in the arterial wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwmL2IOUxmmbVg90H21EOLACvtfcHk0lgccPyt6rPTdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOnsL4%253D&md5=876af51d8d672d28e02be75e53bb24d2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fng1311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1311%26sid%3Dliteratum%253Aachs%26aulast%3DHelgadottir%26aufirst%3DA.%26aulast%3DManolescu%26aufirst%3DA.%26aulast%3DThorleifsson%26aufirst%3DG.%26aulast%3DGretarsdottir%26aufirst%3DS.%26aulast%3DJonsdottir%26aufirst%3DH.%26aulast%3DThorsteindottir%26aufirst%3DU.%26aulast%3DSamani%26aufirst%3DN.%2BJ.%26aulast%3DGudmundsson%26aufirst%3DG.%26aulast%3DGrant%26aufirst%3DS.%2BF.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DSveinbjornsdottir%26aufirst%3DS.%26aulast%3DValdimarsson%26aufirst%3DE.%2BM.%26aulast%3DMatthiasson%26aufirst%3DS.%2BE.%26aulast%3DJohannsson%26aufirst%3DH.%26aulast%3DGudmundsdottir%26aufirst%3DO.%26aulast%3DGuerney%26aufirst%3DM.%2BE.%26aulast%3DSainz%26aufirst%3DJ.%26aulast%3DThorhallsdottir%26aufirst%3DM.%26aulast%3DAndresdottir%26aufirst%3DM.%26aulast%3DFrigge%26aufirst%3DM.%2BL.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DGudnason%26aufirst%3DV.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DGulcher%26aufirst%3DJ.%2BR.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DThe%2520gene%2520encoding%25205-lipoxygenase%2520activating%2520protein%2520confers%2520risk%2520of%2520myocardial%2520infarction%2520and%2520stroke%26jtitle%3DNat.%2520Genet.%26date%3D2004%26volume%3D36%26spage%3D233%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Kajimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoike, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, N.</span><span> </span><span class="NLM_article-title">Validation of the association between gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population</span> <span class="citation_source-journal">Circ. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1253%2Fcircj.69.1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=16127181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGntLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=1029-1034&author=K.+Kajimotoauthor=K.+Shiojiauthor=C.+Ishidaauthor=Y.+Iwanagaauthor=Y.+Kokuboauthor=H.+Tomoikeauthor=S.-i.+Miyazakiauthor=H.+Nonogiauthor=Y.+Gotoauthor=N.+Iwai&title=Validation+of+the+association+between+gene+encoding+5-lipoxygenase-activating+protein+and+myocardial+infarction+in+a+Japanese+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population</span></div><div class="casAuthors">Kajimoto, Kazuaki; Shioji, Keisuke; Ishida, Chisaki; Iwanaga, Yoshitaka; Kokubo, Yoshihiro; Tomoike, Hitonobu; Miyazaki, Shun-ichi; Nonogi, Hiroshi; Goto, Yoichi; Iwai, Naoharu</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1029-1034</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">Background Recently, the 5-lipoxygenase activating protein gene (ALOX5AP) was reported to confer a risk of myocardial infarction (MI) and stroke, independent of conventional risk factors.  The purpose of the present study was to validate those findings in a Japanese population.  Methods and Results The study population consisted of 1,875 subjects (males 871, females 1,004) recruited from the Suita study (control group) and 353 subjects (males 306, females 47) with MI.  The promoter, all of the exons, and 3'UTR regions of ALOX5AP were sequenced in 96 subjects, and 8 polymorphisms were found.  There were significant differences in the frequencies of the haplotypes constructed from the 2 SNPs (A162C and T8733A) between the control and MI groups.  Multiple logistic anal. indicated that the homozygous genotype of the (CA) haplotype was significantly assocd. with a reduced risk for MI.  Conclusion The hypothesis that ALOX5AP contributes to susceptibility for MI was validated in a Japanese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCftA-YseObrVg90H21EOLACvtfcHk0lhkP249_gJSxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGntLfI&md5=ce7bc88f5e53765bf24ae8131f554d6d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1253%2Fcircj.69.1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.69.1029%26sid%3Dliteratum%253Aachs%26aulast%3DKajimoto%26aufirst%3DK.%26aulast%3DShioji%26aufirst%3DK.%26aulast%3DIshida%26aufirst%3DC.%26aulast%3DIwanaga%26aufirst%3DY.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DTomoike%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DS.-i.%26aulast%3DNonogi%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DIwai%26aufirst%3DN.%26atitle%3DValidation%2520of%2520the%2520association%2520between%2520gene%2520encoding%25205-lipoxygenase-activating%2520protein%2520and%2520myocardial%2520infarction%2520in%2520a%2520Japanese%2520population%26jtitle%3DCirc.%2520J.%26date%3D2005%26volume%3D69%26spage%3D1029%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_contrib-group">Girelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallari, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malerba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco Pignatti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrocher, R.</span><span> </span><span class="NLM_article-title"><i>ALOX5AP</i> gene variants and risk of coronary artery disease: an angiography-based study</span> <span class="citation_source-journal">Eur. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fsj.ejhg.5201854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17505527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVaqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=959-966&author=D.+Girelliauthor=N.+Martinelliauthor=E.+Trabettiauthor=O.+Olivieriauthor=U.+Cavallariauthor=G.+Malerbaauthor=F.+Bustiauthor=S.+Frisoauthor=F.+Pizzoloauthor=P.+Franco+Pignattiauthor=R.+Corrocher&title=ALOX5AP+gene+variants+and+risk+of+coronary+artery+disease%3A+an+angiography-based+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study</span></div><div class="casAuthors">Girelli, Domenico; Martinelli, Nicola; Trabetti, Elisabetta; Olivieri, Oliviero; Cavallari, Ugo; Malerba, Giovanni; Busti, Fabiana; Friso, Simonetta; Pizzolo, Francesca; Pignatti, Pier Franco; Corrocher, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">959-966</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of this study was to explore the role of variants of the gene encoding arachidonate 5-lipoxygenase-activating protein (ALOX5AP) as possible susceptibility factors for coronary artery disease (CAD) and myocardial infarction (MI) in patients with or without angiog. proven CAD.  A total of 1431 patients with or without angiog. documented CAD were examd. simultaneously for seven ALOX5AP single-nucleotide polymorphisms, allowing reconstruction of the at-risk haplotypes (HapA and HapB) previously identified in the Icelandic and British populations.  Using a haplotype-based approach, HapA was not assocd. with either CAD or MI.  On the other hand, HapB and another haplotype within the same region (that we named HapC) were significantly more represented in CAD vs. CAD-free patients, and these assocns. remained significant after adjustment for traditional cardiovascular risk factors by logistic regression (HapB: odds ratio (OR) 1.67, 95% confidence interval (CI) 1.04-2.67; P = 0.032; HapC: OR 2.41, 95% CI 1.09-5.32; P = 0.030).  No difference in haplotype distributions was obsd. between CAD subjects with or without a previously documented MI.  Our angiog.-based study suggests a possible modest role of ALOX5AP in the development of the atheroma rather than in its late thrombotic complications such as MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0g1VKKLrDjbVg90H21EOLACvtfcHk0lhkP249_gJSxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVaqsrg%253D&md5=474d70a2f9611a18572a812bf22cd0ca</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejhg.5201854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejhg.5201854%26sid%3Dliteratum%253Aachs%26aulast%3DGirelli%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DN.%26aulast%3DTrabetti%26aufirst%3DE.%26aulast%3DOlivieri%26aufirst%3DO.%26aulast%3DCavallari%26aufirst%3DU.%26aulast%3DMalerba%26aufirst%3DG.%26aulast%3DBusti%26aufirst%3DF.%26aulast%3DFriso%26aufirst%3DS.%26aulast%3DPizzolo%26aufirst%3DF.%26aulast%3DFranco%2BPignatti%26aufirst%3DP.%26aulast%3DCorrocher%26aufirst%3DR.%26atitle%3DALOX5AP%2520gene%2520variants%2520and%2520risk%2520of%2520coronary%2520artery%2520disease%253A%2520an%2520angiography-based%2520study%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2007%26volume%3D15%26spage%3D959%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_contrib-group">Kaushal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haverbusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissela, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindorfer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, D.</span><span> </span><span class="NLM_article-title">Association of <i>ALOX5AP</i> with ischemic stroke: a population-based case-control study</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1007%2Fs00439-007-0338-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=17387518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFKisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=601-607&author=R.+Kaushalauthor=P.+Palauthor=K.+Alwellauthor=M.+Haverbuschauthor=M.+Flahertyauthor=C.+Moomawauthor=P.+Sekarauthor=B.+Kisselaauthor=D.+Kleindorferauthor=R.+Chakrabortyauthor=J.+Broderickauthor=R.+Dekaauthor=D.+Woo&title=Association+of+ALOX5AP+with+ischemic+stroke%3A+a+population-based+case-control+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Association of ALOX5AP with ischemic stroke: a population-based case-control study</span></div><div class="casAuthors">Kaushal, Ritesh; Pal, Prodipto; Alwell, Kathleen; Haverbusch, Mary; Flaherty, Matthew; Moomaw, Charles; Sekar, Padmini; Kissela, Brett; Kleindorfer, Dawn; Chakraborty, Ranajit; Broderick, Joseph; Deka, Ranjan; Woo, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Arachidonate 5-lipoxygenase activating protein (ALOX5AP) has been reported to demonstrate linkage and assocn. with ischemic stroke and myocardial infarction.  However, replication studies have been conflicting and to date, a significant proportion of blacks have not been studied.  We prospectively recruited cases of ischemic stroke from all 16 hospitals in the Greater Cincinnati/Northern Kentucky region and demog. matched them to stroke-free population-based controls.  Single nucleotide polymorphisms (SNPs) were selected based on assocn. with ischemic stroke in prior studies.  Allelic, genotypic and haplotypic assocn. testing was performed using HAPLOVIEW.  Multiple logistic regression was used to control for the presence of traditional risk factors including hypertension, diabetes, hypercholesterolemia and smoking.  A total of 357 cases and 482 controls were genotyped.  The SNPs, rs9579646 and rs4769874 were found to be significantly assocd. at both allelic (P = 0.019 and P < 10-4, resp.) and genotypic level with ischemic stroke among whites after correction for multiple testing.  Haplotype assocn. was identified with ischemic stroke as well as ischemic stroke subtypes among whites.  Although an overall haplotype assocn. with ischemic stroke was identified among blacks no evidence of assocn. among individual haplotypes, alleles or genotypes were obsd.  Allele frequencies for the SNPs examd. were markedly different among whites and blacks.  In conclusion, we report significant assocn. of variants of ALOX5AP with ischemic stroke and ischemic stroke subtypes among whites.  No significant assocn. was identified among blacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW57iGMmXNebVg90H21EOLACvtfcHk0lhkP249_gJSxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFKisb4%253D&md5=30a111ce3c4dacf56b3ee3a9ed12adfb</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1007%2Fs00439-007-0338-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-007-0338-y%26sid%3Dliteratum%253Aachs%26aulast%3DKaushal%26aufirst%3DR.%26aulast%3DPal%26aufirst%3DP.%26aulast%3DAlwell%26aufirst%3DK.%26aulast%3DHaverbusch%26aufirst%3DM.%26aulast%3DFlaherty%26aufirst%3DM.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DSekar%26aufirst%3DP.%26aulast%3DKissela%26aufirst%3DB.%26aulast%3DKleindorfer%26aufirst%3DD.%26aulast%3DChakraborty%26aufirst%3DR.%26aulast%3DBroderick%26aufirst%3DJ.%26aulast%3DDeka%26aufirst%3DR.%26aulast%3DWoo%26aufirst%3DD.%26atitle%3DAssociation%2520of%2520ALOX5AP%2520with%2520ischemic%2520stroke%253A%2520a%2520population-based%2520case-control%2520study%26jtitle%3DHum.%2520Genet.%26date%3D2007%26volume%3D121%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_contrib-group">Lohmussar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschwendtner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Org, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, M.</span><span> </span><span class="NLM_article-title">ALOX5AP gene and the PDE4D gene in a central european population of stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=731-736&author=E.+Lohmussarauthor=A.+Gschwendtnerauthor=J.+C.+Muellerauthor=T.+Orgauthor=E.+Wichmannauthor=G.+Hamannauthor=T.+Meitingerauthor=M.+Dichgans&title=ALOX5AP+gene+and+the+PDE4D+gene+in+a+central+european+population+of+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmussar%26aufirst%3DE.%26aulast%3DGschwendtner%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DJ.%2BC.%26aulast%3DOrg%26aufirst%3DT.%26aulast%3DWichmann%26aufirst%3DE.%26aulast%3DHamann%26aufirst%3DG.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DDichgans%26aufirst%3DM.%26atitle%3DALOX5AP%2520gene%2520and%2520the%2520PDE4D%2520gene%2520in%2520a%2520central%2520european%2520population%2520of%2520stroke%2520patients%26jtitle%3DStroke%26date%3D2005%26volume%3D36%26spage%3D731%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tsai, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, N. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=487-491&author=A.+K.+Tsaiauthor=N.+Liauthor=N.+Q.+Hansonauthor=M.+Y.+Tsaiauthor=W.+Tang&title=Associations+of+genetic+polymorphisms+of+arachidonate+5-lipoxygenase-activating+protein+with+risk+of+coronary+artery+disease+in+a+European-American+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DA.%2BK.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHanson%26aufirst%3DN.%2BQ.%26aulast%3DTsai%26aufirst%3DM.%2BY.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DAssociations%2520of%2520genetic%2520polymorphisms%2520of%2520arachidonate%25205-lipoxygenase-activating%2520protein%2520with%2520risk%2520of%2520coronary%2520artery%2520disease%2520in%2520a%2520European-American%2520population%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D207%26spage%3D487%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_contrib-group">Mehrabian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allayee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaposhnik, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusis, A. J.</span><span> </span><span class="NLM_article-title">Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=120-126&author=M.+Mehrabianauthor=H.+Allayeeauthor=J.+Wongauthor=W.+Shihauthor=X.-P.+Wangauthor=Z.+Shaposhnikauthor=C.+D.+Funkauthor=A.+J.+Lusis&title=Identification+of+5-lipoxygenase+as+a+major+gene+contributing+to+atherosclerosis+susceptibility+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMehrabian%26aufirst%3DM.%26aulast%3DAllayee%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.-P.%26aulast%3DShaposhnik%26aufirst%3DZ.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%25205-lipoxygenase%2520as%2520a%2520major%2520gene%2520contributing%2520to%2520atherosclerosis%2520susceptibility%2520in%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, M. P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräbner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pédrono, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanbroek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lötzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habenicht, A. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span> </span><span class="NLM_article-title">The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1038%2Fnm1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=15322539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=966-973&author=L.+Zhaoauthor=M.+P.+W.+Moosauthor=R.+Gr%C3%A4bnerauthor=F.+P%C3%A9dronoauthor=J.+Fanauthor=B.+Kaiserauthor=N.+Johnauthor=S.+Schmidtauthor=R.+Spanbroekauthor=K.+L%C3%B6tzerauthor=L.+Huangauthor=J.+Cuiauthor=D.+Raderauthor=J.+F.+Evansauthor=A.+J.+R.+Habenichtauthor=C.+D.+Funk&title=The+5-lipoxygenase+pathway+promotes+pathogenesis+of+hyperlipidemia-dependent+aortic+aneurysm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm</span></div><div class="casAuthors">Zhao, Lei; Moos, Michael P. W.; Graebner, Rolf; Pedrono, Frederique; Fan, Jinjin; Kaiser, Brigitte; John, Nicole; Schmidt, Sandra; Spanbroek, Rainer; Loetzer, Katharina; Huang, Li; Cui, Jisong; Rader, Daniel J.; Evans, Jilly F.; Habenicht, Andreas J. R.; Funk, Colin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">966-973</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the 5-lipoxygenase (5-LO) pathway leads to the biosynthesis of proinflammatory leukotriene lipid mediators.  Genetic studies have assocd. 5-LO and its accessory protein, 5-LO-activating protein, with cardiovascular disease, myocardial infarction and stroke.  Here we show that 5-LO-pos. macrophages localize to the adventitia of diseased mouse and human arteries in areas of neoangiogenesis and that these cells constitute a main component of aortic aneurysms induced by an atherogenic diet contg. cholate in mice deficient in apolipoprotein E.  5-LO deficiency markedly attenuates the formation of these aneurysms and is assocd. with reduced matrix metalloproteinase-2 activity and diminished plasma macrophage inflammatory protein-1α (MIP-1α; also called CCL3), but only minimally affects the formation of lipid-rich lesions.  The leukotriene LTD4 strongly stimulates expression of MIP-1α in macrophages and MIP-2 (also called CXCL2) in endothelial cells.  These data link the 5-LO pathway to hyperlipidemia-dependent inflammation of the arterial wall and to pathogenesis of aortic aneurysms through a potential chemokine intermediary route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTVY7nl9JpzLVg90H21EOLACvtfcHk0lgI0Jv3XJDdKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSktLw%253D&md5=db42c20964c5c2bead459cd9198e061c</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1038%2Fnm1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1099%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DMoos%26aufirst%3DM.%2BP.%2BW.%26aulast%3DGr%25C3%25A4bner%26aufirst%3DR.%26aulast%3DP%25C3%25A9drono%26aufirst%3DF.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DB.%26aulast%3DJohn%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSpanbroek%26aufirst%3DR.%26aulast%3DL%25C3%25B6tzer%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DRader%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHabenicht%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26atitle%3DThe%25205-lipoxygenase%2520pathway%2520promotes%2520pathogenesis%2520of%2520hyperlipidemia-dependent%2520aortic%2520aneurysm%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D966%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Jawien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateuszuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszanecki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzik, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichocki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlopicki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korbut, R.</span><span> </span><span class="NLM_article-title">Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases artherosclerosis in apoE/LDLR-double knockout mice</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=141-146&author=J.+Jawienauthor=M.+Gajdaauthor=M.+Rudlingauthor=L.+Mateuszukauthor=R.+Olszaneckiauthor=T.+J.+Guzikauthor=T.+Cichockiauthor=S.+Chlopickiauthor=R.+Korbut&title=Inhibition+of+five+lipoxygenase+activating+protein+%28FLAP%29+by+MK-886+decreases+artherosclerosis+in+apoE%2FLDLR-double+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJawien%26aufirst%3DJ.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DRudling%26aufirst%3DM.%26aulast%3DMateuszuk%26aufirst%3DL.%26aulast%3DOlszanecki%26aufirst%3DR.%26aulast%3DGuzik%26aufirst%3DT.%2BJ.%26aulast%3DCichocki%26aufirst%3DT.%26aulast%3DChlopicki%26aufirst%3DS.%26aulast%3DKorbut%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520five%2520lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520by%2520MK-886%2520decreases%2520artherosclerosis%2520in%2520apoE%252FLDLR-double%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D36%26spage%3D141%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_contrib-group">Tardiff, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L’Allier, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olukotun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R.</span><span> </span><span class="NLM_article-title">Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients with recent acute coronary syndrome</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1260&author=J.-C.+Tardiffauthor=P.+L.+L%E2%80%99Allierauthor=R.+Ibrahimauthor=J.+C.+Gregoireauthor=A.+Hegedusauthor=J.+Francauthor=J.+Blueauthor=M.+Cooperauthor=A.+Olukotunauthor=R.+Taub&title=Three+months+of+treatment+with+5-lipoxygenase+inhibitor+VIA-2291+in+patients+with+recent+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTardiff%26aufirst%3DJ.-C.%26aulast%3DL%25E2%2580%2599Allier%26aufirst%3DP.%2BL.%26aulast%3DIbrahim%26aufirst%3DR.%26aulast%3DGregoire%26aufirst%3DJ.%2BC.%26aulast%3DHegedus%26aufirst%3DA.%26aulast%3DFranc%26aufirst%3DJ.%26aulast%3DBlue%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DOlukotun%26aufirst%3DA.%26aulast%3DTaub%26aufirst%3DR.%26atitle%3DThree%2520months%2520of%2520treatment%2520with%25205-lipoxygenase%2520inhibitor%2520VIA-2291%2520in%2520patients%2520with%2520recent%2520acute%2520coronary%2520syndrome%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_contrib-group">Brotz, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Blasis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson-Shea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olukotun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R.</span><span> </span><span class="NLM_article-title">Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients scheduled for elective carotid endarterectomy surgery</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1261&author=T.+M.+Brotzauthor=G.+De+Blasisauthor=L.+Carbonariauthor=M.+S.+Perryauthor=E.+Chiangauthor=A.+Hansson-Sheaauthor=M.+Cooperauthor=A.+Olukotunauthor=F.+Cipolloneauthor=R.+Taub&title=Three+months+of+treatment+with+5-lipoxygenase+inhibitor+VIA-2291+in+patients+scheduled+for+elective+carotid+endarterectomy+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrotz%26aufirst%3DT.%2BM.%26aulast%3DDe%2BBlasis%26aufirst%3DG.%26aulast%3DCarbonari%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DM.%2BS.%26aulast%3DChiang%26aufirst%3DE.%26aulast%3DHansson-Shea%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DOlukotun%26aufirst%3DA.%26aulast%3DCipollone%26aufirst%3DF.%26aulast%3DTaub%26aufirst%3DR.%26atitle%3DThree%2520months%2520of%2520treatment%2520with%25205-lipoxygenase%2520inhibitor%2520VIA-2291%2520in%2520patients%2520scheduled%2520for%2520elective%2520carotid%2520endarterectomy%2520surgery%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorvaldsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helgadottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zink, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andresdottir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnar, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnarsson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottskalksson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsdottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adalsteinsdottir, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristjansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardarson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristinsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2005&pages=2277-2279&author=H.+Hakonarsonauthor=S.+Thorvaldssonauthor=H.+Helgadottirauthor=D.+Gudbjartssonauthor=F.+Zinkauthor=M.+Andresdottirauthor=A.+Manolescuauthor=D.+O.+Arnarauthor=K.+Andersenauthor=A.+Sigurdssonauthor=G.+Thorgeirssonauthor=A.+Jonssonauthor=U.+Agnarssonauthor=H.+Bjornsdottirauthor=G.+Gottskalkssonauthor=A.+Einarssonauthor=H.+Gudmundsdottirauthor=A.+E.+Adalsteinsdottirauthor=K.+Gudmundssonauthor=K.+Kristjanssonauthor=T.+Hardarsonauthor=A.+Kristinssonauthor=E.+J.+Topolauthor=J.+Gulcherauthor=A.+Kongauthor=M.+Gurneyauthor=G.+Thorgeirssonauthor=K.+Stefansson&title=Effects+of+a+5-lipoxygenase-activating+protein+inhibitor+on+biomarkers+associated+with+risk+of+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DThorvaldsson%26aufirst%3DS.%26aulast%3DHelgadottir%26aufirst%3DH.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DAndresdottir%26aufirst%3DM.%26aulast%3DManolescu%26aufirst%3DA.%26aulast%3DArnar%26aufirst%3DD.%2BO.%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DSigurdsson%26aufirst%3DA.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DJonsson%26aufirst%3DA.%26aulast%3DAgnarsson%26aufirst%3DU.%26aulast%3DBjornsdottir%26aufirst%3DH.%26aulast%3DGottskalksson%26aufirst%3DG.%26aulast%3DEinarsson%26aufirst%3DA.%26aulast%3DGudmundsdottir%26aufirst%3DH.%26aulast%3DAdalsteinsdottir%26aufirst%3DA.%2BE.%26aulast%3DGudmundsson%26aufirst%3DK.%26aulast%3DKristjansson%26aufirst%3DK.%26aulast%3DHardarson%26aufirst%3DT.%26aulast%3DKristinsson%26aufirst%3DA.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DGulcher%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DGurney%26aufirst%3DM.%26aulast%3DThorgeirsson%26aufirst%3DG.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DEffects%2520of%2520a%25205-lipoxygenase-activating%2520protein%2520inhibitor%2520on%2520biomarkers%2520associated%2520with%2520risk%2520of%2520myocardial%2520infarction%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2005%26volume%3D293%26spage%3D2277%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulkower, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malo, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. D. W.</span><span> </span><span class="NLM_article-title">Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsV2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=690-705&author=T.+Kolasaauthor=D.+E.+Gunnauthor=P.+Bhatiaauthor=K.+W.+Woodsauthor=T.+Ganeauthor=A.+O.+Stewartauthor=J.+B.+Bouskaauthor=R.+R.+Harrisauthor=K.+I.+Hulkowerauthor=P.+E.+Maloauthor=R.+L.+Bellauthor=G.+W.+Carterauthor=C.+D.+W.+Brooks&title=Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic+acids+as+leukotriene+biosynthesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors</span></div><div class="casAuthors">Kolasa, Teodozyj; Gunn, David E.; Bhatia, Pramila; Woods, Keith W.; Gane, Todd; Stewart, Andrew O.; Bouska, Jennifer B.; Harris, Richard R.; Hulkower, Keren I.; Malo, Peter E.; Bell, Randy L.; Carter, George W.; Brooks, Clint D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">690-705</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids was studied as leukotriene biosynthesis inhibitors.  The hypothesis of structure-activity optimization by insertion of an oxime moiety was investigated using REV-5901 as a starting point.  A systematic structure-activity optimization showed that the spatial arrangement and stereochem. of the oxime insertion unit proved to be important for inhibitory activity.  A promising lead inhibited LTB4 biosynthesis in the intact human neutrophil with IC50 of 8 nM and had superior oral activity in vivo, in a rat pleurisy model (ED50 = 0.14 mg/kg) and rat anaphylaxis model (ED50 = 0.13 mg/kg).  Spa.  In a model of lung inflammation, the compd. blocked LTE4 biosynthesis (ED50 of 0.1 mg/kg) and eosinophil influx (ED50 of 0.2 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG88LL4q8nJrVg90H21EOLACvtfcHk0liGsGwj-yOhhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsV2gtQ%253D%253D&md5=5df5b791b96d1690456a976dea72155b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9904102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904102%26sid%3Dliteratum%253Aachs%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGane%26aufirst%3DT.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BB.%26aulast%3DHarris%26aufirst%3DR.%2BR.%26aulast%3DHulkower%26aufirst%3DK.%2BI.%26aulast%3DMalo%26aufirst%3DP.%2BE.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%2BW.%26atitle%3DHeteroarylmethoxyphenylalkoxyiminoalkylcarboxylic%2520acids%2520as%2520leukotriene%2520biosynthesis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D690%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Freed, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magomedov, N. A.</span><span> </span><span class="NLM_article-title">Trapping of the putative cationic intermediate in the morin rearrangement with carbon nucleophiles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0013406" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=839-852&author=J.+D.+Freedauthor=D.+J.+Hartauthor=N.+A.+Magomedov&title=Trapping+of+the+putative+cationic+intermediate+in+the+morin+rearrangement+with+carbon+nucleophiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo0013406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0013406%26sid%3Dliteratum%253Aachs%26aulast%3DFreed%26aufirst%3DJ.%2BD.%26aulast%3DHart%26aufirst%3DD.%2BJ.%26aulast%3DMagomedov%26aufirst%3DN.%2BA.%26atitle%3DTrapping%2520of%2520the%2520putative%2520cationic%2520intermediate%2520in%2520the%2520morin%2520rearrangement%2520with%2520carbon%2520nucleophiles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D839%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Prasit, P.; Fortin, R.; Hutchinson, J. H.; Belley, M. L.; Leger, S.; Frenette, R.; Gillard, J.</span> U.S. Patent 5,272,145, Dec 21,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prasit%2C+P.%3B+Fortin%2C+R.%3B+Hutchinson%2C+J.+H.%3B+Belley%2C+M.+L.%3B+Leger%2C+S.%3B+Frenette%2C+R.%3B+Gillard%2C+J.+U.S.+Patent+5%2C272%2C145%2C+Dec+21%2C+1993."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=1588922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK38XlvVCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1992&pages=873-879&author=S.+Charlesonauthor=P.+Prasitauthor=S.+Legerauthor=J.+W.+Gillardauthor=P.+J.+Vickersauthor=J.+A.+Manciniauthor=P.+Charlesonauthor=J.+Guayauthor=A.+W.+Ford-Hutchinsonauthor=J.+F.+Evans&title=Characterization+of+a+5-lipoxygenase-activating+protein+binding+assay%3A+correlation+of+affinity+for+5-lipoxygenase-activating+protein+with+leukotriene+synthesis+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a 5-lipoxygenase-activating protein binding assay:  Correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition</span></div><div class="casAuthors">Charleson, Stella; Prasit, Petpiboon; Leger, Serge; Gillard, John W.; Vickers, Philip J.; Mancini, Joseph A.; Charleson, Peter; Guay, Jocelyne; Ford-Hutchinson, Anthony W.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-9</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">A binding assay has been developed to measure the affinity of leukotriene synthesis inhibitors for 5-lipoxygenase-activating protein (FLAP), using human leukocyte membranes as the source of FLAP and a radioiodinated leukotriene synthesis inhibitor, 125IL-691,831, as ligand.  Linearity of specific binding of radiolabeled ligand was demonstrated with increasing protein and ligand concns.  Satn. anal. of radioligand binding showed a Kd of 6 nM and a Bmax that, depending on the membrane prepn., varied between 8 and 53 pmol/mg of protein.  An excellent correlation was shown between affinity for FLAP in the binding assay and inhibition of leukotriene synthesis in human polymorphonuclear leukocytes for compds. from two structurally distinct classes, namely indoles and quinolines.  A large no. of membrane-active compds. did not compete with 125I-L-691,831 binding to FLAP.  In addn., direct 5-lipoxygenase inhibitors and a selection of eicosanoids were unable to compete for FLAP binding.  This study validates a selective binding assay for leukotriene synthesis inhibitors whose protein target is FLAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5FEWpt5XUsrVg90H21EOLACvtfcHk0lh7XKIAt1Tn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVCqu7w%253D&md5=957d4c75d28d36cd8e12814cc5cdb1b5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DGillard%26aufirst%3DJ.%2BW.%26aulast%3DVickers%26aufirst%3DP.%2BJ.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DCharleson%26aufirst%3DP.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520a%25205-lipoxygenase-activating%2520protein%2520binding%2520assay%253A%2520correlation%2520of%2520affinity%2520for%25205-lipoxygenase-activating%2520protein%2520with%2520leukotriene%2520synthesis%2520inhibition%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D41%26spage%3D873%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span> </span><span class="NLM_article-title">Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=510-512&author=A.+D.+Fergusonauthor=B.+M.+McKeeverauthor=S.+Xuauthor=D.+Wisniewskiauthor=D.+K.+Millerauthor=T.+Yaminauthor=R.+H.+Spencerauthor=L.+Chuauthor=F.+Ujjainwallaauthor=B.+R.+Cunninghamauthor=J.+F.+Evansauthor=J.+W.+Becker&title=Crystal+structure+of+inhibitor-bound+human+5-lipoxygenase-activating+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DYamin%26aufirst%3DT.%26aulast%3DSpencer%26aufirst%3DR.%2BH.%26aulast%3DChu%26aufirst%3DL.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DCunningham%26aufirst%3DB.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26atitle%3DCrystal%2520structure%2520of%2520inhibitor-bound%2520human%25205-lipoxygenase-activating%2520protein%26jtitle%3DScience%26date%3D2007%26volume%3D27%26spage%3D510%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D<sub>2</sub> receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1036-1040&author=N.+Stockauthor=D.+Volkotsauthor=K.+Stebbinsauthor=A.+Broadheadauthor=B.+Stearnsauthor=J.+Roppeauthor=T.+Parrauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+Kingauthor=C.+Leeauthor=D.+S.+Lorrainauthor=P.+Prodanovichauthor=A.+Santiniauthor=J.+F.+Evansauthor=J.+H.+Hutchinsonauthor=P.+Prasit&title=Sodium+%5B2%E2%80%B2-%5B%28cyclopropanecarbonyl-ethyl-amino%29-methyl%5D-4%E2%80%B2-%286-ethoxy-pyridin-3-yl%29-6-methoxy-biphenyl-3-yl%5D-acetate+%28AM432%29%3A+a+potent%2C+selective+prostaglandin+D2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DVolkots%26aufirst%3DD.%26aulast%3DStebbins%26aufirst%3DK.%26aulast%3DBroadhead%26aufirst%3DA.%26aulast%3DStearns%26aufirst%3DB.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DT.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DSodium%2520%255B2%25E2%2580%25B2-%255B%2528cyclopropanecarbonyl-ethyl-amino%2529-methyl%255D-4%25E2%2580%25B2-%25286-ethoxy-pyridin-3-yl%2529-6-methoxy-biphenyl-3-yl%255D-acetate%2520%2528AM432%2529%253A%2520a%2520potent%252C%2520selective%2520prostaglandin%2520D2%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1036%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Smith, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span> </span><span class="NLM_article-title">Characterization of 5-lipoxygenase inhibitors in biochemical and functional in vivo assays</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1332</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=8531100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADyaK28XhvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=1332-1338&author=W.+G.+Smithauthor=A.+F.+Shafferauthor=J.+L.+Currieauthor=J.+M.+Thompsonauthor=S.+Kimauthor=T.+Raoauthor=P.+C.+Isakson&title=Characterization+of+5-lipoxygenase+inhibitors+in+biochemical+and+functional+in+vivo+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 5-lipoxygenase inhibitors in biochemical and function in vivo assays</span></div><div class="casAuthors">Smith, Walter G.; Shaffer, Alex F.; Currie, Jerry L.; Thompson, Janice M.; Kim, Suzanne; Rao, Tadimeti; Isakson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1332-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Several potent and selective inhibitors of 5-lipoxygenase (5-LO) have been recently developed with excellent activity in certain in vivo assays of leukotriene prodn.  The efficacy of three such inhibitors that have been in clin. trials (zileuton, A-78773 and ZD2138) were evaluated in: (1) ex vivo whole blood assay, (2) dermal Arthus reaction, and (3) functional airway response.  In addn., a model of eicosanoid prodn. in rat lung was developed that provides a simple assay for evaluation of the biochem. efficacy of 5-LO inhibitors in the lung.  Bronchoalveolar lavage of rat lung with calcium ionophore A23187 resulted in rapid and robust prodn. of PGE2, 6-keto-PGF1α, thromboxane (TxB2), and leukotriene B4 (LTB4).  Supplementation of lavage fluid with arachidonic acid markedly augmented prodn. of all eicosanoids except LTB4.  All three inhibitors were potent and selective blockers of LTB4 prodn. in the ex vivo whole blood assay and in the dermal Arthus reaction.  In contrast, higher doses of inhibitor were needed to block LTB4 prodn. in the rat lung lavage model than were needed to block ex vivo whole blood LTB4 prodn. when both end points were measured in the same animal.  Similarly, zileuton and A-78733 were less effective in suppressing the functional airway response to antigen in sensitized guinea pigs, whereas both inhibitors were effective in suppressing LTB4 prodn. in the ex vivo whole blood assay.  These results demonstrate that different 5-LO inhibitors have markedly distinct efficacy for inhibition of leukotriene prodn., depending on the animal model.  The results also suggest that the lung is relatively resistant to treatment by the current 5-LO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFSnaUV_BdIrVg90H21EOLACvtfcHk0lh7XKIAt1Tn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVyrsQ%253D%253D&md5=1f14c1313202d6c03e1a3d6294fa6215</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BG.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DCurrie%26aufirst%3DJ.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26atitle%3DCharacterization%2520of%25205-lipoxygenase%2520inhibitors%2520in%2520biochemical%2520and%2520functional%2520in%2520vivo%2520assays%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D1332%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Walsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Validated assays for human cytochrome P450 activities</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2008369&amp;key=10.1124%2Fdmd.32.6.647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2008369&amp;key=15155557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2008369&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=647-660&author=R.+L.+Walskyauthor=R.+S.+Obach&title=Validated+assays+for+human+cytochrome+P450+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Validated assays for human cytochrome P450 activities</span></div><div class="casAuthors">Walsky, Robert L.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-660</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The measurement of the effect of new chem. entities on human cytochrome P 450 marker activities using in vitro experimentation represents an important exptl. approach in drug development.  In vitro drug interaction data can be used in guiding the design of clin. drug interaction studies, or, when no effect is obsd. in vitro, the data can be used in place of an in vivo study to claim that no interaction will occur in vivo.  To make such a claim, it must be assured that the in vitro expts. are performed with abs. confidence in the methods used and data obtained.  To meet this need, 12 semiautomated assays for human P 450 marker substrate activities have been developed and validated using approaches described in the GLP (good lab. practices) as per the code of U.S. Federal Regulations.  The assays that were validated are: phenacetin O-deethylase (CYP1A2), coumarin 7-hydroxylase (CYP2A6), bupropion hydroxylase (CYP2B6), amodiaquine N-deethylase (CYP2C8), diclofenac 4'-hydroxylase and tolbutamide methylhydroxylase (CYP2C9), (S)-mephenytoin 4'-hydroxylase (CYP2C19), dextromethorphan O-demethylase (CYP2D6), chlorzoxazone 6-hydroxylase (CYP2E1), felodipine dehydrogenase, testosterone 6β-hydroxylase, and midazolam 1'-hydroxylase (CYP3A4 and CYP3A5).  High-pressure liq. chromatog.-tandem mass spectrometry, using stable isotope-labeled internal stds., has been applied as the anal. method.  This anal. approach, through its high sensitivity and selectivity, has permitted the use of very low incubation concns. of microsomal protein (0.01-0.2 mg/mL).  Anal. assay accuracy and precision values were excellent.  Enzyme kinetic and inhibition parameters obtained using these methods demonstrated high precision and were within the range of values previously reported in the scientific literature.  These methods should prove useful in the routine assessments of the potential for new drug candidates to elicit pharmacokinetic drug interactions via inhibition of cytochrome P 450 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF04TGeyYbbVg90H21EOLACvtfcHk0lg9qVKItfCYzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D&md5=35532b907c15f1053aa8233dab2ec581</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DValidated%2520assays%2520for%2520human%2520cytochrome%2520P450%2520activities%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D647%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/jm2008369">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57882"></div></div></div></div></div><hr /></hr><p class="last">Information for the characterization of final compounds <b>11b</b>, <b>11d</b>–<b>11z</b>, <b>11bb</b>–<b>11ll</b> and <b>29</b>, <b>30</b>, <b>31a</b>,<b>b</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2008369/suppl_file/jm2008369_si_006.pdf">jm2008369_si_006.pdf (1.31 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2008369&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm2008369%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-23%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2008369" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                610KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c9e28c03193d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
